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Para ser grande, sê inteiro: nada 
        Teu exagera ou exclui. 
Sê todo em cada coisa. Põe quanto és 
        No mínimo que fazes. 
Assim em cada lago a lua toda 
        Brilha, porque alta vive. 
 
 
~ 
 
 
To be great, be whole: nothing that's you  
         Should you exaggerate or exclude.  
In each thing, be all. Give all you are  
         In the least you ever do.  
The whole moon, because it rides so high,  
         Is reflected in each pool. 
 
 
 
 
 
In Odes de Ricardo Reis, 1933 
Fernando Pessoa 
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Abstract 
 
 
Sleeping sickness is a fatal human infectious disease caused by the 
unicellular Trypanosoma brucei parasite. This disease can be divided into two 
stages: an early stage in which parasites are restricted to the bloodstream and 
interstitial spaces of peripheral organs; and a late stage, in which parasites 
invade the central nervous system. The most characteristic symptom of this 
disease is the disruption of the sleep/wake cycle, however disruption of 
temperature and hormone release rhythms are also observed. Since in humans 
these rhythms are regulated by the circadian clock, we hypothesized that the 
parasite could disrupt daily rhythms by deregulating the clock genes that drive 
them. 
Initially we carefully characterized the C57BL/6J mouse model of 
sleeping sickness, to acquire a comprehensive description of the distribution of 
the parasites among the different organs/tissues of the host. From this study 
emerged the surprising conclusion that the so-far neglected adipose tissue is in 
fact a major parasite reservoir. With further RNA sequencing and biochemical 
analyses we discovered the adaptation of the parasite the lipid-rich environment 
of adipose tissue by utilizing the beta-oxidation of fatty acids, a pathway not 
previously shown to be used by this parasite. 
After documenting the distribution of the parasite in the mouse, we 
proceeded to test whether this mouse model mimicked the sleep-wake cycle 
disruptions observed in sleeping sickness patients. Locomotor activity and 
temperature analysis confirmed the sleep disruption and provided new insight 
into how the parasite influences circadian rhythms, by shortening the period the 
host. Characterization of the clock gene expression in infected mice confirmed 
this shortening of the clock period occurred in the organs with highest parasite 
load – the adipose tissue. This period shortening could be reversed upon 
clearance of the parasite with suramin, an anti-Trypanosoma drug commonly 
used in the field. By contrast, infection with the rodent malaria parasite, 
Plasmodium chabaudi, did not affect the period of the host clock suggesting an 
effect specific to T. brucei. In addition, T. brucei co-cultured with fibroblasts in 
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vitro shortened the period of the clock of the fibroblasts suggesting a rather 
direct effect on host cells. 
Finally, we tested whether T. brucei parasites have intrinsic circadian 
rhythms themselves, through analysis of their daily gene expression in vitro, by 
RNA sequencing. We found robust circadian oscillations in gene expression 
that could be entrained by temperature and to a lesser extent by light, in the two 
stages of the parasite life cycle. Such daily rhythmic gene expression lead to 
differences in the parasite population during 24 h, which impacts their 
susceptibility to treatment with suramin at different times of the day. 
 
In summary we identified a new type of host-parasite interaction that may 
underlie one of the most characteristic symptoms of sleeping sickness in 
humans and opens new therapeutic possibilities.  Our work also showed the 
existence of circadian rhythms in T. brucei, suggesting that other pathogens 
may also be able to sense, adapt and anticipate the environment. 
  
  
 
 
4 
Resumo 
 
 
A doença do sono é uma doença infeciosa fatal causada pelo parasita 
Trypanosoma brucei. Esta doença pode ser dividida em dois estados: um 
estado inicial, no qual os parasitas se encontram em circulação no sangue e 
espaços intersticiais de vários órgãos periféricos; e um estado tardio, no qual 
os parasitas invadem o sistema nervoso central. O sintoma mais característico 
desta doença é a desregulação do ciclo de sono. No entanto, a desregulação 
da temperatura corporal e dos níveis rítmicos de hormonas no sangue também 
são observados nos doentes de doença do sono. Em humanos, estes ritmos de 
sono, temperatura e hormonas são regulados pelo ritmo circadiano, o que nos 
levou a formular a hipótese de que os parasitas poderiam desregular os genes 
de ritmo circadiano que criam estes ritmos. 
Inicialmente caracterizámos o modelo de ratinho C57BL/6J de doença 
do sono para uma melhor compreensão da distribuição dos parasitas nos 
diferentes órgãos/tecidos do hospedeiro. Desta caracterização emergiu a 
conclusão surpreendente de que, no estado tardio, o tecido adiposo, até ao 
momento negligenciado, é o tecido com maior número de parasitas infiltrados. 
Com análises de transcriptómica e bioquímicas, descobrimos que o parasita se 
adapta ao ambiente rico em lípidos do tecido adiposo através da utilização da 
via da beta-oxidação de ácidos gordos, uma via nunca anteriormente 
observada neste parasita. 
Após a documentação da distribuição do parasita no hospedeiro, 
testámos se este modelo animal reproduzia as manifestações de desregulação 
de sono observada nos doentes. Através da medição da atividade e 
temperatura corporal dos ratinhos, confirmámos que este modelo recapitula os 
sintomas dos doentes e que tal pode ser em parte pelo facto do parasita 
acelerar o período do ritmo circadiano do hospedeiro. Molecularmente, quando 
analisámos a expressão dos genes de ritmo circadiano, confirmámos a 
observação do período acelerado nos órgãos com maior número de parasitas 
infiltrados. Curiosamente, se eliminarmos os parasitas com o tratamento pelo 
fármaco suramina, o período retorna ao normal. Pelo contrário, quando 
infectámos ratinhos com o agente causador da malária, Plasmodium chabaudi, 
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não observámos diferenças no período dos genes de ritmo circadiano, o que 
sugere que este efeito é específico do parasita T. brucei. Cultivámos ainda T. 
brucei juntamente com fibroblastos e observámos que o período do genes de 
ritmo circadiano dos fibroblastos também acelerou, o que sugere que este 
efeito possa ser direto. 
Por fim, testámos se o parasita T. brucei tem, tal como o ratinho, o seu 
próprio ritmo circadiano, através de análise de transcriptómica. Descobrimos 
oscilações diárias na expressão de vários genes do parasita, que podem ser 
sincronizadas principalmente pela temperatura, mas também pela luz exterior. 
Estas oscilações na expressão génica induzem diferenças na população dos 
parasitas a diferentes horas do dia, o que tem impacto na susceptibilidade 
deste ao tratamento com suramina, dependente da hora do dia. 
  
Em conjunto, estes resultados abrem novas vias de investigação no 
estudo do parasita responsável pela doença do sono, bem como sugerem a 
existência de ritmos circadianos nos microrganismos patogénicos em si. 
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CHAPTER I – Introduction 
 
 
1. Sleeping sickness 
1.1. Clinical features and treatment  
 
Human African African trypanosomiasis (HAT), best known as sleeping 
sickness, is a fatal human infectious disease caused by the unicellular 
Trypanosoma brucei parasite. This disease can be included in the group of 
African trypanosomiasis, which comprises a variety of human and animal 
pathologies caused by different Trypanosoma species transmitted through the 
bite of a blood-feeding tsetse fly (1). It is endemic mainly in sub-Saharan Africa, 
where the tsetse fly vector (Glossina spp.) finds optimal environmental 
conditions to survive (2).  
Only Trypanosoma brucei spp. are pathogenic to humans, causing 
sleeping sickness: T. b. gambiense and T. b. rhodesiense - which are 
widespread in western and eastern Africa, respectively, where they cause 
approximately 97% and 3% of current cases (3). Both species lead to coma and 
death if patients are left untreated. A third T. brucei subspecies, T. b. brucei is 
non-infective to humans, but parasitizes domestic and wild animals, causing a 
disease called Nagana, which severely hampers cattle production in one-third 
of the African continent (2). The difference between these species is that T. b. 
brucei cannot escape an innate immune response that humans have: 
trypanosome lytic factor (TLF) serum complexes. TLF-1 and TLF-2 contain 
haptoglobin related protein (HPR) and apolipoprotein L1 (APOL1), which enter 
via the haptoglobin–hemoglobin receptor of the trypanosome (TbHpHbR) killing 
the parasite (4). Both human infective trypanosomes escape this TLF lytic 
mechanism: T.b. rhodesiense expresses serum resistance-associated (SRA) 
protein, which neutralizes the lytic activity of APOL1 (5); and T.b. gambiense 
expresses Trypanosoma gambiense-specific glycoprotein (TgsGP), which 
stiffens endo/lysosomal membranes, presumably blocking the internalization of 
APOL1 (6). Despite this difference T. b. brucei is very close to the human 
Introduction 
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infective subspecies, making it a widely used experimental model of HAT in 
murine and rat models (7, 8). 
 
Clinically, sleeping sickness can be divided into two stages. In the early 
stage, parasites can be found in the bloodstream and interstitial spaces of 
several organs, after which they actively invade the central nervous system, 
starting the late stage. T. b. gambiense infection is chronic, with estimated 
average duration around 3 years, which is evenly divided between the two 
stages (9). T. b. rhodesiense disease is usually acute, and death occurs within 
weeks to months (10) likely due to this parasite being less adapted to human 
beings, affecting mostly animals (livestock and wildlife), which act as dangerous 
reservoirs of the parasite (2).  
Patients experience a myriad of symptoms, from neuropsychiatric, motor 
and weight loss disturbances, among others (2, 11). The leading signs and 
symptoms of the early stage are chronic and intermittent fever, headache, 
pruritus, lymphadenopathy, and, to a lesser extent, hepatosplenomegaly. In the 
late stage, sleep disturbances and neuropsychiatric disorders dominate the 
clinical presentation. This common sleep disruption experienced by patients 
gives the disease its common name of ‘sleeping sickness’. However, studies in 
which patients sleep state was measured have shown that, unlike a 
hypersomnia, the total amount of time spent asleep by these patients is similar 
to healthy individuals, instead it is the sleep structure and the timing at which 
sleep occurs that are affected (12).  
 
The resurgence of sleeping sickness epidemics in the 1980’s and 1990’s 
alerted the international community for the risks of neglecting this disease. 
Since then, an international coordinated effort led by the World Health 
Organization reinforced control and surveillance programs which led to a drop 
in sleeping sickness cases since 2009 to less than 10,000 new cases per year 
(2). Nevertheless, it is believed that a substantial number of cases remain 
unreported since the disease is endemic in rural areas and more recent 
estimates predict that 70 million people in tropical Africa are at risk of infection 
(2). Although, sleeping sickness is lethal if left untreated; however sporadic 
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cases of natural progression to asymptomatic carriage or even apparent 
spontaneous resolution of the infection have been reported for gambiense 
infection, resembling the trypanotolerance phenomena described for some 
African cattle species (13, 14). 
As a whole, African trypanosomiasis represents a serious health and 
socio-economic burden. Besides the severe life threat posed by sleeping 
sickness to humans, animal African trypanosomiasis, or Nagana causes around 
3 million cattle deaths and total annual losses of US $4.75 billion. Nagana is an 
incredibly heavy burden particularly in rural areas where livestock production is 
the main livelihood, perpetrating underdevelopment and poverty in these 
regions (15).  
In humans, a major obstacle for eradication of sleeping sickness is the 
insufficiency of the existing treatments. No prophylactic treatment or vaccine is 
available and the drugs used to treat early and late stage sleeping sickness are 
largely not accessible orally, often very toxic, and sometimes ineffective (16). 
The first-line of treatment for early stage T. b. gambiense is pentamidine, which 
has been used since 1940 and is usually administered intramuscularly 
(sometimes intravenously) (11). Pentamidine is usually effective but has the 
potential complications of hyperglycemia or hypoglycemia, hypotension, and 
gastrointestinal features (17). Early stage of T. b. rhodesiense infection is 
treated with intravenous suramin, used since the early 1920s and, although 
usually effective, especially when given early in the disease, can result in 
potential complications such as renal failure, skin lesions, anaphylactic shock, 
bone marrow toxicity, and neurological complications such as peripheral 
neuropathy (17) (Table 1).  
 
Table 1. Treatment used for sleeping sickness 
 First-line treatment Second-line treatment 
Early stage 
T. b. gambiense Pentamidine Suramin 
T. b. rhodesiense Suramin Pentamidine 
Late stage 
T. b. gambiense 
Eflornithine + 
nifurtimax (oral) 
Melarsoprol 
T. b. rhodesiense Melarsoprol Non-available 
 
Introduction 
 
 
 
13 
 
Treating late stage sleeping sickness is more complicated because the 
drugs that can cross the blood brain barrier (BBB) are more toxic. The effective 
drug for treating late stage T. b. rhodesiense sleeping sickness is the arsenical 
melarsoprol, which acts on trypanothione, a parasite molecule that maintains an 
intracellular reducing environment (18). Melarsoprol injections are extremely 
painful and this drug is extremely toxic. It induces post-treatment reactive 
encephalopathy in 10% of the patients, half of whom die, leading to an overall 
mortality from treatment of about 5% (19). Although this drug is also effective for 
late stage T. b. gambiense infection, it is no longer used due to its toxicity. 
Instead, eflornithine, an ornithine decarboxylase inhibitor, is the treatment used 
for late stage T. b. gambiense since 1981 (17). Unfortunately, eflornithine is 
ineffective against T. b. rhodesiense, treatment is still intravenous, patients 
suffer from side effects (bone marrow toxicity, alopecia, seizures, and 
gastrointestinal deregulation) (17), and there is the potential for drug resistance 
to arise through loss of the putative amino acid transporter TbAAT6 (20). The 
standard procedure in case of successful treatment requires a regular follow-up 
with repeated lumbar punctures for 1 year, after which patients are considered 
cured if the cerebrospinal fluid (CSF) remains clear - no parasites nor more than 
5 lymphocytes/mm3.  
While some new promising drugs are in the pipeline (e.g. fexinidazole 
and oxaborole SCYX-7158) (http://www.dndi.org) (16), investment in the search 
for more effective treatments has been set as a priority. That, together with 
continued surveillance, improved diagnostics and vector control policies will be 
vital to meet the World Health Organization’s target to eliminate sleeping 
sickness as a public health issue by 2020 (21). 
 
 
1.2. Sleep disruption and other physiological parameters 
 
The sleep/wake cycle in humans is remarkably stable and consolidated. 
As diurnal animals, humans are mostly active during the day period and sleep 
~6-8 hours at night. Sleep starts with non-REM (NREM – non rapid eye 
movement) sleep or slow wave sleep (SWS) followed by rapid eye movement 
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(REM) sleep (Fig. 1B – healthy individual). These two types of sleep are defined 
by electrophysiological signs detected in humans by a combination of 
electroencephalography (EEG, which records cortical activity), 
electrooculography (records eye movement) and electromyography (records 
muscle tone). The measurement of such electrophysiological parameters is 
collectively termed polysomnography (22). 
In sleeping sickness patients, sleep abnormalities include deregulation of 
the sleep/wake cycle, when patients experience periods of nocturnal insomnia 
and daytime sleepiness; episodes of uncontrollable sleep and fragmentation of 
the normal sleep structure (12, 23). Sleep/wake cycle disruption, meaning the 
time at which patients sleep have been both documented by EEG but also by 
actigraphy, with wrist-worn watches allowing to measure rest/activity pattern in 
humans (24) (Fig. 1). The timing at which patients sleep is the most remarkable 
sign of this disease, the quality of their sleep is altered. Both T. b. gambiense 
and T. b. rhodesiense patients show particular poor sleep efficiency with 
frequent awakenings and arousals at night and recurrent short naps during the 
day (25, 26).  
 
 
 
Figure 1. Activity and sleep disruption in sleeping sickness patients. (A) Activity 
record of both a healthy individual and a sleeping sickness patient, measured by using 
activity watches. The same patient had his/her activity measured both before and after 
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pentamidine treatment, in which is clear the reversal of the abnormal activity profile. 
(adapted from (24)). (B) EEG recording of a healthy individual and a sleeping sickness 
patient. Sleeping sickness patient record shows both increased sleep during the 
daytime and transitions from wake to REM state, highlighted with orange stars 
(adapted from (27)). (C) EEG recording of a sleeping sickness patient before and after 
the first treatment session, showing a clear reversal of the sleeping time to the 
nighttime, upon treatment (adapted from (28)). 
 
SOREM (sleep onset rapid eye movement) episodes are characteristic of 
narcolepsy. SOREM episodes mean a sudden abnormal transition to REM 
sleep episodes while the person is awake or after a very short NREM sleep 
period, thus disrupting wakefulness or the NREM–REM cycle during sleep (29). 
In sleeping sickness patients the alterations of the internal sleep structure 
include SOREM episodes (Fig. 1 – orange star), which may appear earlier than 
the sleep/wake alterations. At least the Gambian form of HAT shares other 
features, besides SOREM episodes, with narcolepsy, such as excessive 
daytime sleepiness, and sleep fragmentation (30, 31). This observation was 
reproduced in a rat model of sleeping sickness (32-34). 
Narcoleptic patients have low or undetectable CSF levels of orexin (also 
known as hypocretin) due to the loss of the orexin neurons in the lateral 
hypothalamus (35). Intriguingly, the CSF orexin levels measured in patients 
affected by T. b. gambiense HAT are significantly lower than in control cases. 
Although not as low as narcoleptic patients, the low CSF orexin concentrations 
in sleeping sickness patients still indicates a dysfunction of this hypothalamic 
peptide may be involved in sleeping sickness (29). Lower orexin levels than 
control were also observed in rat models of sleeping sickness (36). 
 
Interestingly, prostaglandin D2 (PGD2), which induces NREM sleep 
when injected into the ventricle system (37), is significantly increased in CSF of 
late stage sleeping sickness patients (38). Trypanosomes can themselves 
produce PGD2 (39) that they also use for cell density regulation. Further studies 
are needed to assess if this contributes to the physiological deregulation 
observed in sleeping sickness patients, since these patients do not experience 
overall increase of NREM, but perhaps the timing of PGD2 release is disrupted. 
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 Humans and other animals, in addition to cyclic sleep/wake cycle, also 
have daily secretion of hormones and daily temperature fluctuations, with a 
high/low temperature fluctuation during day/night, respectively. 
Similar to the sleep/wake cycle disruption observed in sleeping sickness, 
daily rhythms of hormonal secretion are also affected in T. b. gambiense HAT 
patients. However this is not the case for all hormones: secretion of the pineal 
hormone melatonin is maintained in HAT patients in the encephalitic stage, 
though being secreted earlier than expected (phase advanced) (40). The 
cortisol, prolactin plasma hormone levels and the renin activity (an index of 
release of renin, a key enzyme in the renin–angiotensin system) are severely 
disrupted in HAT patients at an advanced stage of disease (41, 42).  
The studies available on daily temperature regulation in sleeping 
sickness patients seem to have controversial results. In healthy humans, there 
is a subtle fluctuation in body temperature, being lower during the nighttime., 
but overall body temperature regulation appears to be preserved (40). However, 
in rat models, core temperature differences of morning and evening are 
reduced in some of the animals (33, 43), indicating disturbances in the daily 
regulation of body temperature rhythm, as well as sudden hypothermia (44).  
 
It is notable that sleep structure and sleep/wake cycle disruption in 
sleeping sickness patients can both be reversed upon treatment (45) (Fig. 1A 
and 1C). In addition, based upon autopsy studies, despite strong inflammatory 
response and microglia activation, there does not seem to be massive neuronal 
damage (46). These two observations suggest that the presence of the parasite 
itself might be responsible for the symptoms observed in sleeping sickness 
patients. 
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2. Trypanosoma brucei 
2.1. Evolutionary origins 
 
Deciphering the evolution of the first eukaryotic lineages is an enigma. 
Many groups of protists have claimed phylogenetic positioning at the early 
branches of the eukaryotic tree of life, diverging substantially from the fungi, 
plant and animal branches. Despite their apparent simplicity, among protists 
there is tremendous diversification in lifestyles and unique biological features. 
The supergroup Excavata, phylum Euglenozoa to which the parasite 
Trypanosoma brucei belongs is a good example. Trypanosomes such as T. 
brucei are evolutionary highly distant organisms from the well-known eukaryotic 
groups of animals, fungi and plants (47). Within Euglenozoa, trypanosomes 
belong to a very particular clade, the Kinetoplastida, distinct by the presence of 
special mitochondrial DNA, the kinetoplast or kinetoplast DNA (kDNA). This is a 
large disc-shaped mass consisting of an extensive network of interlocked 
circular DNA molecules, located adjacent to the basal body at the base of the 
flagellum (48) (Fig. 2).  
Trypanosomatida, such as T. brucei, offer a rare opportunity to study the 
origin and evolution of parasitism, because trypanosomatids were the only 
kinetoplastids acquiring an obligatory parasitic lifestyle (49). Trypanosoma and 
Leishmania genus contain species that spend their life between a mammalian 
host and insect vector and might either develop intracellularly in host cells at 
some stage of its life cycle, such as T. cruzi and Leishmania spp., or, as in the 
case of T. brucei, live exclusively as an extracellular parasite. 
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Figure 2. Life cycle of Trypanosoma brucei. In the bloodstream of the mammalian 
host, parasites exist as a polymorphic population of bloodstream forms (BSF) 
consisting of dividing (circle gray arrows) slender forms and cell cycle arrested stumpy 
forms. In the tsetse fly vector, after entering the midgut, stumpy forms differentiate to 
the procyclic forms (PCF). In the salivary glands there is the final differentiation into the 
infective metacyclic forms, which are injected during the next blood meal of the fly into 
the mammalian host. 
 
 
African trypanosomes, such as T. brucei, have a mechanism of antigenic 
variation of their protective coat of variant surface glycoproteins (VSGs), 
providing an extremely efficient adaptation to extracellular life inside its host. 
The long history of research on T. brucei has made it a great model system to 
study evolution, disease mechanism and even basic eukaryotic biology: it has 
now a small fully sequenced 35 Mb genome (50), simple genetic manipulation 
tools available and an RNA interference (RNAi) system (51). Indeed, various 
discoveries were primarily made in cultured T. brucei such as RNA editing (52), 
trans-splicing (53) and glycosyl-phosphatidylinositol (GPI) anchors (54).  
 
 
2.2. A life of adaptations: from vector to host and back 
 
Trypanosoma brucei is a heteroxenous parasite, i.e., it requires more 
than one obligatory host to complete its life cycle: a mammalian host and the 
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blood-feeding tsetse fly vector. Mammalian infection starts with a bite of an 
infected tsetse that inoculates the infective cell cycle arrested metacyclic stage 
into the mammal bloodstream and draining lymphatics. T. brucei then 
differentiates to a long slender bloodstream form (BSF) that divides asexually 
by binary fission. In the mammal, parasites live extracellularly in the 
bloodstream or in the extravascular fluids and interstitial spaces of organs and 
tissues, such as the brain, heart and lungs (55). In the bloodstream, at high 
parasite density, a yet unidentified parasite-released factor induces 
differentiation from long slender forms to short stumpy BSF, passing through an 
intermediate form (56). These stumpy forms are cell cycle arrested and the only 
life cycle stage transmissible to the tsetse upon a blood meal of the fly (Fig. 2).  
Once in the fly midgut, the stumpy forms differentiate into procyclic forms 
(PCF), which re-enter cell cycle, actively multiplying and colonizing the fly gut. 
PCF undergo a complex differentiation process while migrating to the fly 
proventriculus. During this process each PCF divides asymmetrically into one 
long and one short epimastigote; the long epimastigotes arrest their 
development while the short epimastigotes migrate to the tsetse salivary 
glands. Here, they attach to epithelial cells and start to multiply. Attached 
epimastigotes are the only life cycle stage known to perform meiosis (57). 
Finally, in the salivary glands, epimastigotes differentiate to metacyclic forms, 
ready to be transmitted back to the mammalian host by a tsetse bite (Fig. 2).  
 
Throughout its life cycle, T. brucei exhibits a series of specific changes 
that allow it to adapt to completely different environments it encounters within 
the mammal and the fly. The process of differentiating from one life cycle stage 
to the other is complex and implicates dramatic changes in cell morphology, 
metabolism, cell cycle and cell surface proteins, accompanied by a strong 
reprogramming in gene expression (58).  
Recent studies uncovered the genome-wide changes in gene expression 
between these BSF and PCF, identifying 6–40 % of genes differentially 
expressed between them (depending on the method used) (59-62). This 
highlights the parasite capacity of rapidly remodeling its gene expression 
pattern upon sensing the environmental changes. The most striking change the 
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parasite undergoes is the cyclic full renovation its surface protein composition: i) 
inside the fly, PCF are coated with highly acidic and repetitive proteins - the 
procyclins (GPEET and EP procyclins) (63, 64); ii) these are then exchanged for 
a coat of brucei alanine-rich protein (BARP) coat in epimastigotes (65); iii) 
differentiation into the metacyclic stage replaces BARP for a dense coat of 
metacyclic variant surface glycoproteins (MVSGs); iv) in the mammal, a similar 
type of VSG is maintained as the major surface protein in the BSF slender and 
stumpy forms of T. brucei (66); v) finally, when stumpy forms differentiate to 
PCF, the VSG coat is shed and replaced by procyclins (38).  
Over the years, researchers documented T. brucei dramatic changes in 
adaptation to different environments, from the mammalian host bloodstream to 
the fly midgut. Although, it is well established that the parasites in the 
mammalian host are not restricted to the bloodstream, but in fact infiltrate 
different tissues, it remains unknown whether parasites adapt to these new 
environments.    
 
 
2.3. Life inside the mammalian host 
 
Inside the mammalian host parasites enter the bloodstream where they 
must face a strong immune response. As extracellular parasites, they cannot 
hide from the highly resourceful immune system of the host; instead they 
developed ways to deceive it.  
The dense VSG coat of T. brucei acts as protective barrier against the 
innate and adaptive immune system of the mammal. It protects parasites from 
both recognition and lysis by the alternative complement pathway (67) and from 
anti-VSG antibody-mediated phagocytosis (14), in part by internalization of anti-
VSG antibody complexes from the parasite surface via high rates of 
endocytosis when recycling the existent VSG (68-70) and by their release due 
to hydrodynamic forces generated by its flagellar movement (71). This constant 
VSG shedding is also actively triggered by the parasite, led by a trypanosome 
membrane-associated phospholipase C (GPI-PLC), which cleaves the GPI 
anchor. Puzzlingly, the substantial release of soluble VSG (sVSG) is sufficient 
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to activate macrophages and Th1 cell response (which may be a distractive 
tactic), but also downregulate the production of trypanocidal factors such as 
nitric oxide (NO) and tumor necrosis factor alpha (TNF-α) at later time points of 
infection (72). Finally, the densely packed VSG coat probably acts as a 
protective cover for other cell-surface molecules from immune recognition (73, 
74). Although all these phenomena contribute to deceive the immune system, 
the most sophisticated mechanism this parasite has for immune evasion is 
called antigenic variation. As anti-VSG antibodies can eventually eliminate the 
parasite population, a few parasites have switched their VSG coat to a new VSG 
that have not yet been recognized by the immune system. As a result, these 
parasites with new VSG will successfully replicate and replace the previous 
parasite population that is being targeted by the antibodies. The continuous 
clearing of the recognized VSG followed by the emergence of newly switched 
variants leads to the characteristic periodic waves of parasitemia described for the 
first time in humans more than a century ago (75) (Fig. 3). 
 
 
 
Figure 3. Antigenic variation: a mechanism to evade the immune system. A 
population of parasites expressing the same variant surface glycoprotein (VSG) 
dominates (blue curve). This population will be targeted by the antibody response but a 
second population expressing a new VSG will proliferate (yellow line), and the cycle 
continues. The outcome is the purple line of total parasite load, representing the waves 
of parasitemia characteristic of this infection. 
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 In the mammalian host the parasites initially reach the blood, however 
they are not restricted to the bloodstream. Evidence from patient autopsies and 
from animal models allowed the tracking of parasites over the course of 
infection and identified them in the interstitial spaces of multiple tissues/organs. 
 The parasite entry into the brain has been extensively studied, as it 
marks the late stage of this disease and consequently the type of treatment to 
administer. Two possible entry points exist: the blood-brain barrier (BBB) and 
the blood-csf barrier (BCB). Data have been presented for the use of both 
pathways (76, 77), although it is believed that trypanosomes initially cross the 
BCB, as their massive accumulation in the choroid plexus area is obvious 
earlier in infection, whereas presence in the brain parenchyma is only 
sporadically observed. This preferential crossing at different locations is likely 
due to a more permeable anatomy of the choroid plexus barrier, BCB (78). The 
BBB is formed by endothelial cells connected by tight junctions, which on the 
brain side of the vessel are also enfolded by astrocyte feet, forming an 
additional cellular layer (79, 80). In contrast, the BCB does not contain the 
astrocyte layer and consists of two spatially isolated cellular barriers: i) 
fenestrated endothelial cells line out the capillaries of the choroid plexus and 
attach to a basal lamina; ii) epithelial cells form the surface of the choroid (81).  
Later during infection, however, trypanosomes and white blood cells 
pass across the BBB into the brain parenchyma. Whether this process happens 
via diapedesis (as lymphocytes cross, by adhesion to endothelial cells and 
actively crossing between them) (82) or through extravasation due to BBB 
leakiness (83, 84), is still controversial. However, no matter which of these 
processes are responsible for the penetration in the brain parenchyma, it seems 
that it happens during later time points of infection when high levels of interferon 
gamma (IFN-γ) are detected, which seems to facilitate the penetration, since 
IFN-γ-/- and IFN-γ receptor -/- mice have fewer parasites in the brain (82).  
In human infections the late stage symptoms, which correlate with 
appearance of parasites in brain, has a latency of at least a few weeks. In rats 
or mouse models, similarly trypanosomes can be detected in the brain ~20 days 
post-infection (77, 85). Controversially, one recent study showed that with high 
inoculum, parasites could be detected in the brain within 24 h of infection (86).  
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The heart is another organ with infiltrated trypanosomes. More 
specifically parasites can be found on the endocardial, epicardial side, valves 
and in the lymphatic system draining the heart, the latter being particularly 
evident in late infection (87). In T. b. brucei-infected dogs parasites were also 
identified in the heart lymphatic system (88). Moreover, cardiac involvement in 
sleeping sickness has been reported, as recently demonstrated by 
electrocardiography (ECG) alterations, and appears early in the course of the 
disease in humans (89). 
 
Many other organs have few infiltrated parasites since the early stages of 
infection. In addition to the heart, parasites also infiltrate the lung, spleen, liver, 
kidney, testis and epididymis (90-92). However not all these organs show viable 
parasites, in cases such as the liver and the spleen they are mostly found 
degraded or inside phagocytic cells (93). Recent studies with bioluminescent 
parasites confirmed the general distribution of parasites reported previously 
with histological studies (55). Prior to the work presented in this dissertation, 
only indirect evidence has described the presence of parasites in the adipose 
tissue, as massive infiltration of inflammatory cells in this tissue in a model of T. 
b. gambiense (90). 
 
 Despite these studies characterizing parasite presence in organs/tissues 
other than the bloodstream, brain and heart, the correlation between anatomical 
changes, clinical symptoms and pathogenesis remains largely unknown.  
 
 
2.4. Genome organization 
 
Trypanosoma brucei is a diploid organism with a nuclear genome of 
approximately 35 Mb/haploid DNA content, which contain ~10,000 genes. 
Despite its small genome, the karyotype in T. brucei is remarkable, consisting of 
more than 120 chromosomes divided into three different classes according to 
their size: 11 megabase chromosomes (1-6 Mb), 1-5 intermediate 
chromosomes (200-900 kb) and ~100 minichromosomes (30-150 kb) (50, 94). 
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The core of minichromosomes consists mostly of repetitive palindromes of 177-
bp repeats. Intermediate chromosome structure is not entirely known but it 
shares with minichromosomes a large core of 177-bp repeats (95). Some 
strains of T. brucei also contain nuclear extrachromosomal circular DNAs, 
termed NlaIII repeat-elements of unknown function (96).  
About 15% of the total DNA in trypanosomes corresponds to the kDNA 
which consists on a intertwined network of thousands of double-stranded 
circular DNA molecules which include large maxicircles (~23 kb) and smaller 
minicircles (~1 kb) (97). Similarly to mitochondrial DNA in other eukaryotes, 
maxicircles encode ribosomal RNA (rRNA) genes plus genes mostly coding for 
subunits of the mitochondrial membrane complexes involved in oxidative 
phosphorylation.  
 
2.5. Gene expression in T. brucei  
 
In trypanosomatids large clusters of unrelated genes are co-transcribed 
by RNA polymerase II (Pol II) from the same coding strand as a single 
polycistronic unit (PCU) (50). Typically, the regions between PCUs are strand-
switch regions (SSRs) because they separate PCUs with opposite coding 
strands. Experimental evidence supports that Pol II transcription initiates 
bidirectionally at divergent SSRs and terminates at convergent SSRs (98-100). 
Pol II transcription can also initiate internally within transcripton units and at 
other non-SSRs, for instance where a change of RNA polymerase type likely 
occurs (98). Regions between Pol II transcription units often contain transfer 
RNAs (tRNAs) and other RNA polymerase III (Pol III)-transcribed small RNAs. 
Besides, in T. brucei the Pol I-transcribed rDNA units and procyclin loci also lie 
between Pol II transcription units (TriTrypDB 9.0) (Fig. 4).  
Remarkably, T. brucei Pol I is the only known multifunctional Pol I among 
eukaryotes. Besides transcribing the rDNA unit (18S, 5.8S and 28S-like genes) 
it also transcribes three other protein-coding loci: the VSG bloodstream 
expression sites (BESs), the procyclin loci and the MVSG expression sites 
(MESs) (101, 102). Only ~10 rDNA transcription units are predicted in T. brucei, 
a smaller number compared with the hundreds estimated for other eukaryotes. 
Pol I transcription of rDNA genes is the most active transcription in a eukaryotic 
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cell, generally accounting for over 50% of the total transcription activity. This is 
also achieved with high transcription initiation rates by ~150 Pol I enzymes 
simultaneously transcribing an rDNA gene (103). Evolutionarily, it seems likely 
that in order to be able to generate ~107 VSG surface copies from a single 
gene, Pol I was the selected RNA polymerase to maintain the cell surface 
protein production. 
T. brucei Pol II transcribes most mRNAs, the spliced leader (SL) RNA 
gene required for mRNA processing by trans-splicing and small nucleolar RNAs 
(snoRNAs) (104, 105). No Pol II promoters or associated transcription factors 
have been found except for the SL RNA gene promoter (106). Chromatin 
immunoprecipitation (ChIP) sequencing revealed epigenetic marks associate 
with putative Pol II transcription start sites (TSSs) and transcription termination 
sites (TTSs): H2A.Z, H2B.V acetylated H4K10, tri-methylated H3K4 and a 
putative acetyl-binding protein, the bromodomain factor 3 (TbBDF3) are 
enriched at predicted transcription start sites (TSSs) whereas H3.V and H4.V 
preferentially locate at potential TTSs (107, 108) (Fig. 4). 
Pol III transcribes tRNAs, 5S rRNA, small nuclear RNAs (snRNAs), 
similarly to the other eukaryotes (109).  
 
 
Figure 4. Transcription units and flanking epigenetic signals in T. brucei. Most of 
T. brucei genome is organized in polycistronic transcription units (PCUs) transcribed by 
Pol II. Neighboring PCUs are usually separated by strand-switch regions (SSR). Pol II 
transcription initiates at divergent SSRs and terminates at convergent SSRs. 
Transcription might also initiate at non-SSRs. Arrows indicate direction of transcription. 
Regions in-between Pol II units often contain Pol I-transcribed rDNA units and 
procyclin loci, and Pol III-transcribed genes such as tRNAs. Predicted transcription 
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start sites (TSS) are enriched for acetylated H4K10 (H4K10ac), tri-methylated H3K4 
(H3K4me3), H2A.Z, H2B.V and TbBDF3. Putative Pol II transcription termination sites 
(TTSs) are enriched for H3.V and H4.V. Trans-splicing and polyadenylation events 
occur simultaneously to transcription, splicing of the pre-mRNA with the addition of a 
5’-Splice leader cap (SL) and a poly(A) tail. 
 
 
One of the most curious distinct characteristics of kinetoplastids is their 
lack of transcriptional regulation, a conserved feature among most eukaryotes. 
Instead genes are transcribed as long polycistrons of 10–100 genes (110) (Fig. 
4). It is believed that all polycistronic precursor RNAs are transcribed at roughly 
the same rate; consequently, the regulation of gene expression occurs entirely 
post-transcriptionally. Within the same polycistronic unit the steady-state mRNA 
may vary 50-fold (37), with the regulation of transcript levels achieved by post-
transcriptional regulation. There are few known exception to this: the genes 
coding for the very abundant T. brucei cell surface proteins procyclin and VSG 
and a few associated genes which are transcribed by Pol I from a well-
characterized promoter (102). The unusual genome organization may have 
evolved to allow kinetoplastids to have a very gene-dense genome (even 
introns are almost absent) and reduce cell cycle time. However, how the post-
transcriptional regulation in T. brucei occurs remains largely a mystery. One of 
the few known cases is the upregulation of phosphoglycerate kinase B gene 
upon differentiation of BSF to PCF, which results from the control of mRNA half-
live mediated by U-rich regulatory elements at the 3’UTR that destabilize 
mRNAs in BSF (111). Inroads are being made with genome-wide approaches, 
providing a comprehensive view on the dominant post-transcriptional 
mechanisms. RNA-seq studies have gathered evidence for the importance of 
alternative splicing and polyadenylation (59, 60, 98) and control of mRNA half-
live and decay rates (112) in regulation of mRNA levels. Widespread RNA 
translation control, assessed by ribosome profiling in BSF and PCF, add to the 
list of post-transcription regulation mechanisms in T. brucei (113, 114). Finally, 
trans-acting RNA-binding proteins have been emerging as crucial players in 
remodeling gene expression patterns during the T. brucei life cycle: 
overexpression of a single T. brucei RNA-binding protein (RBP), TbRBP6, is 
sufficient to trigger the entire differentiation pathway of BSF to metacyclic 
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parasites in axenic cultures (115, 116). In addition, several other studies have 
identified subsets of target mRNAs potentially regulated by RBPs throughout 
the life cycle development in T. brucei (117, 118).  
 
In T. brucei, the mRNA maturation process is also unusually different 
from other eukaryotes. Polycistronic precursor transcripts are processed into 
mature monocistronic mRNAs via trans-splicing, which adds a m7G-capped 39-
nucleotide Spliced Leader RNA to the 5’ untranslated region (5’UTR), and by 
polyadenylation of the 3’ untranslated region (3’UTR) (53). These two events – 
trans-splicing and polyadenylation – occur during transcription itself, while 
polyadenylating the upstream mRNA trans-splicing of the downstream occurs 
(119) (Fig. 4). The common mRNA maturation process of eukaryotes consists 
of cis-splicing, which excises non-coding introns from the pre-mRNAs. In T. 
brucei, however, cis-spliced introns seem to be restricted to only two genes, the 
poly(A) polymerase (120) and a putative RNA helicase gene (50, 60).  
 
 
3. Circadian rhythms 
 
Circadian rhythms control a variety of biological processes in numerous 
organisms, ranging from bacteria to humans. These rhythms are an intrinsic 
way to count the time that provides the capacity to anticipate the rhythmic daily 
changes in our environment. Perhaps the most obvious function regulated by 
circadian rhythms is the daily sleep and wake cycle in animals. However, many 
other physiological processes are regulated by circadian rhythms, including 
body temperature, feeding behavior, hormone secretion, glucose homeostasis, 
and cell cycle progression. When circadian cycles are disrupted, either by 
genetic or environmental insults (e.g. jet lag and alternating shift work), 
disorders of diverse physiological processes can occur, spanning from obesity 
to cancer (121). 
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3.1. An evolutionary advantage among kingdoms 
 
The regular 24 h rotation of the earth has led to the evolution of circadian 
oscillators in virtually all life forms, from prokaryotes to eukaryotes. Geological 
records suggest that non-heterocystous cyanobacteria represent one of the 
most ancient cellular life forms on Earth, first appearing perhaps more than 3.8 
billion years ago. These cyanobacteria have circadian oscillators which 
indicates circadian clocks are a truly ancient biological timing system (122). 
What selective pressures would these ancient organisms experience? 
For cyanobacteria the pressure is likely to have been the need of having 
temporally separated the processes of oxygenic photosynthesis and nitrogen 
fixation. For all organisms, the direct effects of ultraviolet radiation and photo-
oxidative damage have given rise to the “escape from UV” hypothesis, in which 
the restriction of S phase (DNA synthesis) of the cell cycle to nighttime would 
have strong selective value (123). But in general, having a clock provides an 
organism with a predictive mechanism to tune its internal physiology to the 
external world, and several studies have shown that a robust internal clock 
offers a competitive advantage. A plant, instead of starting to transcribe and 
translate all the proteins required for the photosynthetic process upon sensing 
the sun in the early morning, would, with a circadian clock, benefit from having 
them ready at the end of the night anticipating the first sun rays. And this is in 
fact what having a circadian clock allows, which has obvious beneficial 
consequences. When wild-type plants (circadian rhythmicity period of ~24 h) 
are compared with mutant plants whose circadian rhythm period is long (>24 h) 
or short (<24 h), plants with a clock period matched to the environment grow 
faster, contain more chlorophyll, fix more carbon and survive better than plants 
with circadian periods differing from their environment (119). Similar 
observations were made in cyanobacteria, which grow faster than mutant 
cyanobacteria whose circadian clock period differs from 24 h (124, 125). 
 
So, how can organisms count the time and anticipate the rhythmic 
changes of their environment?  
Organisms have cell autonomous circadian oscillators that include 
positive and negative elements, which together form feedback loops. In most 
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eukaryote organisms, positive elements of the loop are transcription factors that 
activate the transcription of genes encoding the negative elements (Fig. 5). As a 
result, the concentrations of the negative elements rise allowing them to interact 
with the positive elements, inhibiting their activity. This inhibition decreases 
transcription rates of negative element genes. Phosphorylation-induced decay 
of the negative elements decreases their concentrations, which leads to 
reactivation of the positive elements, allowing the cycle to start again. These 
positive and negative elements are the so-called ‘clock genes’ that together 
keep the time keeping mechanism of the core loop. However, it is now known 
that this is a very complex process with more loops interlocked, important for 
maintaining the stability and robustness of the oscillator. All of these events 
impose time delays within the core feedback loop, such that the molecular cycle 
takes ~24 hours (126).  
Although a similar timekeeping mechanism, involving positive and 
negative elements is present across all kingdoms of life, the key regulatory 
elements that drive this are different and very little conserved. This suggests 
that the appearance of circadian clocks occurred in more than one event during 
evolution. Animals such as drosophila and mice, which diverged from a 
common ancestor some 600–700 million years ago, share many of the genes 
comprising the circadian clock. Although the general feedback-loop mechanism 
is similar among these species, there are differences in specific functions 
between orthologues for several of the components. Furthermore, gene 
duplication has led to increased complexity among vertebrate clock genes (126) 
(Fig. 5). 
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Figure 5. Molecular circadian clock in model organisms. Positive and negative 
regulators of the core clock of different organism are represented. In blue are the clock 
proteins that are not conserved in mammals, however sharing similar feedback loop 
mechanism. 
 
 
Because the targets of the positive elements of the timekeeping 
mechanism are not restricted to the negative elements, but include other genes 
involved in various cellular pathways, daily rhythms are observed in genes 
involved in multiple pathways resulting rhythmic in physiological functions 
(Table 2). 
 
Table 2. Examples of processes regulated by circadian clock 
Organism Model system 
Master clock tissue / 
oscillator 
Processes regulated by 
pacemaker 
Cyanobacteria 
Synechoccus 
elongatus 
Kai periodosome 
Cell division, photosynthesis, 
carbohydrate synthesis, gene 
expression, amino-acid uptake 
Yeast 
Neurospora 
crassa 
FRQ/WC oscillator Conidiation, gene expression 
Plant 
Arabidopsis 
thaliana 
Vasculature (not fully 
coupled) Leaf movement, photosynthesis 
Fly 
Drosophila 
melanogaster 
Ventral lateral neurons 
Olfactory sensory 
neurons 
Locomotor activity 
Odor-dependent 
electrophysiological responses 
Gene expression 
Birds 
Passer 
domesticus 
Brain (SCN) 
Retina 
Pineal gland 
Locomotor activity, noradrenaline 
levels, electrical firing, sympathetic 
tone 
Melatonin levels 
Mammals Mouse 
 
Brain (SCN) 
 
Locomotor activity, electrical firing, 
hormone secretion, cytosolic 
calcium levels, metabolic activity, 
immune response, neuropeptide 
secretion, gene expression 
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An additional clock exists in cells: the presence of reduction–oxidation 
(redox) cycles of ROS-scavenging peroxiredoxins. This seems to be present in 
all domains of life, which has led to the speculation that circadian oscillators co-
evolved from this redox homeostasis system following oxygenation on Earth 
(127). 
 
 
3.2. Mammalian circadian clock 
 
In all circadian systems identified to date, regardless of phylogenetic 
origin, three major components are present: 1) a light input, 2) the circadian 
pacemaker itself, and 3) output pathways by which the circadian pacemaker 
regulates physiology, and behavior throughout the organism (128). In humans 
and other mammals, entrainment of the circadian system by light relies on 
retinal photoreceptors (rods, cones and retinal ganglion cells, ipRGC). These 
ipRGCs express melanopsin photopigment, their photoresponse has slow 
kinetics and a relatively high threshold to light, making them ideally suited to 
function as circadian photoreceptors. This is because an optimal circadian 
photoreceptor must integrate light information over relatively long durations and 
must be insensitive to transient light signals that are not associated with the 
solar light cycle. The photic information received by the retina is projected to the 
hypothalamus via the retinohypothalamic tract (RHT). In the hypothalamus 
there is an area designated suprachiasmatic nuclei (SCN), composed of 
∼20,000 neurons, each of which is thought to contain a cell autonomous 
circadian oscillator that together make the master circadian clock. Conclusive 
evidence that the SCN is the master pacemaker came from lesioning studies 
and from experiments showing that transplantation of SCN tissue from donor 
animals harboring circadian clock gene mutations into SCN-lesioned wild-type 
hosts conferred upon the host the mutant circadian phenotype (129, 130).  
Light information entering the SCN is transduced into neural and humoral 
output signals that influence various rhythms in the body including, for example, 
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temperature, sleep-wake cycle, levels of activity and hormone secretion (131) 
(Fig. 6). 
 
 
Figure 6 - A schematic diagram of the suprachiasmatic nucleus and its input and 
output pathways. The mammalian circadian pacemaker in the hypothalamic 
suprachiasmatic nucleus (SCN) receives light information through the 
retinohypothalamic tract (RHT). Both neuronal and humoral signals function as output 
signals from the SCN to other regions of the brain and the periphery. The SCN output 
pathways are responsible for proper timing of diverse physiological functions, including 
hormone release, sleep–wake cycle, feeding behavior, and thermoregulation. The 
medial preoptic region (MPO) controls circadian rhythms of body temperature, 
paraventricular nucleus (PVN) controls daily hormone secretion and lateral 
hypothalamus (LH) and ventrolateral preoptic nucleus (VLPO) regulate and sleep–
wake cycles.  
 
In circadian biology, the term Zeitgeber (literally, “time giver” in German) 
is used to describe any daily environmental cue to which the circadian system 
can synchronize or entrain. Light is the most important cue for most animals, 
but other ~24 h recurring fluctuations also qualify as Zeitgebers including 
temperature (132) and social cues (133). In the laboratory, the daily period of 
light and dark can be controlled and Zeitgeber time (ZT) is defined relative to 
the experimental light/dark (LD) cycle. In a LD cycle of 12 hours light and 12 
hours darkness (LD 12:12), by definition ZT0 = lights are turned on, and ZT12 = 
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lights are turned off. When animals are experimentally isolated from all external 
time cues, as for example either in constant darkness (DD) or constant light 
(LL), it is possible to measure the endogenous or “free-running” period of the 
circadian clock. For rodents, the gold standard assay to measure circadian 
period of the free-running locomotor activity rhythm using running wheels 
connected to computerized data acquisition systems (134). Animals are first 
entrained to an LD cycle for a few weeks, after which they are exposed to 
constant conditions (e.g., DD) for several additional weeks during which the 
endogenous circadian period is measured by analyzing daily locomotor activity 
records (Fig 7). Each day of the free-running circadian rhythm measured in 
constant conditions is divided into 24 hours of circadian time (CT). The first half 
of the cycle (CT0–CT12) is termed subjective day, while the second half of the 
cycle (CT12–CT24) is termed subjective night. For nocturnal rodents, active 
period in DD is mainly restricted to the animal’s subjective night. When in DD, 
the mice period = subjective day + subjective night, is extremely precise (a 
standard deviation in period that is ∼0.2 h or 12 min in mice) (135), however it is 
not exactly 24 h but ~23.7 h, as observed by the slope in activity in the 
actogram of figure 7. 
 
Figure 7. A representative wheel-running locomotor activity record from a wild-
type mouse. The record is double-plotted so that 48 h are shown for each horizontal 
trace. Dark regions represent locomotor activity. For the first seven days the animal 
was housed in an LD 12:12 cycle, denoted by the bar above the record. The animal 
was transferred to DD conditions on day 8, as indicated by the horizontal line to the 
right of the record. Indicated are also the environmental times ZT0, ZT12 and circadian 
times CT0 and CT12, defined when the animal is in DD. 
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As I mentioned above, the molecular circadian clock is primarily 
regulated by a core transcription-translation feedback loop. In mammals, the 
primary loop involves the activators circadian locomoter output cycles kaput 
(Clock; and its paralog neuronal PAS domain protein 2, Npas2), Bmal1 (also 
known as aryl hydrocarbon receptor nuclear translocator-like; Arntl); and their 
repressors period homologue 1 (Per1), Per2, Cryptochrome 1 (Cry1) and Cry2 
(Fig. 8). During the day, the basic helix-loop-helix PAS-domain containing 
transcription factor CLOCK (or NPAS2) interact with BMAL1 to activate 
transcription of the Per and Cry genes, resulting in high levels of these 
transcripts. The resulting PER and CRY proteins heterodimerize, translocate to 
the nucleus and interact with the CLOCK–BMAL1 complex to inhibit their own 
transcription (131). During the night, the PER–CRY repressor complex is 
degraded, and CLOCK–BMAL1 can then activate a new cycle of transcription. 
This feedback cycle takes ∼24 h, and the turnover of the PER and CRY proteins 
is tightly regulated by E3 ubiquitin ligase complexes. There are additional 
feedback loops interlocked with the core CLOCK-BMAL1/PER-CRY loop. 
Prominent among these is a loop involving Rev-erbα (Nr1d1) and Rora, which 
are also direct targets of CLOCK-BMAL1. The feedback effects of this loop 
affect Bmal1 transcription (and to a lesser extent Clock). Other feedback loops 
involve the PAR-bZip family members, DBP, HLF, and TEF; the bZip protein, 
E4BP4 (Nfil3); and the bHLH proteins, DEC1 and DEC2 (Bhlhb2, Bhlhb3), all of 
which are transcriptional targets of CLOCK-BMAL1 (131, 136). 
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Figure 8. The mammalian circadian clock is composed of a transcriptional–
translational feedback network. In mammals, the circadian clock is composed of a 
primary negative feedback loop involving the genes Clock, Bmal1, Per1, Per2, Cry1 
and Cry2. CLOCK and BMAL1 are basic helix-loop-helix PAS-domain containing 
transcription factors that activate transcription of the Per and Cry genes. The resulting 
PER and CRY proteins heterodimerize, translocate to the nucleus and interact with the 
CLOCK–BMAL1 complex to inhibit their own transcription. After a period of time, the 
PER–CRY repressor complex is degraded and CLOCK–BMAL1 can then activate a 
new cycle of transcription. The secondary autoregulatory feedback loop is composed of 
Rev-erba, which is a direct target of the CLOCK–BMAL1 transcription activator 
complex. REV-ERBA feeds back to repress Bmal1 transcription and competes with a 
retinoic acid-related orphan receptor (ROR) to bind ROR response elements (RREs) in 
the Bmal1 promoter. In addition to the transcriptional activators and repressors, post-
translational modification and degradation of circadian clock proteins are crucial steps 
for determining circadian periodicity. Key kinases for PER (and CRY) phosphorylation 
are casein kinase 1 delta (CSNK1D) and CSNK1E. One of the roles for 
phosphorylation of clock proteins is to target them for polyubiquitylation and 
degradation by the 26S proteosomal pathway. The β-TrCP1 and FBXL3 E3 ubiquitin 
ligase complexes target the PER and CRY proteins, respectively, for degradation. 
CCG, clock-controlled genes; CREB, cAMP response element-binding; E-box, 
CACGTG/T consensus sequence; MAPK, mitogen-activated protein kinase; SCF, SCF 
E3 ubiquitin ligase; Ub, ubiquitin. Figure from (131). 
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CLOCK–BMAL1 rhythmically bind to E-box cis-regulatory elements of 
multiple genes, the clock controlled genes (ccg) (137). This rhythmically binding 
to their promoter leads to rhythmic transcription and therefore rhythmic levels of 
numerous mRNAs in the cell. This is the mechanism by which the clock can 
regulate a variety of cellular and metabolic processes.  
 
 
3.3. Circadian clock and immunity 
 
43% of all protein coding genes showed circadian rhythms in 
transcription somewhere in the body, largely in an organ-specific manner (138). 
This clearly shows the importance of the circadian clock regulating multiple 
physiological functions in the body, among those the immune response. A cell 
autonomous circadian clock has been found in multiple types of immune cells 
(139), including macrophages (140), monocytes (141), Th cells (142), dendritic 
cells, and B cells (143). 
Classic studies in the 1970s showed a remarkable daily variation in 
survival when mice were infected with pneumococcal bacteria (144). There is 
increased lethality when infection occurs at the end of the rest phase, 
approximately 2 h before onset of activity. The reason for differences is 
susceptibility of the mice at different times of the day appears to be due to the 
daily rhythms in immune response. The immune system is more reactive by the 
end of the rest phase. The induction of proinflammatory cytokines and 
chemokine ligands is far greater when mice are challenged with LPS at ZT12 
versus ZT0. This includes a greater induction of interleukin-6 (IL6), IL-12 (p40), 
chemokine (C-C motif) ligand 2 (CCL2), and CCL5 from macrophages 
challenged at ZT12 versus ZT0 (145). These natural rhythms in immune system 
are probably to prepare the mice for the active phase, when it is more likely to 
encounter dangers and get wounds. But equally, a reactive immune system 
corresponds to a greater risk of sepsis resulting from an overactive response. 
The time of the day at which mice get infected determines the outcome 
of the infection. When mice are infected with Salmonella enterica Typhimurium 
at different times, during the day (ZT4) and night (ZT16), the degree of intestinal 
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inflammation and cytokine gene expression, as well as bacterial colonization, 
varies. These changes seem to be because the antimicrobial peptide lipocalin-
2, to which Salmonella is resistant, is higher during the day than at night. The 
lipocalin-2 suppresses the resident microbiota, allowing for the massive 
outgrowth of Salmonella during the day versus the night (146).  
The SCN and adrenal clock drive rhythms in glucocorticoid secretion 
from the adrenal glands. The SCN controls the release of adrenocorticotropin 
(ACTH) from the pituitary gland and ACTH in turn stimulates release of 
glucocorticoids from the adrenal gland (147). Glucocorticoids exhibit broad anti-
inflammatory properties and can control cytokine production and leukocyte 
trafficking (148). 
Time of day is critical in terms of the type of immune response generated 
by an organism. The type of immune response can be broadly partitioned into 
two states, one of high alert and the other of rest and repair. 
 
 
3.4. Daily rhythms of parasites and microbiota 
  
 To this point we have been focusing on the existence of circadian 
rhythms in free-living organisms that are exposed to dramatic changes, for 
example light/dark cycles, in their environment. However, organisms living 
within hosts have also been described to have daily alterations. What remains 
unknown is whether those daily alterations are due to the circadian clock on 
those non-free-living organisms, or whether they are simply responding to daily 
changes within their host. 
 If the host is a mammal, a non-free-living organism in the bloodstream 
would be exposed to multiple daily changes: variations in the number and 
reactivity of patrolling immune cells, temperature, nutrient availability 
(consequence of the feeding behavior of the host), redox, blood pressure, etc. 
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In order to be considered an intrinsic circadian rhythm, the daily 
variations need to have: 
i) Self-sustaining periodicity 
The rhythms repeat once a day, with a period of 24h, even in the 
absence of external cues (constant conditions). This criteria allows to 
distinguish circadian rhythms from simple responses to daily external 
cues 
ii) Entrainment 
The rhythms can be adjusted to match the local time (entrainable). 
When travelling across time zones, human experience jet lag, however, 
within a few days the sleep/wake cycle and feeding schedule becomes 
synchronized/entrained to the time of the destination, it resets to match 
the external stimuli. 
iii) Temperature compensation 
The rhythms maintain circadian periodicity over a range of physiological 
temperatures. Some organisms experience a broad range of 
temperatures in their habitat, and those differences in thermal energy 
will affect the kinetics of all molecular processes in their cell(s). In order 
to keep track of time, the organism's circadian clock must maintain a 
roughly 24-hour periodicity despite the changing kinetics, a property 
known as temperature compensation. 
 
 
Daily variations have been observed in parasites, which are eukaryotic 
organisms living within hosts. Avian Isospora intestinal parasites are transmitted 
when a host ingests sporulated oocysts. In both 12:12 h light/dark of the tropics 
(149, 150) and 24 h light of the artic (150, 151), the emergence of the 
transmissible oocysts in the bird feces peaks in the afternoon, coinciding with 
evening bird feeding activity. Also observation of rhythmic fluctuations have 
been made in human parasites. Human species of filariae show daily fluctuation 
of microfilariae density (the transmissible form) in their hosts’ peripheral blood. 
These parasites can be usually found in the lymphatic system, which leads to 
the characteristic limb swelling common in filariasis patients. The microfilaria 
parasites migrate from the lymphatic system to the peripheral blood at night, 
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which ensures transmission through their vector’s blood-meal (152). Human 
malaria parasite species also display synchronous cell cycle durations of 48 or 
72 h causing fever every 2 or 3 days, a hallmark of this disease (153).  
Recent studies showed that the intestinal microbiota, in both mice and 
humans, exhibits diurnal oscillations that are influenced by feeding rhythms of 
the animal. This dictates the microbiome composition at different times of the 
day, leading to daily functional profiles. Ablation of host molecular clock 
components or induction of jet lag leads to aberrant microbiota diurnal 
fluctuations, which imposes damaging metabolic consequences for the host 
(154, 155). 
Despite such daily fluctuations, it has not been previously established 
whether non-free-living have intrinsic clocks that anticipate the changes in the 
environment or whether they are simply responding to host rhythmic 
physiological cues.  
 
 
 
4. Aims 
 
The main goal of this work has been to test the hypothesis that the 
sleep/wake cycle disruption observed in sleeping sickness patients is due to 
changes in expression of circadian clock genes. 
First, we carefully characterized the C57BL/6J mouse model of sleeping 
sickness in order determine which organs carry with higher parasite load. A 
careful parasite distribution analysis would allow correlations with the symptoms 
observed and potentially with circadian clock disruption. From these studies 
arose the surprising conclusion that the so-far neglected adipose tissue is in 
fact the organ with higher parasite load, later in infection. With further analyses 
we uncovered a parasite adaptation to the adipose tissue lipid-rich environment 
by activating the beta-oxidation of fatty acids, a pathway not previously 
documented to be used by this parasite. 
With the parasite distribution in the mouse, we proceeded to test whether 
this model mimicked the sleep-wake cycle disruptions observed in humans, 
followed by the characterization of the clock gene expression in infected mice.   
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Finally, we sought to determine whether T. brucei parasites have intrinsic 
circadian rhythms through analysis of their daily gene expression in vitro, by 
RNA sequencing. 
 
These data open new avenues for the research on the pathogen 
responsible for the fatal sleeping sickness, as well as for the studying the 
existence of circadian rhythms in other pathogens. 
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CHAPTER II – Results 
 
 
In the chapter II, I documented the result section of my research projects 
in the form of three stories: 
 
1. Trypanosoma brucei parasites occupy and functionally adapt to the 
adipose tissue in mice 
 
2. Trypanosoma brucei infection accelerates the mouse circadian rhythm 
 
3. Post-Transcriptional Circadian Regulation of Genes Related to 
Metabolism and Suramin Sensitivity in Trypanosoma brucei 
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Chapter II – section 1 
 
Trypanosoma brucei parasites occupy and 
functionally adapt to the adipose tissue in mice 
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The “Chapter II – Results – 1. Trypanosoma brucei parasites occupy and 
functionally adapt to the adipose tissue in mice” consists of a co-first authorship 
publication. Here is clarified the contribution of each of the authors: 
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Dias, Terry K. Smith, Luisa M. Figueiredo 2016. Trypanosoma brucei 
parasites occupy and functionally adapt to host adipose tissue. Cell 
Host&Microbe (in press) 
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Filipa Rijo-Ferreira, the candidate for the PhD degree at the University of 
Porto, contributed to the paper by initially establishing single-handed a mouse 
model of Trypanosoma brucei infection in my laboratory. Filipa also contributed 
by designing original experiments that led to the publication of this paper. As 
part of this initial work, she observed that parasites preferentially accumulate in 
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the adipose tissue, characterizing this accumulation by histological analysis, 
genomic DNA and RNA quantifications. She demonstrated that throughout 
infection there is a gradual increase in the parasite load in many organs, 
including the brain, but that is in the adipose tissue where more parasites can 
be found. Filipa also designed and prepared the RNA samples for RNA 
sequencing, as she was further involved in the planning of the transplantation 
experiments presented in the publication.  
The contribution of each author to the publication is clarified in the section 
“Authors contribution” with the following text: 
“Authors contribution: S.T., F.R.F., T.K.S. and L.M.F. designed the experiments 
and wrote the paper; S.T., F.R.F., T.C., F.A.-B., F.B., A.P., T.K.S. conducted 
the experiments; D.P.N. and S.A.Y. analyzed the RNA-seq data; J.V.D.A. 
designed and conducted experiments with Tsetse flies; R.M.R. conducted the 
statistical analysis; S.D. designed experiments.” 
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1. Trypanosoma brucei parasites occupy and 
functionally adapt to the adipose tissue in mice 
 
 
 
Keywords: African trypanosomes, fat, mouse infection, fatty acid b-oxidation, 
metabolism, transcriptome 
 
1.1. Summary 
 
Trypanosoma brucei is an extracellular parasite that causes sleeping 
sickness. In mammalian hosts, trypanosomes are thought to exist in two major 
niches: early in infection they populate the blood; later, they breach the blood 
brain barrier, at which point the disease is terminal. Here we report the 
unexpected finding that adipose tissue is a third major functional reservoir for T. 
brucei. We show that adipose tissue contains replicative parasites capable of 
infecting a naïve mouse. We also demonstrate they are transcriptionally very 
different from parasites in the blood, and that these differences are functionally 
significant, with parasites in fat having adapted their metabolism to the 
utilization of lipids as a carbon source. Together, these findings identify the 
adipose tissue as a novel niche, which is populated by a new form of T. brucei 
life cycle (which we termed ATF) and which has potential consequences for 
pathogenesis.  
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1.2. Introduction 
 
Human African Trypanosomiasis (HAT), also known as sleeping 
sickness, is a neglected tropical disease that is almost always fatal if left 
untreated. This disease is caused by Trypanosoma brucei, a unicellular parasite 
that lives in the blood, lymphatic system and interstitial spaces of organs 
(reviewed in(16)).  
Disease pathology often correlates with sites of accumulation of the 
infectious agent within its host, including the brain, which is associated with 
characteristic neuropsychiatric symptoms and sleep disorder. Weight loss is 
another typical clinical feature of sleeping sickness pathology (16), but is 
essentially unstudied. 
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T. brucei is transmitted through the bite of a tsetse and quickly adapts to 
the mammalian host to become what is known as a “slender” bloodstream form 
(BSF). As parasitemia increases, slender forms are capable of sensing 
population density and this triggers differentiation to the stumpy form, which is 
pre-adapted to life in the transmitting tsetse vector and, once there, further 
differentiates into procyclic form (PCF). Several studies have shown 10-30% of 
genes being differentially expressed between BSF and PCF (reviewed in(156)), 
including genes involved in metabolism, organelle activity, cell cycle regulation 
and endocytic activity. Recent proteomic studies also revealed around 33% of 
proteins that are developmentally regulated(157).  
A major difference between BSF and PCF is their energy production, 
with the former utilizing glucose via glycolysis within the glycosome and the 
latter utilizing proline and to a lesser extent other amino acids as their carbon 
source, via the Krebs cycle in its mitochondrion (reviewed in (158)). To date, no 
fatty acid β-oxidation has been observed as a carbon source in any life cycle 
stage of this parasite. This has been a puzzling observation, as the genes 
required for productive β-oxidation, including the carnitine-acyltransferases (for 
mitochondrial import of fatty acids) are present in the genome.  
Here, we describe a new form of T. brucei in mammalian hosts: we 
demonstrate that T. brucei accumulates in adipose tissue (consistent with 
recent studies showing accumulation of parasites in the lower abdomen (55, 
159, 160) and that this accumulation is functional. Namely, fat resident T. brucei 
have a different metabolic profile from either slender or stumpy forms in the 
blood, and this profile is consistent with their utilization of fatty acids (Myristic 
Acid) as a carbon source. These experiments describe a new form of T. brucei 
life cycle, and possibly explain weight loss (wasting), one of the characteristic 
pathological features of this disease.  
 
1.3. Results 
T. brucei parasites are heterogeneously distributed in mice  
 
The well-established mouse model (C57BL/6J mice with a pleomorphic 
clone AnTat1.1E) was used to confirm weight loss during infection as observed 
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in humans with sleeping sickness. Parasitemia followed a previously described 
pattern: the first peak of parasitemia occurred 5-6 days post-infection, at around 
2x108 parasites/mL and, after approximately 4 days of undetectable 
parasitemia, parasites could be detected again with a fluctuating parasitemia of 
106 - 107 parasites/mL (Figure 1A). After the first peak of parasitemia, all 
infected animals showed reduced food intake and a 10-15% decrease in body 
weight. Eventually all mice recovered normal food intake, although their body 
weight remained 5% lower than that of non-infected animals (Figure 1B and 
S1A). The weight of most organs from mice sacrificed on 6 and 28 post-
infection showed minimal changes relative to day 0, except fat depots that 
decreased on average 43% (±12%). Spleen size and weight increased 
dramatically as previously reported (Figure 1C). Infected mice died 35 ± 2.5 
days post-infection (Figure 1D).  
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Figure 1. Tissue distribution of T. brucei during a mouse infection is 
heterogeneous.  (A) Mean parasitemia profile of 20 mice infected with T. brucei 
AnTat1.1E. Parasitemia was assessed from tail-blood using a hemocytometer (limit of 
detection is around 4x105 parasites/mL). Light grey shaded area represents SEM. (B) 
Variation of body weight during infection. Daily body weight measurement of control 
and infected mice (n = 15 per group). Light grey shaded area represents SEM. (C) 
Variation of organ weight during infection (n = 4 per group). (D) Survival curve of T. 
brucei infected mice (red curve) (n = 8). (E) Representative light microscopic images of 
T. brucei distribution in several organs/tissues, at days 6 and 28 post-infection, 
assessed by immunohistochemistry with a non-purified rabbit anti-VSG antibody 
(parasites appear brown). n = 5 per time point. Original magnification, 40x.  
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 To assess the parasite load in different organs, we used  
immunohistochemistry at different days of infection (Figure 1E and Figure S1B). 
Parasites were consistently detected in the fat 6 days post-infection and at later 
time points, while in other organs they were seen sporadically and at very low 
densities. As infection progressed, we observed an increase in parasite load in 
most organs, with fat, heart, brain, lung and kidney being the most visibly 
infiltrated. Parasites were always found extracellularly within the interstitium of 
these organs. In the brain, our data corroborate the extensively reported 
evidence for the localization of parasites being restricted to the choroid 
plexuses and meninges (16) (Figure 1E).  
Histologically, thymus, lymph nodes, bone marrow, skin, salivary glands, 
spleen, gastrointestinal mucosa, testis and liver displayed few or no parasites 
(Figure 1E and data not shown). Although parasites in the stroma of the testis 
were absent, the epidymal fat body and stroma of the epididymis (a small 
paired organ in the posterior end of the testis) contained many parasites many 
of which appeared as debris, but which could explain the bioluminescence 
detected by (55). 
 
Early in infection, T. brucei accumulate in fat 
 
Immunohistochemical staining showed parasites in the stroma of several 
fat depots: gonadal, mediastinic, mesenteric, retroperitoneal, perirenal, and 
interscapular (Figure 2A). TEM confirmed that these parasites were indeed 
extravascular as numerous trypanosomes were observed in the interstitial 
space, either between adjacent adipocytes or between the adipocytes and the 
capillaries (Figure 2B).  
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Figure 2. Fat depots are a major parasite reservoir. (A) Schematic representation of 
mice fat depots and Anti-VSG immunohistochemistry images of six different fat depots, 
collected 28 days post infection. Original magnification, 40x. (B) Transmission electron 
micrograph of a gonadal fat depot 6 days post infection. Trypanosome (T) and 
lymphocyte in the interstitial space, adjacent to an adipocyte and next to a small 
capillary. Scale bars represent 2 and 0.5 µm in the left and right panels, respectively.  
(C) Parasite density in multiple organs/tissues (6 and 28 days post-infection) was 
measured by qPCR of gDNA (T. brucei 18s rDNA normalized to the weight of the 
tissue/organ). Blood density was assumed 1.05 g/mL. Fat value is the average of 
quantification of the six depots indicated in panel A. Each point represents the 
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geometric mean of the parasite density on days 6 (n = 3-9) and 28 post-infection (n = 
3-6). (D) Parasite load in multiple organs/tissues estimated by multiplying parasite 
density with organ weight at the corresponding day of infection. Each point represents 
the geometric mean of the parasite density on days 6 (n =3-9) and 28 post-infection (n 
= 3-6). 
 
To quantify parasite density, we used as a proxy Trypanosome DNA, 
which was quantified at 6 and 28 days post-infection in the organs/tissues 
where parasites had been detected by histology, i.e. fat, lung, heart, kidney, 
brain and blood (Figure 2C and Figure S2A). The blood had the highest 
parasite density on day 6. Among solid organs/tissues, for the same day of 
infection, parasite density is relatively low, except for fat that has on average 
60-fold more parasites than lung, heart, kidney and brain and 7-fold less than 
blood. On day 28 of infection, parasite density remained equally high in fat (104-
105 parasites/mg), while it increased, on average 20-fold in the brain, heart and 
lung (Figure 2C). The overall high parasite density was detected in all fat depots 
characterized in this study, with no significant differences between white and 
brown adipose depots (Figure S2B and Supplemental Experimental 
Procedures). The blood is the only site where we observed a decrease in 
parasite density during infection, which is consistent with parasitemia dynamics 
(Figures 1A and 2C). As a consequence, on day 28, fat is the compartment with 
the highest parasite density (LME, p < 0.0001). 
Overall the density of parasites per mg of organ/tissue correlated well with the 
density calculated as a ratio of parasite DNA versus mouse DNA in each tissue 
(Figure S2C). We also observed essentially the same pattern of parasite density 
and the same preferential accumulation in the fat when we quantified parasite 
RNA (qPCR), instead of DNA (Figure S2D), suggesting that DNA quantification 
reflects accurately the number of live parasites. Immunohistochemistry also 
showed accumulation of parasites in fat regardless of parasite strain 
(EATRO1125 AnTat1.1E, Lister 427), infection route (intraperitoneal, 
intravascular), mouse strains (C57BL/6J, BALB/c), animal gender (male, 
female) or rodent species (mice, rat) (Figure S2E).  
Fat represents around 14% of the body weight of a healthy mouse (Jackson 
Mouse Phenome Database), thus it is potentially a very large reservoir of 
parasites. The number of parasites in the organs/tissues (parasite load) was 
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determined by multiplying parasite density by the weight of the organ at the 
corresponding time of infection. For fat, we used the weight of the six depots 
characterized in this work, which comprises around 25% of the total body fat. 
We observed that, while 6 days post-infection, the blood contains the majority of 
the parasites (around 108 parasites), on day 28 the six depots of fat contain 
overall more parasites than the blood, brain and all other tested organs 
combined (LME, p < 0.0001) (Figure 2D). A similar preference for accumulation 
in adipose tissue was observed when the mouse infection was initiated by a 
tsetse bite, which deposits metacyclic forms in the skin of the mouse (Figure 
S3) (LME, p < 0.0001). Overall, these data revealed that fat represents a major 
reservoir of parasites, regardless of whether the infection was initiated by BSF 
or metacyclic forms. 
 
Adipose tissue contains replicative and infective parasites  
 
In the blood, parasites can be either replicative slender or G1-arrested 
stumpy forms (161). To investigate whether the parasites from fat (referred 
hereafter to as adipose tissue forms (ATF)) are replicative or not, we infected 
mice with a GFP::PAD1utr reporter cell-line, in which a GFP gene is followed by 
a PAD1 3’UTR that confers maximum expression in stumpy forms (J Sunter, A 
Schwede and M Carrington, unpublished; (162)). Four and six days post-
infection, blood and fat were collected and parasites isolated and purified. As 
described by(163), on day 4 we observed that most parasites in the blood were 
GFP-negative (98% ± 0.3%); while on day 6 most parasites expressed GFP 
(86% ± 2.6%). Interestingly, we noted that intermediate forms can also be 
detected in the blood as a transient population of intermediate GFP-intensity 
around day 5 post-infection (data not shown). As the yield of isolation of ATF 
parasites was very low on day 4 and 5, we analyzed these parasites only on 
day 6. The majority of the ATF parasites were GFP-negative (79% ± 4.6%), 
while 21% ± 4.6% expressed GFP, indicating that fat contains fewer stumpy 
forms than blood (Figure 3A).  
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Figure 3. Adipose tissue harbors replicative forms that can establish a new 
infection. (A) Frequency of GFP expression measured by flow cytometry in parasites 
isolated from blood and fat, 4 and 6 days post-infection with a GFP::PAD1utr T. brucei 
reporter cell-line (n = 2-3). (B) Cell cycle analysis assayed by flow cytometry of 
propidium iodide stained parasites (n = 2-3). (C) Fluorescence microscopy of gonadal 
adipose tissue from a mouse infected for 6 days with GFP::PAD1utr. Lipid droplets were 
stained with LipidTOX (red) and nuclei of GFP-expressing parasites (stumpy forms) are 
green. (D) Onset of parasitemia curves in mice that were injected i.p. with infected 
organs/tissues lysates from a first mouse. Lysates from blood, heart, brain and gonadal 
fat depot were prepared from mice sacrificed between 21-28 days post-infection to 
ensure presence of a larger number of parasites (n = 9).  
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To confirm if GFP-negative ATF parasites are replicative and GFP-
positive parasites are cell cycle arrested, we stained the parasite nuclear DNA 
with propidium iodide and quantified it by flow cytometry. In all samples (blood 
day 4, blood day 6 and fat day 6) we observed that GFP-negative parasites 
displayed a cell cycle profile characteristic of replicative cells (around 60-70% of 
cells in G1, 5% in S-phase and 20-30% in G2/M), while GFP-positive cells were 
cell cycle arrested in G1/G0 (90-95%) (Figure 3B). Similar data were obtained 
by performing cell cycle analysis with DyeCycle Violet (Figures S4A and S4B), 
further confirming the presence of slender and stumpy forms in adipose tissue.  
To validate the presence of stumpy forms in adipose tissue, we used 
fluorescence microscopy on an intact gonadal depot infected with 
GFP::PAD1utr expressing parasites (Figure 3C). LipidTOX stains the lipids in 
the large lipid droplet of adipocytes. Among the adipocytes, we could clearly 
observe many green foci, which represent the parasite nuclei where GFP 
accumulates, thus confirming the presence of GFP-positive parasites (stumpy 
forms) in close proximity to adipocytes. The presence of replicating parasites in 
intact tissue was confirmed by immunohistochemistry with an anti-H2A 
antibody. Dividing nuclei were clearly visible in close proximity to adipocytes 
(Figure S4C), further confirming the FACS cell cycle data.  
To test whether ATF parasites are capable of establishing a new 
infection, an infected donor mouse was sacrificed, perfused and several organs 
collected, homogenized and injected intraperitoneally into recipient naïve mice. 
Parasitemia was assessed daily thereafter, and scored on the first day it 
became detectable (Figure 3D). Mice that received blood or a fat homogenate 
showed parasitemia earlier (around 3 days post-transplantation) than animals 
injected with heart and brain homogenates (around 4 days post-
transplantation), consistent with the observed parasite load in these organs 
(Figure 2D and Figure 3D). Transplant of intact gonadal fat depot also led to 
successful infection of the recipient naïve mice (data not shown); suggesting 
that parasites can exit from an intact tissue. These results showed that 
parasites from fat, heart and brain are capable of reinvading the bloodstream 
and establishing a new infection. 
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Morphology of Adipose Tissue Forms 
 
Although T. brucei is always extracellular, its morphology changes during 
the life cycle, which may reflect a specific adaptation to the host niche (164). 
ATF, like BSF, have an ondulating appearance, with a flagellum attached to the 
cell body. Kinetoplast is positioned between nucleus and flagellar pocket.  
To characterize the morphology of ATF, we compared the length and 
width of GFP::PAD1utr parasites isolated from adipose tissue (day 6 post-
infection) and blood (day 4 and 6 post-infection) (Figure 4A and 4B). Automatic 
measurements of phase contrast microcopy images were generated via HTIAoT 
(165) and confirmed with manual measurements (Figure S5A). We observed 
that slender forms (GFP-negative) from blood and adipose tissue were very 
similar both in length (blood: 24.39 ± 2.50 µm; fat: 24.57 ± 2.99 µm) and width 
(blood: 2.15 ± 0.26 µm; fat: 2.12 ± 0.26 µm). This average length is consistent 
with previous reports (166, 167). In blood day 6 post-infection, GFP-positive 
parasites were, as expected, shorter (18.43 ± 1.81 µm) and wider (3.11 ± 0.38 
µm) than slender counterparts of day 4, corresponding to the morphology of 
stumpy forms (168). Interestingly, in adipose tissue, we found not only stumpy 
forms, but also GFP-positive parasites that morphologically were in-between 
slender and stumpy forms (length: 21.32 ± 2.73 µm; width: 2.29 ± 0.31 µm). 
These probably correspond to the previously described blood intermediate 
forms, which as the name suggests, are not fully differentiated into stumpy 
forms, but that already express GFP::PAD1 (162). These results indicate that 
adipose tissue is populated by parasites whose morphology has been 
previously found in the blood. The only significant difference is their relative 
distribution: on day 6 of infection, while blood is mostly populated by stumpy 
forms, adipose tissue appears to be “delayed” as we detected both intermediate 
and stumpy forms.  
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Figure 4. ATF parasites are morphologically similar to parasites from the blood. 
(A) Morphological features (length and width) of fixed parasites isolated from fat and 
blood of mice infected with GFP::PAD1utr reporter. Fat gonadal tissue was collected 
on day 6 post-infection. The blood “controls” were obtained as follows: GFP-negative 
parasites were collected on day 4 post-infection (mostly slender forms); GFP-positive 
parasites were collected on day 6 post-infection (mostly stumpy forms). Morphometric 
measurements were scored from phase contrast microscopy images and analyzed via 
HTIAoT and confirmed by manual measurement. GFP-negative: slender form; 
GFPpositive: stumpy and intermediate forms. n = 100 per group. Statistical significance 
was assessed using a Wilcoxon rank sum test. (B) Representative images of parasites 
isolated from fat. Replicating parasites (such as the second from the left) were 
excluded from morphometric analysis. (C) Transmission electron micrograph and 3D 
Tomography images of a parasite isolated from gonadal adipose tissue. Mitochondrion 
is represented in blue/green, glycosomes in pink, nucleus in white and plasma 
membrane in yellow. Scale bar represents 500 nm. 
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At the ultrastructure level, ATF contain all major structures described in 
other stages of life cycle (169), including an electron dense coat, nucleus, 
mitochondrion, endoplasmic reticulum, Golgi apparatus, glycosomes, dense 
granules and numerous vesicles compatible with endosomes, an internal 
subpellicular corset of microtubules underneath plasma membrane and a 
flagellum attached to the cell body (Figure 4C and Figure S5B). Using serial 3D-
Tomography, we observed that the single mitochondrion of ATF occupies a 
small volume of parasite body and it is not highly branched (Figure 4C and 
Supplemental Movie). This organization was confirmed by Mitotracker Green 
staining, which showed no major differences between the mitochondrion of 
parasites in blood and adipose tissue (Figure S5C and Supplemental Movie). 
 
Transcriptome of ATF parasites reveals differences in several key 
regulatory processes 
 
During its life cycle, T. brucei adapts to its environment by changing gene 
expression (reviewed in(170). To test whether parasites within fat also adapt to 
the lipid-rich environment, total RNA was extracted from infected gonadal fat 
depot (n = 3) on day 6, along with parasites from blood (n = 2) on day 4 
(maximizing slender and minimizing stumpy forms), and was subjected to RNA-
seq analysis. As expected, sequence reads from blood samples corresponded 
mainly to parasite transcripts, while sequence reads from fat corresponded 
mainly to host transcripts. Nevertheless, the 1% to 9% of the sequence reads 
from T. brucei provided enough statistical power to detect changes in the 
transcriptomes of ATF parasites (Table S1). Two previously published RNA-seq 
datasets of BSF parasites grown in culture were also included in this analysis 
(171). 
Unbiased clustering of gene expression profiles revealed that ATF 
parasites cluster separately from parasites isolated from blood or culture (Figure 
5A), suggesting significant changes in their overall transcriptome. Changes 
were identified using three methods of differential expression analysis, and only 
those genes identified by at least two methods with an adjusted p value < 0.01 
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were considered. These analyses showed that 2,328 genes (around 20% of 
transcriptome) were differentially expressed between BSF and ATF parasites: 
1,160 were up-regulated in ATF parasites and 1,178 were up-regulated in BSF 
(Figure 5B-5C and Table S2).  
Significant changes were found in genes involved in gene expression 
regulation, cell cycle and cell signaling (Table 1). RNA binding proteins play an 
important role in gene expression and differentiation throughout the T. brucei 
life cycle. RNA binding protein 42 (RBP42, Tb927.6.4440) binds many mRNAs 
involved in cellular energy metabolism (172). Up-regulation of RBP42 in ATF 
parasites could be involved in the metabolic rewiring when parasites enter the 
fat. Overexpression of the RNA helicase DHH1 leads to up-regulation of RBP5 
in BSF (173). Interestingly, ATF parasites showed a simultaneous up-regulation 
of both genes (11 and 7-fold, respectively) (Table 1).  
 ATF parasites transcriptome also showed dramatic changes in gene 
expression of various post- and co-translational modifying enzymes that might 
have considerable influence on diverse cellular processes (Table 1). A small 
number of genes potentially acting in the cell cycle and cytokinesis was 
identified with significant differential expression, including the cytoskeleton 
associated AIR9 protein and spastin, which were up-regulated (Table 1), 
suggesting differences in cell cycle regulation in these parasites. Consistent 
with a minor stumpy form population in fat, we did not find enrichment of stumpy 
specific genes in the transcriptome of ATF parasites. Extracellular signaling 
mechanisms also seem to be affected in ATF parasites, including up-regulation 
of TOR3, which can relate the supply of external nutrients to internal energy 
levels to regulate cellular growth (174).  
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Figure 5. ATF parasites are transcriptionally different from bloodstream forms. 
(A) Hierarchically clustered heat map of Pearson correlations of transcript levels (log2 
transformed RPKM)) from independent RNA-seq datasets: Lister427 parasites grown 
in culture (n = 2); parasites isolated from blood of AnTat1.1-infected mice on day 4 
post-infection (n = 2); parasites isolated from gonadal fat on day 6 post-infection (n = 
3).  (B) Heat map view of relative transcript levels for differentially expressed genes 
from culture and in vivo in parasites isolated from the two tissues (adjusted p < 0.01 in 
at least two of three methods). (C) Volcano plot displaying in red the differentially 
expressed genes represented in (B). Displayed p values and fold-changes are from 
DESeq2. 
 
Interestingly, although by TEM, an electron dense coat can be observed 
at the parasite surface (Figure 2B), we found that the transcripts levels of the 
active VSG (VSG AnTat1.1, CAA25971.1) are 3-fold down-regulated in adipose 
tissue. As the VSGnome of AnTat1.1E clone is currently unknown, we could not 
test whether silent VSGs were up-regulated as a compensatory mechanism. 
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Genes encoding for other surface molecules, such as the haptoglobin-receptor 
and most procylins, were not differentially expressed.  
 
Transcriptome of ATF parasites reveals metabolic adaptations  
 
One of the most evident changes in ATF transcriptome is the up-
regulation of many metabolic pathways including glycolysis, pentose 
phosphate, purine salvage, sterol and lipid metabolism and, surprisingly, β-
oxidation. 13 of the 14 enzymatic steps of glycolysis are up-regulated relative to 
BSF (Table 1). This may either be a response to the lower glucose 
concentration in fat interstitial fluid relative to bloodstream or alternatively, ATF 
parasites may have up-regulated gluconeogenesis, which relies mostly on the 
same enzymes. 
In ATF parasites, genes involved in 3 out of the 5 biosynthetic steps in 
the pentose-phosphate pathway were up-regulated, including the rate-limiting 
glucose-6-phosphate dehydrogenase (Tb927.10.2490). This observation, taken 
together with the fact that numerous enzymes (16 in total) involved in purine 
salvage are also up-regulated suggests that ATF parasites may increase purine 
production. Interestingly, the purine phosphatases (Tb927.8.3800 and 
Tb927.7.1930) and cAMP phosphodiesterase PDEA (Tb927.10.13000) are up 
and down-regulated, respectively, suggesting that the increased purine 
production may be directed towards cAMP signaling (Table 1). 
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Table 1. Classes of transcripts differentially expressed between parasites in 
adipose tissue and blood. 
 
 
 
 
ATF parasites showed significant up-regulation of the alanine and 
aspartate aminotransferases and the glutamate shunt, which feed products into 
the tricarboxylic acid (TCA) cycle. Additionally, this cycle also appeared to be 
more active, given the up-regulation in three key steps, allowing it to process 
succinate, fumarate and 2-oxoglutarate, resembling the TCA cycle of the T. 
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brucei insect form (reviewed in (158)). These changes suggest that the F0/F1 
ATP synthase complex is functional and that the associated electron transport 
chain is operating in ATF parasites in a manner similar to that in PCF parasites.  
Significant changes in gene expression of lipid and sterol metabolic 
pathways were also observed in ATF parasites. But one of the most striking 
observations in the RNA-seq data was the potential presence of an active fatty 
acid β-oxidation, which produces energy from fatty acid catabolism. This was 
unexpected, as β-oxidation activity has never been detected in any T. brucei life 
cycle stage to date. ATF parasites showed up-regulation of the putative genes 
responsible for the 2nd and 4th steps of the β-oxidation cycle (enoyl-CoA 
hydratase and 3-ketoacyl-CoA thiolase, respectively) (Figure 6A). Moreover, 
fatty acid transport across the mitochondrial membrane (facilitated by acyl-CoA 
synthases and carnitine-acyltransferases) were up-regulated, while fatty acid 
elongases 2 and 4 were down-regulated, suggesting that in ATF parasites, 
endocytosed fatty acids are not being elongated and anabolized into more 
complex molecules. Instead they may enter the glycosomes and/or 
mitochondrion, where they are catabolized via a β-oxidation pathway to form 
acetyl-CoA (experimentally validated, see below and Figure 6), which feeds into 
the now active TCA cycle. 
 
ATF parasites have active fatty acid b-oxidation 
 
 To investigate whether ATF parasites are capable of β-oxidation, labeled 
myristate was used in a pulse-chase experiment with living trypanosomes and 
potential labeled β-oxidation intermediates were identified by gas 
chromatography-mass spectrometry (GC-MS). Myristate (C14:0) was chosen as 
it is efficiently uptaken up and incorporated into lipids and 
glycosylphosphatidylinositol (GPI) anchors in the slender BSF parasites 
(reviewed in(175)). Isolated ATF parasites were labeled with deuterated-
myristate (D27-C14:0) for 1 hour and then chased with serum, following which 
labeled myristate metabolites were identified. As expected, BSF showed 
accumulation of D27-C14:0 during the pulse and chase periods (Figure 6B-6C). 
ATF parasites also showed D27-C14:0 accumulation during the pulse (Figure 6B 
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upper panel and Figure 6C), but the amount of D27-C14:0 decreased 
significantly during the chase (Figure 6B lower panel and Figure 6C). 
Importantly, the decrease of D27-C14:0 in ATF parasites coincided with the 
detection of β-oxidation metabolites derived from the labeled myristate, 
including myristoleic acid (D25-C14:1), 3-hydroxy-myristate (D25-3-OH-C14:0) 
and 3-oxo-myristic acid (D24-3-keto-C14:0) (Figure 6B, right panels, Figure 6C 
and Figure S6 and S7). The latter two metabolites were also observed to some 
minor extent during the pulse (Figure 6B, upper panel and Figure 6C), while 
D25-C14:1 was present in higher amount during the chase period. Minor 
amounts of unlabeled 3-hydroxy-myristrate (H26-3-OH-C14:0) were also 
observed in ATF parasites, but not BSF (Figure 6C). 
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Figure 6: Fatty acid b-oxidation is active in ATF parasites. (A) Schematic of fatty 
acid b-oxidation pathway. Four enzymatic modifications are indicated by shaded box 
on the fatty acid structures where biotransformation takes place. Formulas in blue and 
green indicate the myristate and b-oxidation metabolites, thereof from the non- and 
labeled myristate, respectively, identified in this work. (B) FAME analysis by GC-MS of 
D27-C14:0 labeled bloodstream (left) or ATF (right) parasites for 1 hour (upper) and 
chased for a further 1hour (lower). GC-MS trace shows 30-34 minutes (n = 3). (C) 
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Uptake of D27-C14:0 and b-oxidation metabolites after normalization to the added 
internal standard C17:0. 100% equates to the amount of D27-C14:0 taken up by 
bloodstream form in the 1 hour labeling (pulse) (n = 3). Represented are the means 
and the respective average absolute deviations of the means.  
 
Collectively these data show that ATF parasites are able to actively 
uptake exogenous Myristic acid and form β-oxidation intermediates, 
demonstrating for the first time the existence of this pathway in trypanosomes, 
and suggesting that ATF parasites could in part use fatty acid β-oxidation to 
satisfy their energy requirements. 
 
1.4. Discussion 
 
A well-established feature of the unicellular, extracellular T. brucei 
parasite is their ability to invade the central nervous system (CNS). Here we 
show that, while blood is the major site of parasite accumulation on the first 
peak of parasitemia, fat contains the highest density and total number of 
parasites later in infection (around 100- to 800-fold more than the brain). 
Although the reason(s) why parasites accumulate in adipose tissue remain 
unknown, we clearly show it has dramatic consequences for the parasites. They 
functionally adapt to the tissue environment by rewiring gene expression, 
including the possibility of using lipids as a carbon source. 
 
Possible advantages to parasite accumulation in the adipose tissue 
 
The differential parasite distribution among blood and organs/tissues 
could be due to several non mutually-exclusive reasons: parasites may be more 
efficiently eliminated by some tissue-specific immune responses parasites may 
grow at different rates in each organ/tissue and/or parasites may not equally 
penetrate and exit organs/tissues. Depending on the dynamics of entry and exit 
of parasites to/from adipose tissue, it is possible that fat acts as a source of 
parasites that can repopulate the blood. This reversible movement between 
blood and fat could have important implications for (i) the transmission 
dynamics, since stumpy formation is triggered by a quorum-sensing mechanism 
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(163); and (ii) antigenic variation, if fat, for example, would favor the 
appearance of new VSG variants that could later go to the blood (176). 
An intriguing question is whether stumpy forms could be directly ingested 
by a tsetse fly from the subcutaneous fat, which would be a novel root of 
transmission. In our histology analysis, we did not find a significant number 
parasites in this fat depot, but we have obviously not screened the entire skin of 
the mouse. Moreover, we performed this analysis in mice infected by 
intraperitoneal injection, which bypasses the skin as the first entry point of 
metacyclic forms. So, it remains to be determined whether subcutaneous fat is 
important for accumulation of metacyclics and/or ATFs and how it impacts 
transmission. 
  Not all Trypanosoma species occupy the same niche in the host. T. 
brucei and T. evansi are mainly tissue-invading parasites, while T. congolense 
stays in smaller capillaries and venules of tissues and T. vivax remains mainly 
in circulation (177). These differences have been associated to the different 
swimming properties of each Trypanosoma species (167). Previous reports had 
indirectly suggested that T. brucei parasites could be present in adipose tissue 
(7, 178). Our study demonstrates that T. brucei parasites accumulate in high 
numbers in the fat of rodent animals. Although mouse is an accepted model to 
study T. brucei infection (7), we cannot exclude the possibility that accumulation 
in adipose tissue is a result of the selection process that happens when T. 
brucei infects a non-natural host. In the future, it would be interesting to confirm 
whether fat preference is a common feature of this and other Trypanosoma 
species in their natural hosts and to compare their swimming properties in 
different tissues/organs.  
 It is intriguing to note that several pathogens infect adipose tissue. T. 
cruzi, the causative agent of Chagas disease in Latin America, invades 
adipocytes during acute infections in mice and humans (179). Also Plasmodium 
berghei, a causative agent of rodent malaria, sequesters in lungs and fat in a 
CD36-dependent fashion. Mycobacterium tuberculosis infects adipocytes where 
it accumulates in intracytoplasmic lipid inclusions and survives in a “dormant” 
non-replicating state that is insensitive to anti-mycobacterial drugs(182). Human 
immunodeficiency viruses (HIV) take advantage of the fat as a viral reservoir 
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during the chronic stage of infection and persistence on this reservoir is actually 
an obstacle for treatment(183). It is possible that persistence of T. brucei in the 
fat may account for some of the treatment failures in humans(184).  
 
Functional adaptation to host adipose tissue 
 
A major observation in this work is that 20% of the genes are 
differentially expressed between ATF and BSF, which is comparable with the 
differences between BSF and PCF (around 30%) and between slender and 
stumpy BSF forms (around 12%) (reviewed in(170). Parasites adapt to the fat 
environment by changing transcript levels of genes involved in metabolism, 
signaling, cell cycle control and RNA binding. Using biochemical assays, we 
confirmed that ATF can uptake free fatty acids (Myristic Acid) and catabolize 
them by fatty acid β-oxidation, which could lead to the production of ATP via the 
TCA cycle and oxidative phosphorylation. Therefore, it seems that parasites 
can sense and adapt to the fat, by rewiring their gene expression, including the 
ability of using lipids as a carbon source. 
The major carbon source of BSF and PCF parasites is glucose and 
proline, respectively, both of which are readily available nutrients in the host 
and tsetse (reviewed in(158)). Fat is in its essence a lipid-rich environment. 
Therefore, it is possible that free fatty acids or some other form of lipid are 
readily available for the parasites to endocytose or actively transport via a 
receptor-mediated process (185). So far only one receptor has been identified 
in T. brucei as necessary for the import of LDL particles(186). Its transcript 
levels are not altered in ATF, suggesting either that this protein can be up-
regulated (post-) translationally or that lipid/fatty acid import is mediated by yet 
uncharacterized transporters.  
An abnormal consumption of the host lipids during a T. brucei infection 
could contribute to the weight loss observed in patients with sleeping sickness, 
cattle with Nagana and mice infected with T. brucei (16, 187). Interestingly, 
obese mice (db-/- knock-out mice) infected with T. brucei live 3-fold longer than 
their littermates, suggesting that having more adipose tissue partially protected 
mice from a T. brucei infection(188). Because obesity is associated with 
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persistent low-grade chronic inflammation in adipose tissue (189), it is possible 
that in obese mice parasites get more efficiently eliminated (or controlled), thus 
prolonging the survival of the host. 
 
 Most of what is known today about the mechanisms of virulence, 
persistence and transmission of T. brucei results from studies performed in 
bloodstream form parasites. The fact that adipose tissue is major reservoir of 
functionally differentiated parasites inevitably brings a new perspective to the 
current state of the art. First of all, what is the relative contribution of BSF and 
ATF for pathogenicity and host metabolic alterations? Could fat act as a source 
of parasites expressing novel VSGs? What are the implications of such a large 
reservoir of ATF in terms of transmission? What is the dynamics of parasite 
entry and exit from fat? Given the brain is a lipid-rich organ that is also invaded 
by T. brucei, it is obvious to ask whether parasites in the brain also adapt their 
gene expression and how these are related to brain-associated pathology? Do 
ATF induce changes in the host metabolism providing an advantage to the 
parasitic infection? Is the immune response of the adipose tissue more 
permissive to T. brucei parasites? Are anti-trypanosome drugs equally efficient 
at eliminating ATF and BSF? In sum, our findings have important 
consequences for the understanding of parasite biology, disease and drug 
treatment efficacy. 
 
1.5. Experimental Procedures 
Ethical Statements 
Animal experiments were performed according to EU regulations and approved 
by the Animal Ethics Committee of Instituto de Medicina Molecular (iMM) 
(AEC_2011_006_LF_TBrucei_IMM). The animal facility of iMM complies with 
the Portuguese law for the use of laboratory animals (Decreto-Lei 113/2013); 
and follows the European Directive 2010/63/EU and the FELASA (Federation of 
European Laboratory Animal Science Associations) guidelines and 
recommendations concerning laboratory animal welfare. The tsetse fly 
mediated T. brucei infection work was performed in compliance with the 
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regulations for biosafety and animal ethics (VPU2014_1) and under approval 
from the Environmental administration of the Flemish government. 
Animal Experiments 
Unless otherwise indicated, all infections were performed in wild-type male 
C57BL/6J mice, 6-10 week old (Charles River, France), by intraperitoneal 
injection of 2000 T. brucei AnTat 1.1E 90-13 parasites. For parasite counts, 
blood samples were taken daily from the tail vein. Organs/tissues of infected 
mice were collected at days 6 and 28 post-infection unless otherwise stated. 
Animals were sacrificed by CO2 narcosis, blood collected by heart puncture and 
mice immediately perfused. Collected organs were snap frozen in liquid 
nitrogen or fixed in 10% neutral-buffered formalin. In transplants, homogenates 
as well as 600 µL of blood were transplanted into age and sex-matched naïve 
mice. 
Cell Lines 
The majority of the infections described in this manuscript were performed using 
T. brucei AnTat 1.1E, a pleomorphic clone derived from an EATRO1125 clone. 
AnTat 1.1E 90-13 is a transgenic cell-line encoding the tetracyclin repressor 
and T7 RNA polymerase(190). Tsetse infections were performed with T. brucei 
AnTAR1 strain. We also used T. brucei Lister 427, a monomorphic strain 
derived from antigenic type MiTat 1.2, clone 221a(191). The stumpy reporter 
cell line GFP::PAD1utr derives from AnTat 1.1E 90-13 in which the green 
fluorescent protein, GFP, is coupled to PAD1 3’UTR. A nuclear localization 
signal (NLS) targets GFP protein into the nucleus. Prior to infection, T. brucei 
cryostabilates were thawed and parasite mobility was checked under an optic 
microscope. 
Mice Infections 
Mice were group-housed in filter-top cages and maintained in a Specific-
Pathogen-Free barrier facility. The facility has standard laboratory conditions: 
21 to 22°C ambient temperature and a 12 h light/12 h dark cycle. Chow and 
water were available ad libitum. Unless otherwise stated, all infections were 
performed in wild-type male C57BL/6J mice, 6-10 week old (Charles River, 
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France), by intraperitoneally (i.p.) infection of 2000 T. brucei AnTat 1.1E 90-13 
parasites. 
To test if the presence of parasites in fat was dependent on the model, we 
performed the following variations in the infection protocol: a) male C57BL/6J 
mice were infected with a more virulent strain, the T. b. brucei strain Lister 427; 
b) male C57BL/6J mice were infected intravenously (i.v.) in the tail vein; c) a 
different strain of mice, BALB/c, and 7 week old Wistar rats (Charles River, 
France) were also infected (the latter with 4000 parasites); d) female C57BL/6J 
mice and finally e) male C57BL/6J mice naturally infected by tsetse bite. For 
this latter protocol, freshly emerged Glossina morsitans morsitans flies were fed 
their first blood meal on a T. brucei AnTAR1 infected mice at the peak of 
parasitemia. Subsequently, flies were maintained on commercially available 
defibrinated horse blood through in vitro membrane feeding. Thirty days after 
the infective blood meal, individual flies were evaluated for the presence of 
metacyclic trypanosomes in their salivary glands by salivation on pre-warmed 
(37°C) glass slides. To initiate a natural infection, one individual tsetse fly with a 
mature salivary gland infection was allowed to probe and feed per mouse.  
Clinical Parameters and Organ Collection 
All measurements in mice were made between 17:00 and 18:00. For parasite 
counts, blood samples were taken daily from the tail vein, and parasitemia was 
determined by manual counting using a Neubauer chamber. Organs/tissues of 
infected C57BL/6J mice (male and female) were collected at days 6, 13, 20 and 
28 post-infection; for the infection with T. b. brucei strain Lister 427, organs 
were collected once parasitemia reached 1x108 parasites/mL; for BALB/c mice, 
at day 6 post-infection; and for Wistar rats and C57BL/6J mice i.v. infections, at 
days 6, 13 and 20 post-infection. Animals were sacrificed by CO2 narcosis, 
blood was collected by cardiac puncture and perfusion was performed to 
eliminate blood and parasites from circulation. Briefly, mice were perfused 
transcardially with pre-warmed heparinized saline (50 mL 1X phosphate 
buffered saline (1X PBS) with 250 ml heparine per animal) using a peristaltic 
pump, ranging its speed from 2 mL/min to 8 mL/min. Organs were then 
collected and either used immediately for parasites isolation, snap frozen in 
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liquid nitrogen for molecular analysis, or fixed in 10% neutral-buffered formalin 
for histopathology. 
Transplantations 
Donor mice were sacrificed with CO2 narcosis (at days 21 and 28 post-infection) 
and the gonadal fat depot, brain, heart, and 600 µL of blood were harvested. 
Organs were manually homogenized through a 70 µm mesh into 1X PBS. Cell 
suspension was centrifuged at 1000 g for 10 minutes and resuspended in 800 
µl of HMI11. Tissue lysates were injected intraperitoneally in naïve mice. Blood 
was diluted in 1X PBS and centrifuged for 5 minutes at 2800 g. Cell pellet was 
diluted in 800 µl of 1X PBS and injected intraperitoneally in naïve mice. 
Histology, electron microscopy and fluorescence analysis 
Formalin-fixed organs were embedded in paraffin and 3µm sections were 
stained with hematoxylin and eosin (H&E). For immunohistochemistry, 3µm 
sections were stained for VSG using a non-purified rabbit serum anti-T. brucei 
VSG13 antigen (cross-reactive with most VSGs via the C-terminal domain) or 
non-purified rabbit serum anti-T. brucei H2A (generated against a recombinant 
protein) (kind gift of Christian Janzen), diluted 1:5000 and 1:3000, respectively. 
Briefly, antigen heat-retrieval was performed in a microwave oven (800 w) for 
15 minutes with pH 9 Sodium Citrate buffer (Leica Biosystems, MO, USA). 
Incubation with ENVISION kit (Peroxidase/DAB detection system, Dako Corp, 
Santa Barbara, CA) was followed by Mayer’s hemalumen counterstaining. No 
staining was observed in the negative control (without primary antibody). Tissue 
sections were examined by a pathologist (TC), blinded to experimental groups, 
in a Leica DM2500 microscope coupled to a Leica MC170 HD microscope 
camera.  
For transmission electron microscopy, gonadal fat depot from infected mice 
(days 6 and 28 post-infection) was collected and fixed for three hours at 4ºC in 
0.1 M cacodylate buffer, pH 7.4, containing 2.5% (v/v) glutaraldehyde. After 
staining for 1 hour with 1% (w/v) osmium tetroxide and 30 minutes with 1% 
(w/v) uranyl acetate, samples were dehydrated in an ethanol gradient (70-95-
100%), transferred to propylene oxide and embedded in EPON™ resin. Semi-
thin sections (300-400 nm) were stained with toluidine blue for light microscopy 
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evaluation. Ultra-thin sections (70 nm) were collected in copper slot grids and 
stained with 2% uranyl acetate and lead citrate (Reynolds recipe). Grids were 
screened in a Hitachi H-7650 transmission electron microscope at 100 kV 
acceleration. 
For 3D reconstruction of isolated trypanosomes, parasites isolated from 
gonadal fat depot were centrifuged at 5000rpm and processed as described 
above for whole tissue. After embedding, approximately 26 serial ultra-thin 
sections (70 nm) were collected for each individual parasite. Grids of seven 
parasites were screened in a Hitachi H-7650 transmission electron microscope 
at 100 kV acceleration, serial section alignment was achieved using the IMOD 
software package version 4.7.3 for alignment and modeling (192). Videos were 
projected using ImageJ 4.47v.  
For fluorescence analysis, the gonadal depot was stained with LipidTox, fixed in 
Paraformaldehyde and embedded in Fluoromount-G. Fluorescence images 
were acquired using a 40x objective in a Zeiss Cell Observer wide-field 
microscope. For morphometric analysis, isolated parasites were fixed in 2% 
paraformaldehyde, DAPI stained and embedded in vectashield. Images were 
acquired using a 63x oil objective with optional optovar magnification (1.6x) in 
the same wide-field microscope. Parasite morphometric analysis was done 
essentially as described in(165). 
The mitochondrion of 1-5x106 isolated parasites was labeled using MitoTracker 
Green (Invitrogen/Molecular Probes, M-7514) according to the manufacturer’s 
instructions. Fluorescence and DIC images were acquired using a confocal 
Laser Point-Scanning Microscope (Zeiss LSM 710).  
Parasite Quantification 
T. brucei 18S rDNA genes were amplified from genomic DNA of a known mass 
of tissue and converted into parasite number using a standard curve. For RNA 
quantification, the DDCt method was used by amplifying TbZFP3 and mouse 
Gapdh genes from tissue total RNA. 
Parasite Isolation from Tissues 
Bloodstream parasites were purified over a DEAE column(193), while ATF 
parasites were isolated from gonadal fat depot by incubating the depot in 10mL 
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of MEM or HMI11 at 37ºC and 150 rpm agitation for up to 40 minutes. After 
which parasites in media are centrifuged for 10 min at 1800 rpm at RT, and 
numbers assess with a neubauer chamber. Expected yield is 5 x 106 parasites. 
Flow Cytometry 
Cell cycle analysis was performed using propidium-iodide (PI) or Vybrant 
DyeCycle violet (DCV) in fixed or live cells, respectively. PI staining was done 
according to (194). For DCV staining, cell suspensions were washed and 0.5 
mL of DCV was added per each million of isolated parasites and incubated for 
10 minutes at 37ºC. PI, DCV and GFP intensities were measured with BD 
LSRFortessa™ cell analyzer. 
RNA-sequencing  
RNA and cDNA library of both blood and gonadal fat depot from days 4 and 6 of 
infection, respectively, were prepared as described (171) and samples 
sequenced in an Illumina HiSeq2000 platform. Reads were processed and 
mapped to the T. brucei TREU927 genome. Differential gene expression was 
analyzed and genes were considered differentially expressed if they were 
detected by at least two of the three considered algorithms (p adjusted < 0.01). 
Myristate Metabolic Labeling  
To evaluate myristate incorporation and metabolism, the fat isolation protocol 
was performed in glucose free Minimum Essential Medium (MEM). Parasites 
were placed in an vented tube with 1 mL of MEM and starved for 30 minutes at 
37ºC. Starved parasites were then labeled, with 0.4 mg of radiolabeled D27-
C14:0 pre-coupled with defatted BSA, for one hour. 450 µL of the cell 
suspension were washed, snap frozen in liquid nitrogen and lyophilized in glass 
vials (Pulse sample). The remaining parasites were re-suspended in 500 µL of 
MEM and 100 µL of HMI11 for 1 hour at 37ºC and at the end processed as for 
pulse sample (Chase sample). Metabolite extraction, identification and 
quantification were conducted as described in (195) with the exception that fatty 
acids were released by acid hydrolysis (200 µL of 6M HCl at 110ºC for 16 
hours).  
T. brucei parasites occupy and functionally adapt to host adipose tissue 
 
 
 
76 
Statistical Analysis 
Statistical analyses were performed by fitting linear mixed effect models with 
mice as random effects unless otherwise indicated. At least three independent 
experiments were considered in each case and statistical significance was set 
to a = 0.05 level. Data were analyzed after logarithm transformation.  
 
 
1.6. Supplementary figures 
 
 
 
Figure S1. Related to Figure 1 and Figure 2. Clinical and histology details during 
T. brucei infection. C57BL/6J mice were injected i.p. with 2000 AnTat1.1E parasites. 
(A) Variation of food intake during infection. Animals (n = 15 per group) were group 
housed and food intake was measured daily by weighting the food and dividing by the 
number of mice per cage (n = 4 per condition). Light grey shaded area represents 
SEM. (B) Representative light microscopic images of gonadal fat depots at different 
days post-infection, assessed by immunohistochemistry with anti-VSG antibody 
(parasites appear in brown). Original magnification, 400x. 
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Figure S2. Related to Figure 1 and 2. Further validation of preferential 
accumulation of parasites in adipose tissue. (A) Calibration curve obtained from 
four independent in vitro cultures of known cell density. gDNA was extracted, serially 
diluted and amplified by quantitative PCR using T. brucei 18S rDNA primers. The 
goodness of fit of the linear regression is R2 = 0.933. Calibration curve obtained from 
blood from infected mice (n = 3) (green dots) and from a culture of parasites diluted in 
blood from naive mice (n = 1) (black dots). The goodness of fit of the linear regression 
is R2 = 0.925. (B) Parasite density in six fat depots on day 6 (n = 6-12) and 28 (n = 3-6) 
post-infection determined by qPCR of gDNA. For each depot, significant differences 
were found between days 6 and 28 post infection (Student’s unpaired t test, P < 0.05). 
The average of all the studied depots shows a clear difference between parasite 
densities at days 6 and 28 post-infection (Student’s unpaired t test, P < 0.0001). The 
geometric means and correspoding standard errors are indicated. (C) Two different 
gDNA qPCR methods were compared on day 28 post-infection: i. number of parasites 
per mg of organ (n = 3 - 9) and ii. ratio between T. brucei and mouse 18S gDNA (n = 3 
- 9). Both methods show a similar parasite density in different tissues (LME, P = 0.72). 
(D) Parasite density on day 6 and 28 post-infection determined by qPCR of RNA. 
Transcripts of the parasite TbZFP3 gene were normalized to the mouse Gapdh. Each 
point represents the geometric mean of the parasite density on day 6 (n = 3 - 4) and on 
T. brucei parasites occupy and functionally adapt to host adipose tissue 
 
 
 
78 
day 28 post-infection (n = 3 - 5). RNA quantification validates the conclusions taken 
from gDNA qPCR: the adipose tissue is the major parasite reservoir (LME, P = 
0.0006). The relative contribution of other organs is similar to what was measured by 
gDNA, except for brain, in which parasite density was lower than expected. Perhaps 
TbZFP3 is downregulated in this organ. (E) Representative light microscopic images of 
T. brucei in gonadal adipose tissue in different models of infection, assessed by 
immunohistochemistry with anti-VSG antibody (parasites appear in brown). Original 
magnification, 400x. 
 
Figure S3. Related to Figure 2. Parasites accumulate in fat when infection is 
initiated by tsetse bite. (A) Parasite density in multiple organs in mice naturally 
infected by the bite of a tsetse fly. Mice were sacrificed at the first and second peak of 
parasitemia (10 and 19 days post-infection respectively) and parasite density 
determined by gDNA and qPCR as described in Figure 2. Each point represents the 
geometric mean of the parasite density at day 10 (n = 4) and at day 19 (n = 8). (B) Anti-
VSG immunohistochemistry images of gonadal fat depot, 10 and 19 days post-infection 
by tsetse bite. Original magnification, 40x. 
 
Figure S4. Related to Figure 3. Complementary methods to confirm presence of 
both replicative and cell cycle arrested parasites in fat on day 6 post-infection. 
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(A) GFP Expression and (B) Cell cycle analysis in parasites isolated from blood and 
adipose tissue, 4 or 6 days post-infection, assayed by FACS. A GFP::PAD1UTR T. 
brucei reporter cell-line was stained with DyeCycle Violet. The histograms represent 
the distribution and the percentage of parasites in each cell cycle stage. DyCycle Violet 
staining validates the conclusions taken from propidium iodide staining analysis. (C) 
Representative light microscopy images of gonadal fat depots on day 6 post-infection, 
assessed by immunohistochemistry with anti-T. brucei H2A rabbit serum (parasites 
appear in brown). Original magnification, 20x, 40x and 100x. Arrowheads indicate 
parasites undergoing nuclear division. 
 
 
 
Figure S5. Related to Figure 4. Subcellular organization of parasites from 
adipose tissue. (A) Length and width mean values of GFP-negative (slender) and 
GFP-positive stumpy/intermediate) parasites isolated from blood or fat. (B) 
Transmission electron micrograph images of parasites in gonadal adipose tissue (day 
28 post-infection). T, trypanosome; K, kinetoplast; BB, basal body; F, flagellum; FP, 
flagellar pocket; N, nucleus; Glyc, Glycosomes; Arrow: subpellicular microtubules. 
Scale bars represent 2 and 0,5 µm in the left and right panels, respectively. (C) 
MitoTracker Green, which stains in live cells the mitochondrion membrane, regardless 
of its membrane potential, was used to assess mitochondrion morphology. DNA was 
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stained by DAPI and images were captured under a confocal microscope. Bloodstream 
form parasites from day 4 of infection showed a punctate pattern typical of 
mitochondrion in slender parasites, while on day 6, were wider and shorter, 
mitochondrion displayed a tubular structure with a few branches in what appeared to 
be stumpy forms. The mitochondrion of adipose tissue forms present a tubular 
structure, but with fewer branches and thinner. All panels are shown with the same 
magnification. Scale bar represents 5 µm. 
 
 
 
Figure S6. Related to Figure 6. Lipid metabolites identified by GC-MS. 
All panels show the structure and fragmentation pattern of methyl ester derivatives of: 
(A) myristic acid (C14:0) 
(B) fully deuterated-myristic acid (D27-C14:0) 
(C) 3-hydroxy- myristic acid (3-HO-C14:0) 
(D) 3-hydroxy-deuterated- myristic acid (D24-3-HO-C14:0) 
(E) deuterated-myristoleic acid (D25-C14:1) 
(F) 3-keto-deuterated- myristic acid (D24-3-keto-C14:0) 
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Figure S7. Related to Figure 6. Only ATF parasites produce hydroxyl-fatty acids 
as part of beta-oxidation catabolism of fatty acids. FAME analysis by GC-MS of 
D27-Mys labeled and subsequently chased bloodstream (A) and adipose tissue (B) 
forms. Trace 31-37 minutes showing positions of (3-HO-C14:0) and (D24-3-HO-C14:0) 
in adipose tissue forms only. 
 
 
1.7. Accession Numbers 
 
The ArrayExpress accession number for Lister427 culture parasites is E-
MTAB-1715. Sequence data generated as part of this study have been 
submitted to the ArrayExpress database (EMBL-EBI) under accession number 
E-MTAB-4061. 
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The “Chapter II – Results – 2. Trypanosoma brucei infection accelerates the 
mouse circadian rhythm” consists of a second manuscript that will be soon 
submitted for publication. Here is clarified the contribution of each of the 
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2. Trypanosoma brucei infection accelerates the mouse 
circadian rhythm 
 
2.1. Abstract 
 
Sleeping sickness is a fatal disease caused by Trypanosoma brucei - a 
unicellular parasite that lives in the bloodstream and interstitial spaces of 
several organs, including the brain. Sleeping sickness patients show alterations 
in the sleep/wake cycle, which have led to the hypothesis that this may be a 
circadian rhythm disorder. To test this, we first recorded the circadian running-
wheel activity of T. brucei-infected mice. We observed that infected mice run 7-
fold more during the rest phase, with some animals running ~50% of their daily 
activity during the rest phase. These observations indicate that as infection 
progresses the circadian rhythm of the host is disrupted. In constant dark, we 
detected a gradually shorter period of running-wheel activity a few days after 
infection. This is surprising because parasites take >15 days to accumulate in 
the brain, suggesting that the early effects in mice behavior may be a 
consequence of a peripheral signal that feedback on the master clock. When 
we assessed PERIOD2::LUC expression ex vivo, we observed that, although all 
organs have robust circadian rhythms, those with higher parasite load have ~2 
h shorter period than non-infected organs, indicating that the infection has a 
major but specific impact on peripheral circadian rhythm. Finally, when we co-
cultured T. brucei parasites with PER2::LUC fibroblasts, we also observed a 
shortening of the circadian period, suggesting that T. brucei parasites could 
directly modulate the circadian clock of their host. Overall, we conclude that T. 
brucei causes a circadian rhythm disorder, which by changing the host 
molecular clock may be responsible for the changes in sleep/wake cycle 
observed in mice and humans and that give the name to the disease, as well as 
other physiological characteristics controlled by the clock as metabolism. 
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2.2. Introduction 
 
Sleeping sickness is an infectious disease caused by Trypanosoma 
brucei - a unicellular and extracellular parasite. T. brucei can be initially found in 
the bloodstream and interstitial spaces of several organs and eventually 
crosses the blood brain barrier and reaches the brain, leading to coma and 
death if untreated. Sleeping sickness patients experience a myriad of different 
symptoms: from hypothermia, disturbed appetite, weight loss, motor weakness, 
tremor to even aggressiveness (23). But, the hallmark of sleeping sickness is 
the disruption of the sleep pattern, giving name to the disease. Patients 
experience somnolence during the day and insomnia at night, but with similar 
total time spent sleeping as healthy individuals (28, 41). This curious type of 
sleep/wake cycle disruption, together with changes in body temperature 
regulation and wrong time of endocrine secretion (27, 41, 78, 196), have led to 
the hypothesis that sleeping sickness may be a circadian rhythm disorder (78).  
By living in a 24-hour world, organisms are subjected to daily 
environmental changes. Many organisms, from bacteria to humans have 
evolved molecular mechanisms to anticipate such changes. In humans, the 
master internal clock is located in the hypothalamic suprachiasmatic nuclei 
(SCN) of the brain, which with both neuronal and humoral signals can regulate 
output pathways that control diverse physiological functions: including 
sleep/wake cycle, core body temperature and metabolism (131). Within each 
cell of our body we can find an accurate transcription–translation feedback loop 
comprised of a core set of genes: the activators Clock and Bmal1 and their 
repressors Per (Period 1 and 2) and Cry (Cryptochromes 1 and 2) (126). This 
loop takes 24 h to be completed, leading to the rhythmic expression of multiple 
downstream genes that will then impact a variety of cellular pathways. 
It has been known since 1895, when David Bruce first discovered T. 
brucei as the causative agent of sleeping sickness (197) that this infection was 
in the source of the sleep disruption. However, even though the parasite’s life 
cycle and evasion from host immune system has been studied in detailed (161, 
198, 199), very little is known about how it affects the sleep/wake cycle. We do 
know that, after treatment, the sleep/wake cycle disruption of patients reverts to 
normal (28). Consistently, autopsies of patients who died of sleeping sickness 
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revealed very little neuro-degeneration (46, 78). Together these observations 
suggest that the presence of the parasite, rather than immune response or 
neuronal death, is the direct cause of this disease. 
In this work, we used a mouse model to test if T. brucei causes a 
circadian rhythm disorder. We show that (i) T. brucei mouse infection 
reproduces the circadian behavior and body temperature changes observed in 
humans; (ii) T. brucei infection accelerates the mouse circadian rhythm 
behavior and PER2 expression and (iii) this effect may be partly caused by a 
direct interaction with the parasite. 
 
2.3. Results 
 
To test whether T. brucei infection disrupts a mouse circadian behavior, 
we measured the activity of infected mice using running wheels. Mice were 
individually caged and running wheel revolutions scored with an automated 
system. To confirm that the circadian activity of mice prior to infection was 
normal, mice were first entrained in light/dark (LD) for 7 days and then constant 
darkness (DD) for 10 days. As expected, we observed that every mice, prior to 
infection, had a normal circadian rhythm, perceived by the robust running 
activity in DD. On day 0, mice were injected i.p. either with 2000 T. brucei 
parasites of a pleomorphic strain or with vehichle only. We observed that 
globally infected mice were 4-fold less active than control mice (Fig. 1A-B), in 
particular in the periods following high parasitemia, when anemia is ~50-70% 
(day 6-10 days post-infection, fig. S1A-B). This sickness-like activity reduction is 
likely due to high parasitemia that leads to exacerbated inflammation, as it has 
been shown that injection of pro-inflammatory cytokines reduces global running 
activity of a mouse (200).  
In humans, T. brucei causes relatively low and often undetectable 
parasitemia. In order to make the infection in mice more similar to humans, 
mice are typically treated around day 20 post-infection with suramin, a drug that 
cannot cross the blood brain barrier and thus only kills parasites in circulation 
(201). As a result the sickness-like phenotype disappears, mouse survival is 
prolonged with undetectable parasitemia.  
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Figure 1. Circadian activity and body temperature disruption in Trypanosoma-
infected mice. (A) Representative actograms of daily wheel-running activity of control 
and infected mice in light-dark cycles. All running-wheel experiments involve 7 days 
acclimatization period to wheels followed by 10 days dark period to confirm all animals 
have a normal circadian rhythm. Animals are either infected or injected with vehicle. 
Activity records were double plotted, with each day being represented beneath and 
also to the right of the preceding day. Horizontal black and white bars at the top of 
each actogram represent lights off and on, respectively. (B) Activity levels of control (n 
= 6) and infected (n = 14) mice. Error bars show mean ± SEM. *p < 0.05, **p < 0.01, 
***p < 0.001 by unpaired t test. (C) Representative actograms of daily wheel-running 
activity of control and infected mice in light-dark cycles. Animals were treated with 
suramin i.p. on day 21 post-infection. (D) Daily and relative rest-period activity levels of 
control (n = 6) and infected (n = 14) mice. Error bars show mean ± SEM. *p < 0.05, **p 
< 0.01, ***p < 0.001 by unpaired t test. (E) Representative actograms of core body 
temperature of control and infected mice in light-dark cycles. Animals were treated i.p. 
with suramin on day 21 post-infection. (F) Amplitude of circadian temperature 
oscillation control (n = 5) and infected (n = 7) mice. Bar graphs show mean ± SEM.  
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When we treated mice with suramin at day 21 post-infection, we 
observed that infected mice still run 1.5-fold less than control mice (fig. S1D). 
However, when considering the percentage of daily activity spent running 
during the rest period (day) was only 1% in control mice and ~15% in infected 
mice 50 days post-infection (Fig. 1C-D and fig. S1C). Altogether (day and night) 
infected mice run less than control mice, but even when considering the total 
number of wheel revolutions during the light period (day), infected mice run 4.5-
fold more than controls (fig. S1D, unpaired t test p < 0.05). This is extremely 
surprising because the inhibitory effects of light in running-wheel behavior have 
been extensively studied (202, 203). Remarkably, after day 50 four infected 
mice displayed dramatic changes in their behavior, running more than 25% of 
their daily activity during the rest period (Fig. 1C-D and fig. S1C).  
 
To further confirm that T. brucei infection disrupts circadian rhythm, we 
measured the core body temperature by telemetry (204). Mice were implanted 
under deep anesthesia during the light phase with an i.p. temperature sensor. 
We observed an initial fever-like peak that lasted ~2 days matching the first 
peak of parasitemia (day 5-6 post-infection), followed by a normal oscillation of 
high temperature during the night and low during the day (Fig. 1E and fig. S1E). 
However, around 60 days post-infection the highest core temperature shifted 
from the night to the day period, resembling the activity increase we observed in 
the wheel activity experiment (Fig.1B and E). This indicates that circadian 
temperature regulation is also affected, which is not necessarily always 
synchronized with the regulation of running-wheel activity (205). 
Interestingly, since the beginning of infection the temperature amplitude, 
which assesses the robustness of the circadian oscillation, was reduced in 
infected mice (Fig. 1F). The telemetry system also allowed us to measure 
general cage activity. We observed, once again that later in the infection the 
general cage activity is increase during the rest (light) period (fig. S1F).  
Using an additional independent assay for determination of sleep-like 
behavior by automated video analysis (CleverSys), we confirmed that later in 
infection (day 95) infected mice spend more time resting during the active 
phase than control animals, even though they do not rest more over the 24 h 
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(fig. S2). Together these results show that T. brucei-infected mice show a 
similar disruption of circadian activity along with daily temperature deregulation 
as described in humans.  
 
Because mice started running during light period, which is incredibly rare 
with wild-type mice, we wondered whether they vision was compromised 
affecting the light perception and therefore inhibition of running-wheel activity 
during the day. The elevated plus maze, in which animals are preferentially 
restricted to the closed arms, avoiding the open/exposed arms, showed no 
differences between trypanosome-infected and control mice. This suggested 
that even later during infection, mice have visual depth perception. Next we 
asked if this infection disrupts circadian rhythms in constant darkness, when the 
internal circadian clock is the only temporal cue. In the absence of light, 
circadian clock imposes a stable wheel running activity with a period of ~23.7 h, 
with more activity during the night phase (Fig 2A-C) (134). To address if T. 
brucei infection altered the internal clock period, we infected and let the 
infection progress in the darkness only. We observed that running-wheel activity 
period was shorter in infected mice than in control mice (Fig. 2A-D, 30 min on 
average, unpaired t test). Unlike control mice, whose period is stable over time, 
infected mice showed a progressively shorter period (Fig. 2B-D): from ~23.5 h 
in the first 10 days to ~23.1 h in d70-80. Interestingly, this shorter period was 
immediately detected in the first ten days post-infection, a period in which very 
few or no parasites can be detected in the brain (Fig. 2E) (82). This short period 
is also detected in later time points (after day 40), when parasites are 
exclusively in the brain due to suramin treatment. Our results suggest that 
changes in mice behavior may be not be exclusively due to presence of 
parasites in the brain, but rather a consequence of a peripheral signal, such as 
a metabolite or hormone that feedback on the master clock.  
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Figure 2. Shorter period of running-wheel activity of Trypanosoma-infected mice. 
(A) Representative actograms of daily wheel-running activity of control and infected 
mice in constant darkness (DD). All running-wheel experiments involve 7 days 
acclimatization period to wheels followed by 10 days dark period to confirm all animals 
have a normal circadian rhythm, after which animals are either infected or injected with 
vehicle in the dark. Activity records were double plotted, with each day being 
represented beneath and also to the right of the preceding day. Horizontal black and 
white bars at the top of each actogram represent lights off and on, respectively. (B) 
Period of running-wheel activity of control (n = 6) and infected (n = 14) mice. Bar 
graphs show mean ± SEM. (C) Representative actograms of daily wheel-running 
activity of control and infected mice in constant dark. Animals were treated with 
suramin i.p. on day 21 post-infection. (D) Period of control (n = 8) and infected (n = 27) 
mice. Error bars show mean ± SEM. (E) Temporal histological analysis of infected 
brain. Representative images of the choroid plexus area (n = 5/group).  
 
Since both behavior and core temperature of the mouse were disrupted 
upon infection, next we interrogated if this could be explained by changes in the 
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expression of core clock genes. For this, we infected PERIOD2::LUCIFERASE 
mice (PER2::LUC) (206), we sacrificed animals and we collected multiple 
organs to measure ex vivo the daily PER2 expression. When mice were 
sacrificed 6 days post-infection no changes in period were detected, but 
interestingly the phase of the adipose tissue depots was as advanced. To test 
whether this change in PER2 expression was stronger once more parasites 
have infiltrated the organs, we tested the expression of PER2::LUC in the same 
organs on day 20. 20 days post-infection, we observed that most infected 
organs kept the normal circadian parameters of phase, damping and period of 
the controls (Fig. 3A-C and fig. S3A). Adipose tissue, however, which has the 
highest parasite load (chapter I of this thesis), had a ~2 h shorter period (Fig. 
3A-B and S3B, unpaired t test, p < 0.001). This tissue also showed a phase 
advance as observed on day 6 and importantly remained healthy, with damping 
remaining unaffected. This was observed in both gonadal and perirenal adipose 
tissue depots (Fig. 3B-C). The period shortening observed on day 20 and phase 
advance for both day 6 and 20 in adipose tissue suggests that even though on 
day 6 the presence of parasites was not enough to lead to a shorter period, 
these depots are already having their maximum PER2:LUC expression earlier 
in the day than controls, and as the parasite load increases a shorter period is 
detected, even ex vivo (Fig. 3C). 
To test whether the shorter period of infected adipose tissue could be 
reverted by eliminating the parasites, we treated animals with suramin and 
assessed PER2::LUC expression profile at day 60. When parasites were 
eliminated from the peripheral organs, the period of the adipose tissue was the 
same as in control organs (Fig. 3D-E), suggesting that the shorter period was a 
consequence of high parasite load. Remarkably, on day 60 the period of the 
SCN of infected mice was 30 min shorter than control SCNs (Fig. 3D-F and 
S3B, unpaired t test, p < 0.01). This is particularly interesting because, in 
light/dark conditions only around day 60 we observed disruption of the circadian 
activity and body temperature of infected mice (Fig.1C-F). Together these data 
suggest that the cumulative parasite load in the peripheral organs leads to 
changes in the period of the tissue circadian clock. The SCN seems more 
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resistant to circadian changes than peripheral organs and only at day 60 could 
we detect a statistically significant reduction of the period. 
 
Figure 3. Shorter period of PER2::LUC explants when high number of parasites 
is present. (A) Representative normalized records of bioluminescence reporting of 
circadian expression from gonadal adipose tissue and SCN on day 20 post-
infection/vehicle. Tissues were prepared from mice in LD. Shown are 7 days of 
continuous recording after explant preparation. (B, C) Period and phase plots of 
various tissues harvested from control (black) and infected mice (day 6 yellow, day 20 
orange) mice. The sample size is indicated on right. Shown are mean period ± SD. *p < 
0.05, **p < 0.01, ***p < 0.0001 by unpaired t test. (D) Representative records of 
bioluminescence reporting of circadian expression from gonadal adipose tissue and 
SCN on day 60 post-infection/vehicle. Animals were treated with suramin. Tissues 
were prepared from mice in LD. Shown are 7 days of continuous recording after 
explant preparation. 
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(E, F) Period and phase plots of various tissues harvested from control (black) and 
infected mice (day 60 dark orange) mice. The sample size is indicated on right. Shown 
are mean period ± SD. *p < 0.05, **p < 0.01, ***p < 0.0001 by unpaired t test. 
 
 
To test if the expression of other clock genes was also affected upon 
infection, we infected 18 mice kept in the darkness and on day 20 post-infection 
we collected and extracted RNA from organs. 3 mice were sacrificed every 4 h, 
with the time defined for each time point estimated based on their running-
wheel activity circadian time (203). We measured the gene expression of genes 
involved in the molecular clock: transcriptional activator Bmal1, transcriptional 
repressors Per1 and Rev-erba, and an immediate downstream target of the 
clock D site of albumin promoter (albumin D-box) binding protein (Dbp). As 
expected, even after 20 days in the dark, control mice’s clock gene expression 
cycled in liver, adipose tissue and hypothalamic area (Fig. 4A and S4A). It is 
clear the expected daily oscillations of Bmal1, with its maximum expression at 
circadian time 24 h (CT24). BMAL1 protein heterodimerizes with CLOCK and 
activates transcription of Per1, Rev-erba and Dbp, whose maximum expression 
is detectable at CT8-12. On the contrary, the circadian transcript profile of clock 
genes is highly disrupted when mice are infected by T. brucei (Fig. 4A and S4A, 
two-way ANOVA). 
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Figure 4. Shorter period is not common in every infection. (A) Real-time RT-PCR 
analysis of clock gene expression in control (black) and Trypanosoma-infected 
(orange) mice. Two organs are shown, liver and gonadal adipose tissue. Error bars 
represent SEM for each time point from three independent replicates. Two-way 
ANOVA shows significant statistical differences between control and Trypanosoma-
infected mice, * p < 0.05, ** p < 0.01, *** p < 0.001. (B) Real-time qPCR analysis of 
clock gene expression in control (black) and Plasmodium-infected (blue) mice. Two 
organs are shown, liver and gonadal adipose tissue. Error bars represent SEM for 
each time point from three independent replicates. Two-way ANOVA shows significant 
statistical differences between control and Trypanosoma-infected mice, * p < 0.05, ** p 
< 0.01, *** p < 0.001. (C) Period plot of various tissues harvested from control (black) 
and Plasmodium-infected mice (blue) mice. The sample size is indicated on right. No 
significance was found, unpaired t test. (D) Period plot of various tissues harvested 
from PER2::LUC mice and co-cultured with medium only (black) or 105 Trypanosoma 
brucei (orange). The sample size is indicated on right. No significance was found, 
unpaired t test. (E) Representative records of bioluminescence reporting of circadian 
expression from PER2::LUC ear fibroblasts co-cultured with 105 Trypanosoma brucei 
(orange). (F) Period comparison from PER2::LUC ear fibroblast with medium (black) 
and co-cultured 105 Trypanosoma brucei (orange). Unpaired t test, * p < 0.05. 
 
To test if the disruption of clock gene circadian expression is a specific 
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parasite. Both these infections are chronic in the mouse model, they have 
comparable immune response and similar tissue sequestration (fig. S4B-D). We 
infected 18 mice with P. chabaudi and right before the second peak of 
parasitemia mice were housed in the dark for 48 h. Organs were collected 
during the second peak of parasitemia, every 4 h and the same transcript levels 
of the same clock genes were measured by qPCR. We observed that the 
expression profile of clock genes in the liver was similar in both control and 
Plasmodium-infected mice. However, in the adipose tissue expression of clock 
genes was in general lower in Plasmodium-infected mice (Fig. 4B, two-way 
ANOVA). Even though the effects observed in clock gene expression of T. 
brucei-infected mice, the fact that to some extent there was downregulation of 
clock gene expression in the adipose tissue of Plasmodium-infected mice is 
likely to be due to inflammation, since it has been previously demonstrated that 
TNF-α impairs expression of clock genes in synchronized NIH 3T3 fibroblasts 
(200). The period of oscillations however, remained the same in the control 
fibroblasts in the same study (200). To assess wether the period of clock gene 
oscillations was affected, we infected PER2::LUC mice with P. chabaudi. None 
of the organs tested showed significantly different period than control mice 
(Fig.4C, unpaired t test, p > 0.05), indicating that unlike T. brucei, a P. chabaudi 
infection does not cause any detectable circadian alterations.  
Together our data seem to dissect two different effects of the T. brucei 
infection: i) down-regulation of clock gene expression (common to other 
infections, inflammation-driven); ii) period shortening (probably not 
inflammation-driven).  
To further exclude the contribution of inflammation, we co-cultured 
healthy explants of SCN, lung, gonadal adipose tissue and epididymis of 
PER2::LUC mice with 105 T. brucei parasites. Luminescence was recorded for 
seven days and circadian parameters estimated as above. Whereas no 
significant changes were detected in terms of phase, amplitude and period, in 
the presence of parasites period tended to be shorter (Fig. 4D). Perhaps the 
number of parasites co-cultured was not enough to cause changes in such a 
high number of host cells. Unfortunately due to technical limitations we could 
not test with higher number of parasites (T. brucei in culture differentiate into a 
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non-replicative form and die if their density is higher than 1-3x106/mL), instead 
we tested with lower number of mouse PER2::LUC cells, primarily cultured ear 
fibroblasts. We observed that, in the presence of T. brucei, fibroblasts period 
was 30 min shorter (Fig.4E-F, unpaired t test, p < 0.05). These data suggest 
that the presence of parasites, and not the immune system is responsible for 
the changes in period of host circadian clock.  
 
 
2.4. Discussion 
 
In this study, we showed that T. brucei affects both behavior and 
temperature regulation of its host, which seem to happen since the beginning of 
the infection, prior to the detection of parasites in the brain. The period of 
PER2::LUC infected adipose tissue showed 2h shorter period than control, 
which could be reverted when parasites were cleared by suramin treatment. 
The period of PER2::LUC SCN of infected mice was shorter around day 60, 
when we also detected increase activity and body temperature during the rest 
phase of these mice. Interestingly, P. chabaudi-infected organs showed a slight 
downregulation of clock gene expression but their period remained similar to 
controls. Finally, in co-culture experiments with T. brucei, fibroblasts showed 
shorter period, which may mean that parasites, and not immune response, 
directly accelerate the host’s molecular clock.  
 
Throughout the years evidence has been gathered that connects 
inflammation and in particular cytokines with fever, fatigue, and sleep 
disturbances, which are collectively referred to as sickness behavior syndrome. 
By injecting TNF-α, a pro-inflammatory cytokine, the locomotor activity of mice 
is dramatically decreased (200). TNF-α and IL-1β are also both somnogenic, 
increasing nonrapid eye-movement (NREM) sleep (207, 208). TNF-α leads to 
the suppression of the expression of clock downstream genes Dbp, Tef, and Hlf 
and of the Period genes Per1, Per2, and Per3 (200). So, in general cytokines 
(209-211) and even bacterial infection (146) have been shown to affect the 
circadian clock, which may be a common factor to all infections and responsible 
for the sickness behavior. 
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Although this may explain why Trypanosoma-infected mice run less than 
healthy control mice, and why both Trypanosoma- and Plasmodium-infected 
mice show lower transcript levels of clock genes, it cannot explain the 
differences in timing of expression. Although TNF-α injection decreases activity, 
it does not alter mice circadian rest-activity cycles (200). Similarly, cytokines 
damped the oscillations of clock gene expression but always kept the same 
period (200). The fact that the period of PER2::LUC Trypanosoma-infected mice 
did not change on day 6, when there is already very high inflammation, at least 
in the bloodstream (198, 201), and that despite inflammation (212), 
Plasmodium-infected mice organs also maintained their period, suggests that 
period shortening induced during T. brucei infection is not due to inflammation. 
Furthermore, in vitro PER2::LUC fibroblasts co-cultured with T. brucei showed 
shorter period. Together these results suggest that Trypanosoma brucei 
appears be the first infection capable to disrupt the period of the host circadian 
clock.  
Ex vivo analysis of PER2::LUC expression in neurons of the SCN of T. 
brucei-infected mice showed that this remained similar to controls on day 6 and 
day 20 post-infection. On the contrary, on day 60 post-infection the period of 
PER2::LUC expression of SCN was shorter than controls. This could be due to 
either higher parasite infiltration in the brain parenchyma on day 60 than on day 
20, or to the fact that the master clock has a more robust molecular clock (213), 
with higher intrinsic resistance that requires more time to be affected. One or 
both of these possibilities are likely the cause for why, even when significantly 
shorter than controls, SCN period is only 30 min shorter and not 2 h as 
observed for the high infiltrated adipose tissue. 
 
Interestingly, when behavior of infected mice was recorded in the drak, 
we detected an immediate shorter running period, even before the parasites 
accumulate in the brain. Since running behavior is controlled by the master 
clock in the brain, SCN, these observations mean that the presence of high 
numbers of T. brucei in the brain is not necessary for the master clock to be 
disrupted. Probably a peripheral molecule(s), metabolite or hormone, from the 
host or directly produced by the parasite, is released from the periphery and it 
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feeds back to the master clock. This observation is consistent with a study in 
Uganda, in which 58% and 54% of T. brucei rhodesiense infected patients 
experienced somnolence in both early- and late-stage, respectively (214). 
Similar observations were made in T. brucei gambiense (23, 215). This 
suggests that, even though this disease is divided into two stages: an early-
stage with parasites only in the periphery and a late-stage when parasites 
penetrate the blood brain barrier, patients may experience sleep disruption in 
both stages.  
In this study we described the first infection that interferes with the host 
circadian rhythm at the behavior, cellular and molecular levels. These changes 
are likely the cause of sleep alterations that are typical of sleeping sickness. 
Further studies are required to identify what systemic signal (secreted by the 
parasite, or a molecule produced by the host in response to this infection) that 
could be responsible for such changes in the period of the circadian clock. 
 
 
2.5. Materials and methods 
Ethics Statement 
All animal care and experimental procedures were performed in accordance 
with University of Texas Southwestern Medical Center (UTSW) IACUC 
guidelines, approved by the Ethical Review Committee at the University of 
Southwestern Medical Center and performed under the IACUC-2012-0012 
protocol and according to European Union (EU) Directive 2010/63/EU and 
approved by the Animal Ethics Committee of Instituto de Medicina Molecular 
(IMM) (AEC-2011-006-LF-TBrucei-IMM), following FELASA guidelines 
concerning laboratory animal welfare.  
 
Parasites and Culture Conditions 
T. brucei AnTat 1.1E, a pleomorphic clone, derived from an EATRO1125 clone 
was originally isolated from blood of Tragelaphus scriptus in Uganda. For all the 
experiments, we used AnTat 1.1E 90-13, a transgenic cell-line encoding the 
tetracyclin repressor and T7 RNA polymerase (23). For all mice infections, the 
parasite cryostabilates used were obtained by a previous infection, on day 5 
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post-infection. For co-culture experiments, bloodstream forms were grown 
routinely in HMI-11 at 37°C in 5% CO2 (24). Parasite numbers were calculated 
using a Hemocytometer.  
 
Trypanosoma brucei mice-infection  
The infections of wild-type male C57BL/6J mice, 6-10 week old (UT 
Southwestern Medical Center Mouse Breeding Core Facility or Charles Rivers, 
France) described in this manuscript were performed by intraperitoneally (i.p.) 
injection of 2,000 T. brucei AnTat 1.1E parasites. Prior to infection, T. brucei 
cryostabilates were thawed and parasite viability and numbers were assessed 
by mobility under an optic microscope. For circadian luminescence experiments 
mice were group-housed and maintained in a Specific-Pathogen-Free barrier 
facility. The facility has standard laboratory conditions: 21 to 22°C ambient 
temperature and a 12 h light/12 h dark cycle. For behavioral and telemetry 
experiments mice were individually housed. Chow and water were available ad 
libitum. 
 
Circadian behavioral experiments 
80 mice were placed in individual running wheel cages and their activity 
recorded continuously using the ClockLab data collection system (Actimetrics, 
Evanston, IL) (203). After the first week on an LD12:12 cycle, the mice were 
released into DD for 10 days and then infected with T. brucei either back on LD 
cycle (28 mice) or remaining in DD (28 mice) for the rest of the experiment. 14 
infected mice in LD cycle and 14 mice in DD were treated with suramin on day 
21 post-infection, at ZT10-11. Free running periods were measured by line 
fitting of activity onsets from data collected during the DD period of the assay 
using ClockLab data analysis software.  
 
Core body temperature measurement 
12 mice were implanted with minimitters inside the peritoneal cavity. Animals 
were monitored for 3 weeks to recover from the surgery prior to recordings. 
Baseline recordings of 4 days in LD12:12 cycles and 10 days in DD. Seven 
mice were infected whereas 5 were injected with HMI-11 only. For the 
  T. brucei infection accelerates the mouse circadian rhythm 
 
 
 
101 
remaining period of the experiment the light schedule was LD12:12 cycles. On 
day 21 post-infection all animals were injected i.p. with suramin. 
 
CleverSys behavioral assay 
6 mice were injected i.p. with either HMI-11 or T. brucei. 21 days post-infection 
animals were injected with suramin. On days 50, 65 and 95 post-infection 
animals were individually housed and their movement recorded for 48 h using 
CleverSys software. Data were auto scored by CleverSys.  
 
RNA Isolation and Real-Time PCR of Trypanosoma brucei-infected Mice 
Animals were housed individually and activity monitored using a running wheel. 
36 animals were either infected or injected with medium and released into 
constant darkness. Locomotor activity was recorded and analyzed using 
ClockLab software (Actimetrics, Wilmette, IL) to determine the circadian phase, 
as previously described (203), for each animal on day 20 post-infection. Three 
animals per phase cluster (6 time points) were euthanized by cervical 
dislocation, organs collected and snap frozen.  
RNA isolation and real-time PCR were performed as described previously 
(216). Transcript levels were normalized to Gapdh. Primer sequences are listed 
in table S1. 
 
RNA Isolation and Real-Time PCR of Plasmodium chabaudi-infected Mice  
36 wild-type male C57BL/6J mice, 6-10 week old (Charles Rivers, France) were 
either infected by i.p. injection of 1x105 P. chabaudi infected red blood cells 
(iRBC) in 200 µL PBS or injected with PBS as control animals. Parasitemia was 
assessed daily. On the second peak of parasitemia animals were released into 
constant darkness for 48 h. Three animals per each of the 6 time points (every 
4 h) were euthanized by cervical dislocation, organs collected and snap frozen. 
RNA extracted and gene expression quantified by real-time PCR (216).  
 
Circadian Bioluminescence Experiments 
Trypanosoma-Infected and uninfected mPer2::Luc mice (206) were euthanized 
by cervical dislocation between ZT10 and ZT12 at days 6, 20 and 60 post-
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infection. SCN tissues were isolated from 300 µm coronal sections and pituitary, 
heart, lung, liver, adrenal, adipose tissue and epididymis were dissected and 
kept in chilled Hanks’ buffered salt solution (Invitrogen) until culture. All 
dissected tissues were cultured on Millicell culture membranes (PICMORG50, 
Millipore) and were placed in 35 mm tissue culture dishes containing 2 mL 
TbM50 medium, composed of 50% (v/v) DMEM media (Mediatech) 
supplemented with 2 mM L-Glutamine, 25 units/mL penicillin, 25 µg/mL 
streptomycin (Invitrogen) and 50% (v/v) HMI-11 no phenol 5% FBS and 0.1 mM 
luciferin potassium salt (L-8240, Biosynth AG). Sealed dishes were placed in 
LumiCycle luminometer machines (Actimetrics, Wilmette, IL) and 
bioluminescence was recorded continuously. 
Plasmodium-infected mPer2::Luc mice were euthanized on day 16 post-
infection and organs were processed similarly.  
Primary ear fibroblasts were isolated from the ear of PER2::LUC mice using 5 
mg/mL collagenase I and 0.05% trypsin incubating 30 min at 37ºC. 
 
2.6. Supplementary figures and tables 
 
 
Table S1 – primers 
 
Gene Fw/Rev Seq (5' - 3') 
Reverb a Fw AGA CTT CCC GCT TCA CCA AG 
Reverb a Rev AGC TTC TCG GAA TGC ATG TT 
Period 1 Fw CCC AGC TTT ACC TGC AGA AG 
Period 1 Rev ATG GTC GAA AGG AAG CCT CT 
Dbp Fw CGAAGAACGTCATGATGCAG 
Dbp Rev GGTTCCCCAACATGCTAAGA 
Gapdh Fw caaggagtaagaaaccctggacc 
Gapdh Rev CGAGTTGGGATAGGGCCTCT 
Bmal1 Fw CCACCTCAGAGCCATTGATACA 
Bmal1 Rev GAGCAGGTTTAGTTCCACTTTGTCT 
IL-10 Fw TGCTATGCTGCCTGCTCTTA 
IL-10 Rev TCATTTCCGATAAGGCTTGG 
TNF-a Fw AATGGCCTCCCTCTCATCAGTT 
TNF-a Rev CCACTTGGTGGTTTGCTACGA 
IL-6 Fw TTCCATCCAGTTGCCTTCTT 
IL-6 Rev CAGAATTGCCATTGCACAAC 
IL-1 Fw GCCCATCCTCTGTGACTCAT 
IL-1 Rev AGGCCACAGGTATTTTGTCG 
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Figure S1. Circadian activity and body temperature disruption in Trypanosoma-
infected mice. (A) Parasitemia profile of T. brucei infected mice. (B) Hematocrit of both 
control (black) or Trypanosoma-infected (orange) mice. (C) Two additional actograms 
of daily wheel-running activity of infected mice in light-dark cycles. Animals were 
treated with suramin i.p. on day 21 post-infection. (D) Total activity levels during rest 
period of mice infected and treated with suramin on day 21. Error bars show mean ± 
SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by unpaired t test. (E) Representative 
actogram of telemetry measured body temperature in the initial nine days of infection 
revealing a ~2 day fever period in infected mice. (F) Telemetry measured general cage 
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activity of control (n = 5) and infected (n = 7). Error bars show mean ± SEM. *p < 0.05, 
**p < 0.01, ***p < 0.001 by unpaired t test. (G) Additional actogram of daily wheel-
running activity of infected mice in DD. 
 
 
 
 
Figure S2. Automated video analysis revealed sleep-like behavior disruption in 
Trypanosoma brucei-infected mice. (A) Daily amount of time spent resting in both 
control (black) and Trypanosoma-infected mice (orange) on day 50, 65 and 95 post-
infection. Shaded area represent SEM. (B) Quantification of amount spent resting on 
day 50, 65 and 95 post-infection in the entire 24 h, day- or night-period. error bars 
represent SEM. 
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Figure S3. Shorter period of PER2::LUC explants when high number of parasites 
is present. (A) Damping analysis of various tissues harvested from control or infected 
mice in DD. Control (black, pooled from day 6 and day 20), infected day 6 (yellow), 
infected day 20 (orange), infected day 60 (dark orange, treated with suramin on day 
21) and control on day 60 treated with suramin (gray). Shown are mean period ± SD. 
*p < 0.05, **p < 0.01, ***p < 0.001 by unpaired t test. (B) Representative records of 
bioluminescence reporting of circadian expression from gonadal adipose tissue, day 20 
and SCN on day 60 post-infection/vehicle. (C) Period plots of various tissues harvested 
from control (black) and control day 60 treated with suramin (gray) mice. Shown are 
mean period ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 by unpaired t test. (D) Period 
plots of SCN harvested from control (black) and control day 60 treated with suramin 
(gray) mice show no effect of suramin in this tissue. 
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Figure S4. Shorter period is not common in every infection. (A) Real-time RT-PCR 
analysis of clock gene expression in control (black) and Trypanosoma-infected 
(orange) mice hypothalamus. Error bars represent SEM for each time point from three 
independent replicates. (B) Histological analysis of Liver from mice infected with T. 
brucei (left column) and P. chabaudi (right column), 20 and 16 days post-infection, 
respectively. For T. brucei, there is infiltration by mononuclear cells, periportal and 
parenchymal, multifocal and of minimal to mild severity. For P. chabaudi, inflammatory 
cell infiltrates are also mononuclear-cell rich, frequently laden with hemozoin (brown 
pigment), and distribution is mainly parenchymal, multifocal and of moderate severity. 
(C) Histological analysis of adipose tissue from mice infected with T. brucei (left 
column) and P. chabaudi (right column), 20 and 16 days post-infection, respectively. 
For both infections, adipose tissue displays inflammatory cell infiltrates, but the cell 
type, topography, distribution and severity are distinct. For T. brucei, mixed 
inflammatory cell infiltrates are rich in polymorphonuclear eosinophils and mononuclear 
cells, macrophages, lymphocytes and some plasma cells; cells are located in the 
adipose tissue stroma, with diffuse distribution and the lesion is severe. Trypanosomes 
are frequently seen, scattered among the inflammatory infiltrates. For P. chabaudi 
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inflammatory cell infiltrates are mononuclear-cell rich, composed of macrophages and 
lymphocytes; are mainly ascribed to the perivascular compartment, with multifocal 
distribution and of mild to moderate severity. Infected red blood cells are frequently 
seen, sequestered in the adipose tissue vessels/capillaries. (D) Cytokine expression 
levels in liver of control and infected mice (n = 5/group). Error bars show mean ± SEM. 
*p < 0.05, **p < 0.01, ***p < 0.001 by unpaired t test.   
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3.  Post-Transcriptional Circadian Regulation of Genes 
Related to Metabolism and Suramin Sensitivity in 
Trypanosoma brucei 
 
 
3.1. Abstract 
 
Free-living organisms have evolved circadian molecular clocks to 
anticipate daily changes in their environments; however, it is unclear whether 
parasites have intrinsic clocks. Trypanosoma brucei, the causative agent of 
sleeping sickness, is a unicellular parasite that switches between two hosts, a 
vertebrate and a tsetse fly vector. Here we show that approximately 10% of 
genes in T. brucei are expressed with a circadian rhythm in both entrained and 
constant conditions. The maximum expression of these genes occurs at two 
different phases of the day and depend on a post-transcriptional mechanism. 
Circadian genes are enriched in cellular metabolic pathways, and coincide with 
two peaks of intracellular ATP concentration. Moreover, daily changes in the 
parasite population lead to differences in suramin sensitivity, a drug commonly 
used to treat this infection. 
 
One Sentence Summary: Trypanosoma brucei parasites have a post-
transcriptional intrinsic circadian clock that regulates metabolism and sensitivity 
to suramin. 
 
3.2. Main text 
 
The Earth’s rotation forced life to evolve under cyclic day and night 
environmental changes. In order to anticipate such daily cycles, prokaryote and 
eukaryote free-living organisms evolved intrinsic clocks that regulate 
physiological and behavioral processes. These molecular clocks are robust and 
run with a period of approximately 24 h even in the absence of external 
environmental stimuli, such as light or temperature cycles (217). Daily rhythms 
have been observed in organisms living within hosts, such as parasites. Human 
species of filariae show daily fluctuation of microfilariae density (the 
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transmissible form) in their hosts’ peripheral blood. These parasites migrate 
from the lymphatic system to the peripheral blood at night, which ensures 
transmission through their vector’s blood-meal (152). Human malaria parasite 
species display synchronous cell cycle durations of 48 or 72 h causing fever 
every 2 or 3 days, a hallmark of this disease (153). Despite such clear daily 
rhythms, it has not been previously established whether parasites have intrinsic 
clocks that anticipate the changes in the environment or whether they are 
simply responding to host rhythmic physiological cues.  
Sleeping sickness is a fatal disease caused by Trypanosoma brucei. It is 
transmitted by the tsetse fly and is endemic in 36 sub-saharan African 
countries, where 70 million people are at risk (218). The fact that this unicellular 
parasite is extracellular, easily cultured, genetically amenable and its genome 
has been sequenced, makes T. brucei an ideal system to test whether an 
obligatory pathogen has an intrinsic circadian clock. In eukaryotes, the current 
model for circadian timekeeping is based on a transcription/translation feedback 
loop (TTFL), in which transcriptional activators are negatively regulated by 
target gene repressors (219). However, clock genes are not phylogenetically 
conserved among fungi, plants and vertebrates, indicating that each phylum 
evolved an intrinsic clock with different components (220, 221).  
Here we asked whether T. brucei has an intrinsic circadian clock. We 
probed the parasite transcriptome by RNA-seq, searching for transcripts 
oscillating with a 24 h period. For this we synchronized parasites in vitro for 
three days to alternating temperature cycles of 32ºC and 37ºC at 12 h intervals. 
On the 4th and 5th days, parasites were kept in either these alternating 
conditions or constantly at 37ºC. During these two days, parasite RNA was 
collected every four hours and subjected to RNA-seq analysis (Fig. 1A). We 
measured circadian gene expression after entrainment with temperature cycles 
in both T. brucei bloodstream (32ºC/37ºC cycles) and insect procyclic forms 
(23ºC/28ºC cycles), as well as entrainment with light in the bloodstream form 
(fig. S1).  
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Fig. 1. Experimental design and RNA-seq analysis of circadian gene expression 
of Trypanosoma brucei. (A) Populations of parasites were entrained to 12 h : 12 h 
temperature intervals for three days, after which they were released into constant 
conditions or kept in alternating conditions for two days. During these two days, RNA 
was collected every 4 h for RNA-seq (see Materials and Methods and fig. S1). (B) 
Genome browser views of RNA-seq data from bloodstream form parasites in 
temperature-entrained constant conditions for two genes: Tb927.10.16100, FK506-
binding protein (FKBP)-type peptidyl-prolyl isomerase, putative and Tb927.1.4830, 
phospholipase A1 (genes represented in teal). CDS (coding sequence) is represented 
as a rectangle and intergenic regions as dotted line. Reads are shown in black as 
reads per million total reads (RPM). (C) RNA-seq read coverage in RPKM and 
circadian algorithm fits. ARSER fit is represented in a dark gray dashed line, 
JTK_CYCLE in teal and Fisher’s G-Test in orange. 
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Within each dataset, an unbiased comparison of the 13 samples using 
hierarchical clustering and principal component analysis showed that a cyclic 
pattern component accounted for 16-27% of the total variance, surprisingly 
being the first component in five of the six datasets. This shows that the time of 
sample collection is a key factor in most samples (fig. S2). To identify which 
genes showed a circadian expression pattern, we used three well-established 
algorithms to test if transcript levels cycles with a 24 h period (Fig. 1B-C). We 
considered a gene as cycling when its mean expression was above 10 RPKM 
(reads per kilobase of transcript per million mapped reads) and its circadian 
oscillation was detected by at least two of the three algorithms (p ≤ 0.05, fig. 
S3). Two examples of cycling transcripts are shown in Fig. 1B-C. 
Global analysis (Fig. 2 and data tables S1-3) revealed that hundreds of 
cycling transcripts were expressed in both stages of the life cycle. In 
bloodstream forms entrained with temperature, we found 1,490 genes (~15% of 
genome) oscillating in alternating conditions and 1,092 genes (~11% of 
genome) oscillating in constant conditions (Fig. 2A and S5). To determine the 
false discovery rate (FDR) for detection of cycling transcripts empirically, we 
performed a permutation test in which we randomized the original time of 
sample collection and calculated the number of cycling genes 10,000 times. We 
observed that the number of cycling genes identified in the correct sampling 
order was significantly higher than when sampling order was permutated (FDR 
< 0.05, fig. S4). 
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Fig. 2. T. brucei circadian transcriptome in bloodstream and insect procyclic 
forms. (A) Heat-map views of temperature-entrained cycling genes of bloodstream 
and procyclic forms. Each row represents a gene, ordered vertically by phase, 
determined by ARSER. (B) Phase distribution of cycling genes entrained by 
temperature. The phase of each gene rhythm across the day is represented in a 
histogram plot (top) and rose plot (bottom). The mean circular phase of the different 
phase clusters is indicated in orange. (C) Venn diagram of number of cycling genes 
identified in temperature-entrained cycling and constant conditions for bloodstream 
(left) and insect procyclic forms (right). (D) Heat-map views of light-entrained cycling 
genes of bloodstream for parasites. (E) Phase distribution of cycling genes entrained 
by light. (F) Venn diagram of number of cycling genes identified in light-entrained 
cycling and constant conditions for bloodstream forms. (G) Cycling gene expression in 
vivo. RNA was extracted from blood of infected mice. Transcript levels of proline 
dehydrogenase (Tb927.7.210) and putative amino acid transporter (Tb927.8.7650) 
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were normalized to non-cycling transcripts of zinc finger protein 3 (ZFP3, Tb927.3.720, 
teal) and acidic phosphatase (Tb927.5.610, dark teal). N = 18 (3 mice/time point). (H) 
Period of oscillation of 127 common cycling genes at constant temperatures of 28ºC 
and 37ºC. Distribution of the estimated Q10 for the period of the 127 common cycling 
genes. 
 
 
As observed in other systems, the distribution of the phases of maximal 
expression of cycling genes is bimodal, with the majority of genes peaking at 
environmental Zeitgeber Time (ZT) ZT8 and ZT20 (Fig. 2B). In constant 
temperature, phases are shifted ~2-3 h corresponding to Circadian Time (CT) 
CT11 and CT22 (Fig. 2B). As previously described (222, 223), we found that the 
oscillatory transcriptome is divergent between alternating and constant 
conditions and three categories were identified: i) genes oscillating in 
alternating conditions only (stimulus-driven and clock independent) (1,243 
genes, in the case of temperature-entrained bloodstream forms); ii) genes 
oscillating in both alternating and constant conditions (clock-driven genes) (247 
genes); iii) genes oscillating in constant conditions only (genes whose cycling is 
suppressed or masked during entrainment conditions) (845 genes). The vast 
majority of the 247 genes retained their mean, amplitude, phase and period of 
oscillation in both conditions (Fig. 2C and S8).  
When the host is bitten by a tsetse fly, T. brucei parasites differentiate 
into procyclic forms that are adapted to survive in the mid-gut of the fly where 
the temperature is much lower (~28ºC). Even though the transcriptome of 
bloodstream and insect procyclic forms is ~30% distinct (59), we tested whether 
insect procyclic trypanosomes share a circadian transcriptome. Similarly to the 
protocol used for bloodstream forms, we temperature-entrained cultures of 
procyclic forms for three days using 12 h intervals of 23ºC and 28ºC, followed 
by two days of constant (28ºC) or alternating temperature (fig. S1). In these 
trypanosomes, we identified 1,123 genes cycling in alternating conditions and 
854 genes cycling endogenously (Fig. 2A-C and S6). Of these, 127 genes (~1-
2% of transcriptome) oscillate in both life cycle stages, while 965 are specific to 
bloodstream and 727 are specific to procyclic forms (fig. S9). These data show 
that in two different stages of the life cycle of T. brucei, ~10% of the 
transcriptome undergoes circadian oscillations, suggesting that having a 
circadian rhythm conferred an evolutionary advantage throughout the parasite 
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life cycle. The fact that most cycling genes differ between the two stages 
indicates that the circadian clock can sense and adapt to the different host 
environments, another hallmark of circadian clocks.  
In addition to temperature entrainment, a canonical property of circadian 
clocks is temperature compensation, which is the ability of the period of a 
rhythm to remain relatively constant at various physiologically permissive 
temperatures (204). 127 genes cycled in constant conditions at 28ºC and 37ºC, 
which allowed us to estimate the Q10 for these genes. Period values do not 
significantly change between these two temperatures and the average Q10 is 
0.99 (Fig. 2H) showing that the circadian clock in T. brucei is temperature 
compensated.  
Light is a very strong cue to which most organisms entrain. Hence we 
interrogated whether light could entrain bloodstream forms. We identified 366 
genes cycling in the presence of the light stimulus and 242 genes cycling in 
constant darkness (Fig. 2D-F and S1 and S7). Although a principal component 
analysis identified a cyclic pattern in gene expression through the day (fig. 
S2C), a permutation test was not significant for these datasets (fig. S4B), which 
clearly shows that light is a weaker environmental cue than temperature for T. 
brucei, not surprising for a parasite that is never free-living. Nevertheless, 42 
genes were entrained by both temperature and light (fig. S9).  
Because the identification of the circadian transcriptome was performed 
in parasites in culture, next we tested whether transcript oscillations could also 
be found in vivo, i.e. in parasites from an infected mouse. For this, we collected 
blood every 4 h from mice kept in constant darkness. RNA was extracted and 
subjected to qPCR. We confirmed that transcript levels of several genes also 
cycled in vivo (Fig. 2G and S10), including proline dehydrogenase and a 
putative amino acid transporter. Taken together, these results show that host 
physiological rhythms (in vivo) and temperature (in culture) are capable of 
synchronizing T. brucei parasites, and that the transcriptome circadian 
oscillation is driven by an endogenous clock. 
Even though in eukaryotes the circadian timekeeping mechanism is based on a 
transcription/translation feedback loop model, recent studies have shown that 
post-transcriptional and post-translational steps impose further levels of 
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circadian regulation, in addition to non-transcriptional mechanisms (224). T. 
brucei and other Kinetoplastida are peculiar eukaryotes as most of the genome 
is organized in polycistronic units (PCUs) that are constitutively transcribed and, 
as a result, gene expression is mainly regulated post-transcriptionally (199, 
225). To determine whether T. brucei circadian gene expression was also post-
transcriptionally regulated, we tested whether cycling genes clustered in specific 
PCUs. We found that cycling genes show a uniform distribution among most 
PCUs (similar proportion of cycling and non-cycling genes, Kolmogorov-
Smirnov p > 0.1), with no bias for a specific position within a PCU (Kolmogorov-
Smirnov p > 0.5) nor enrichment for genes peaking at a specific phase 
(Kolmogorov-Smirnov p > 0.1, Fig. 3A-D and S11-13). The fact that co-
transcribed genes can either not cycle or cycle with a maximum expression at 
opposing phases suggests that the timekeeping mechanism used by T. brucei 
is primarily based on post-transcriptional regulation, which represents a novel 
mechanism of timekeeping in eukaryotes. 
 
 
 
Fig. 3. T. brucei cycling gene expression is post-transcriptionally regulated. (A-B) 
Distribution of cycling genes genes across chromosomes 1, 2 and 3. The transcription 
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start site (TSS) at the beginning of each polycistronic unit (PCUs) is indicated by a 
vertical black line. Genes are either: gray when non-cycling; orange when cycling with 
maximal expression between CT3-CT18 for (A) bloodstream or CT18-CT9 for (B) 
insect procyclic forms; and teal when cycling with maximal expression between CT19-
CT2 for (A) bloodstream or CT10-CT19 for (B) insect procyclic forms. (C-D) Examples 
of cycling genes with different phases of expression encoded in the same PCU in (C) 
bloodstream forms and in (D) insect procyclic forms. A representative PCU from each 
of the first three chromosomes is depicted. (E) Cell cycle profile analysis of 
bloodstream parasites throughout the 4th day of entrainment to temperature. Parasites 
were fixed and stained with propidium iodide. (F) Expression profile of two cell cycle 
associated genes (Tb927.11.11540 and Tb927.10.4990) and the algorithms fitted 
curves, showing no circadian oscillation. Gray line represents the raw RPKM in 
constant conditions. 
 
When we compared the mean expression of cycling and non-cycling 
gene sets, we observed that cycling genes have higher expression (fig. S14A) 
(226). Given that the 5’ and 3’ untranslated regions (UTRs) are determinants of 
the fate of an mRNA, we interrogated the length and GC content of both 5’ and 
3’UTR sequences of the two major clusters of cycling genes. We found no 
major differences in length and GC content of cycling and non-cycling UTRs (fig 
S14B-C). Similar to other species, sequence elements in the 3’UTR have been 
identified in T. brucei as regulatory motifs of the mRNA levels of EP Procyclin 
and cytosolic phosphoglycerate kinase (PGKC) (227, 228). As a potential post-
transcriptional regulation mechanism, we searched for common motifs in 5’ or 
3’UTRs of cycling genes of the two major gene clusters using six motif finding 
algorithms. Although this analysis identified hundreds of motifs, when we 
compared with the number of motifs identified in randomly selected sequences, 
the statistical significance enrichment dropped to 29 enriched motifs in the 
5’UTR and 32 in 3’UTRs of bloodstream forms’ cycling genes (4 and 28 
respectively in procyclic forms) (FDR < 0.05, fig. S15A-D). Since relevant 
regulatory sequences are often conserved among species (229), we tested 
whether motifs identified in cycling genes were more conserved among other 
Kinetoplastida species than those identified from a random set of genes. 
Interestingly, motifs identified on bloodstream 5’ and 3’UTRs, and procyclic 
3’UTRs of cycling genes were more conserved in other pathologically relevant 
related species (T. b. gambiense, T. cruzi, T. congolense, T. vivax and 
Leishmania major) than those found in random sequences (FDR < 0.001, fig. 
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S15E-F). These results suggest that conserved motifs of the 5’ and 3’ UTR 
regulatory sequences may play a role in the regulation of the cyclic gene 
expression pattern of T. brucei. 
To rule out that the cell cycle was responsible for the pattern of cycling 
transcripts, we temperature-entrained T. brucei bloodstream cultures and 
collected cells throughout the day to measure DNA content. Not surprisingly, we 
observed that parasite cultures in alternating conditions grew slower than in 
constant 37°C (7:33 h versus 6:53 h, doubling time, fig. S16B). However, the 
frequency of dividing cells in the population was constant throughout the day 
(~25%) suggesting that parasite cell division was not synchronized to occur at a 
certain time of the day (Fig. 3E and S16A). Furthermore, among cycling 
transcripts, we detected no enrichment of cell cycle associated genes (table S1 
and fig. S16C), as illustrated by the expression profile of DNA topoisomerase II 
and cdc2-related kinase 3 (Fig. 3F). Together, these data indicate that the cyclic 
pattern of T. brucei bloodstream transcriptome is independent of the cell cycle. 
To explore the biological relevance of a circadian clock in T. brucei, we 
performed a temporal Gene Ontology (GO) analysis. We assigned the clock-
regulated genes into 12 groups based on the phase of maximal expression and 
evaluated the enrichment of GO terms (Fig. 4A and databases S5 and S6). We 
found that 95% of cycling GO terms are enriched in only one phase cluster in 
bloodstream form (93% in insect procyclic forms) (p < 0.05), suggesting that 
specific cellular processes are upregulated at different times of the day. One 
such process is carbohydrate metabolism, in which 13 out of 31 genes 
annotated to this GO term peaked expression at CT22-24 (Fig. 4A). Among 
those genes, ten belong to the glycolysis pathway (fig. S17). The insect-stage 
parasite circadian gene expression also seems to upregulate different cellular 
functions throughout the day. For example, vesicle-mediated transport GO term 
is composed of 13 genes, nine of which peak at CT0-2 (Fig. 4A). 
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Fig. 4. The T. brucei circadian transcriptome comprises many metabolism related 
genes. (A) Heat-map view of GO term enrichment of both bloodstream and insect-
stage parasite circadian gene expression throughout the day (2 h phase cluster, p < 
0.05). Side plots show individual gene expression profile of the manually curated most 
significantly enriched GO term in the selected clusters. (B) Metabolic pathways are 
enriched in intrinsic cycling genes expressed at different times of the day. (C) Parasite 
intracellular ATP concentrations were measured on day four from cultures in 
alternating or constant temperature. (D) IC50 calculated from oxidative stress sensitivity 
experiment of parasites at different times of the day. N = 6 biological replicates. Error 
bars represent standard error. (E) IC50 calculated from suramin treatment of parasites 
at different times of the day. N = 9 biological replicates. Error bars represent standard 
error. 
 
A pathway analysis (KEGG) confirmed that many cycling genes are 
involved in metabolism or metabolism-associated functions. Even though a 
Post-transcriptional circadian regulation of gene expression in T. brucei 
 
 
 
122
cycling gene peaks only once a day, other genes from the same metabolic 
pathway may not oscillate, peak at the same phase or an opposite phase (Fig. 
4B). This overall transcript oscillation of metabolism-associated genes suggests 
that during the 24 h day the parasite population undergoes qualitative and 
quantitative metabolic adaptations. Because expression of most cycling genes 
peaks at two opposing phases of the day (Fig. 4B), it is likely that, as observed 
in mammals, parasites experience metabolic ‘rush hours’ twice a day (138). To 
test this hypothesis, we temperature-entrained T. brucei cultures and collected 
cells throughout the day to measure intracellular ATP concentrations. We found 
that ATP content was higher at ZT/CT8 and ZT/CT20, which coincided with the 
time at which metabolic genes present the highest transcript levels (Fig. 4C).  
From the pathway analysis we also identified some cycling genes 
involved in redox metabolism (metabolism of other amino acids – glutathione 
pathway, Fig. 4B and S18). To test if such gene expression oscillations lead to 
different levels of sensitivity to oxidative stress throughout the day, we 
temperature-entrained bloodstream forms and, starting every 4 h through the 
day we incubated parasites with H2O2 for 1 h and measured their viability. We 
observed a time-dependent sensitivity to H2O2 treatment, which was 2.5-fold 
higher at ZT4 than at ZT16 (p < 0.001, Fig. 4D and fig. S18). These results 
confirm that circadian metabolic gene expression patterns have functional 
consequences to the overall metabolic and redox state of the parasite. 
Because parasites display a different transcriptome at different times of 
the day, we wondered whether this would affect the sensitivity of the parasite to 
suramin, a drug commonly used in the field. Similar to the oxidative stress 
experiment, we temperature-entrained parasites and beginning every 4 h 
through the day we tested cell viability upon a 24 h in vitro treatment with 
suramin. We observed that the parasites are more resistant to suramin 
treatment beginning at ZT8, which is reflected in a higher IC50 (p < 0.001), as 
2.5-fold higher drug concentration is needed to kill these parasites (Fig. 4E and 
S19). Thus, we conclude that during the day parasites are not equally sensitive 
to suramin treatment. 
Various studies in pathogens (149-153) and microbiota (154, 155) have 
described daily rhythms in microorganisms living inside hosts. However in these 
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experiments it was not established whether such behavior was endogenously 
controlled by the pathogen, or whether rhythms were imposed by the host. 
Indeed in recent microbiome experiments, the 24-hour variations in the 
microbiome appear to be driven by the host and by its feeding regime (154, 
155). In contrast, our results show that T. brucei has an intrinsic mechanism to 
count time, which results in a circadian oscillating transcriptome. This clock 
imposes cyclic changes in the parasite population with a 24 h period, primarily 
at the metabolic level. As a result, upon environment entrainment in vitro, 
parasites in the morning are different from those in the evening, which is likely 
an important adaptation since in vivo their host environment (mammal or insect) 
also undergoes circadian changes (230, 231). This study demonstrates the 
potential of high-throughput approaches for identifying circadian patterns in the 
transcriptome of non-model organisms and it provides a foundation for the 
search of the master regulators of this process in T. brucei and for the search 
for endogenous clocks in other important infectious agents such as the malaria 
parasite. 
 
3.3. Experimental Procedures 
 
Ethics Statement 
All animal care and experimental procedures were performed in accordance 
with University of Texas Southwestern Medical Center (UTSW) IACUC 
guidelines, approved by the Ethical Review Committee at the University of 
Southwestern Medical Center and performed under the IACUC-2012-0012 
protocol.  
 
Parasites and Culture Conditions 
T. brucei AnTat 1.1E, a pleomorphic clone, derived from an EATRO1125 clone 
was originally isolated from blood of Tragelaphus scriptus in Uganda. For all the 
experiments, we used AnTat 1.1E 90-13, a transgenic cell-line encoding the 
tetracyclin repressor and T7 RNA polymerase (190). 
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Bloodstream forms were grown routinely in HMI-11 at 37°C in 5% CO2 (232). 
For all RNA-seq experiments individual cultures of parasites were prepared, 
adjusting the initial parasite density so that parasite cultures would be at 106 
parasites/mL at each collection time point. Parasite numbers were calculated 
using a Hemocytometer. Samples were collected every 4 h throughout two 
consecutive days. For the bloodstream forms - Temperature RNA-seq 
experiment, culture flasks were moved every 12 h between incubators either at 
32°C or 37°C or remained at constant 37°C. In the bloodstream forms - 
Light/Dark entrainment RNA-seq experiment, a warm white LED 3W lamp was 
used to illuminate the cultures inside the incubator. Temperature was kept at 
37°C and fluctuations were monitored and shown to be less than 0.1°C.  
Differentiation of bloodstream forms to procyclic forms was induced by adding 
6  mM cis-acconitate to DTM medium and by reducing temperature to 28°C. The 
newly differentiated procyclic cultures were maintained as described previously 
(233). Differentiation was assessed by EP Procyclin expression, using anti-
Trypanosoma brucei Procyclin, FITC mouse IgG1 (Cedarlane Labs). For the 
procyclic form RNA-seq experiment, culture flasks were moved every 12 h 
between incubators either at 23°C or 28°C or remained at constant 28°C. 
 
Transcriptome Sequencing (RNA-seq) 
RNA was isolated from 107 Trypanosoma brucei cells with TRIzol reagent 
according to the manufacturer’s instructions (Life Technologies). 1 µg of total 
RNA was enriched for mRNA using Poly-A beads for RNA-seq according to the 
manufacturer’s instructions (Invitrogen). The removal of ribosomal RNAs was 
confirmed on a Bioanalyzer Nano Chip (Agilent Technologies). Sequencing 
libraries were constructed using TruSeq RNA Sample preparation protocol 
(Illumina). RNA-sequencing of libraries was performed in HiSeq2000 platform 
(Illumina) with 50-bp reads according to manufacturer’s instructions by the 
UTSW McDermott Next Generation Sequencing Core and Beijing Genomics 
Institute (BGI). Read quality was assessed using the FASTQC quality control 
tool (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The SolexaQA 
suite of programs (234) was used to trim raw reads to their longest contiguous 
segment above a PHRED quality threshold of 28, and reads smaller than 25 
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nucleotides long were discarded. Reads were mapped to the T. brucei 
TREU927 reference genome using bowtie (v1.0.0) (235) allowing for 2 
mismatches and only non-ambiguous alignments (options –v 2 –m 1). The 
number of reads mapping to each gene was determined, and then normalized 
to RPKM (excluding a highly expressed VSG gene from the calculation) using 
the R software environment and the packages GenomicAlignments (236), 
Biostrings (237) and rtracklayer (238) from Bioconductor.  
 
Time Series Analysis for Circadian Cycling 
In figure S2, hierarchical clustering analysis was performed and heatmaps of 
Spearman correlations from centered log2 transformed RPKM values were 
done in the R software environment using the function heatmap.2 from the 
gplots package (239). Principal component analysis (PCA) was done on 
centered and log2 transformed RPKM values using the function princomp. 
RNA cycling was assessed by three programs: GeneCycle (240), that 
implements Fisher’s G-Test, JTK_CYCLE (241) and ARSER (242). For Fisher’s 
G-Test and JTK_CYCLE analyses, RPKM data was detrended by linear 
regression. A gene was considered cycling if two out of three programs 
detected periodic expression with threshold of p ≤ 0.05 and mean expression 
higher than 10 RPKM. This cutoff was defined by assessing the coefficient of 
variation in relation to the mean expression across all time points. The 
amplitude, period and phase reported by ARSER were used for further analysis. 
The heatmaps of phases in figure 2A and 2D plot the z-score transformed 
RPKM values, ordered by the phase determined by ARSER. The peaks of 
expression phase distributions were determined by fitting a mixed von Mises-
Fisher model to the bimodal phase distributions using the R software 
environment and the movMF package (243), extracting the means of the two 
von Mises-Fisher distributions. 
To determine the false discovery rate (FDR) of identification of cycling genes 
the time point of collection were randomized and number of cycling genes 
assessed. These permutation tests were run 10,000 times.  
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Chromosome Distribution of Cycling Genes 
Uniform distribution of cycling genes among PCUs was tested by comparing the 
distribution of proportions of cycling/non-cycling genes per PCU with a 
distribution obtained by randomly sampling 10,000 times the same number of 
genes from the genome. To test if cycling genes displayed a bias in their 
positioning within PCUs, the distance of each gene to its nearest upstream 
transcription start site (TSS) was calculated and then the distributions of these 
distances for cycling genes only and for all genes were compared. In order to 
test if cycling genes within a PCU tend to peak at the same phase, the 
distribution of proportions of each phase cluster within PCUs with a random 
distribution obtained by randomly permuting the cluster assignment of cycling 
genes 10,000 times were compared. For these three analyses significance was 
assessed by a Kolmogorov-Smirnov test. 
 
5’ and 3’UTR length, GC content and Motif identification 
Cycling genes were clustered according to their phase of oscillation. 4 hour 
clusters were centered at the peaks of the bimodal phase distribution and 
expanded if the consecutive cluster had at least 100 genes. 5’ and 3’UTR 
sequences were obtained based on the T. brucei TREU 927 annotation 
obtained from TriTrypDB (v8.0). Those sequences were used to compare the 5’ 
and 3’UTR sequence length and GC content of genes assigned to each cluster 
with the set of non–cycling genes. Significance was assessed with Wilcoxon 
rank sum test. 
For motif identification, annotated UTR sequences less than 25 nucleotides 
(nts) long were discarded, and sequences longer than 1000 nts were trimmed 
to the first 1000 nts. Six motif discovery programs (Weeder2 (244), Trawler 
(245), DREME (246), MEME (247), FIRE (248) and XXmotif (249)) were used to 
identify motifs enriched in the 5’ and 3’UTR region of cycling genes from each 
phase cluster. Because some programs elicit many motifs that are highly similar 
to each other, the motifs elicited by all programs were compared to each other 
(by computing the Euclidean distance between each pair of motifs) and 
clustered using hierarchical clustering with a distance threshold of 0.25. For 
further analysis, a representative motif was chosen from each cluster by 
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selecting the motif with the highest total information content. These 
representative motifs were mapped back to the 3’UTR sequences of all genes 
using FIMO (250) with a threshold p value of 1 x 10-4. Motif enrichment in each 
cluster group was assessed using Fisher’s Exact Test. The number of motifs 
identified in the cycling genes was compared with the number of motifs 
identified from 25 experiments in which we randomly selected the genes from 
the entire gene set. 
To determine the preferred location of occurrence of enriched motifs, FIMO was 
used to map the motifs to the flanking 1000 nts upstream and downstream of all 
annotated coding sequences (CDSs), and for each motif, the number of 
matches inside and outside the UTR region was quantified. A motif was 
considered specific to UTR sequences if it occurred more frequently inside the 
UTR region than expected based on the annotated UTR lengths (binomial test; 
p < 0.01). 
To evaluate the conservation of enriched motifs, the genome references of 5 
species closely related to T. brucei (Leishmania major, T. b. gambiense, T. 
cruzi, T. congolense, T. vivax) were obtained from TriTrypDB, and 
representative UTR sequences of orthologous genes were extracted (100 nts 
and 400 nts for 5’ and 3’ UTRs respectively). FIMO was used to match the 
motifs to these UTR sequences. For each T. brucei UTR containing a given 
motif, the presence or absence of that motif in the UTRs of the annotated 
orthologs of that gene was determined, and the motif was considered 
“conserved” in that UTR if it also appears in at least one ortholog UTR 
sequence. The hypothesis that motifs identified from circadian genes are more 
conserved than motifs identified from random groups of genes was tested with 
Wilcoxon Rank Sum test. 
 
Mice Infection and Real-Time Quantitative PCR Analysis 
The infections of wild-type male C57BL/6J mice, 6-10 week old (UT 
Southwestern Medical Center Mouse Breeding Core Facility) described in this 
manuscript were performed by intraperitoneal (i.p.) injection of 2,000 T. brucei 
AnTat 1.1E parasites. Prior to infection, T. brucei cryostabilates were thawed 
and parasite viability and numbers were assessed by mobility under a 
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microscope. Mice were individually housed in activity wheel-equipped cages 
under LD 12:12 for 7 days after which animals were kept in dark conditions. 
Chow and water were available ad libitum. Locomotor activity was recorded and 
analyzed using ClockLab software (Actimetrics, Wilmette, IL) to determine the 
circadian phase, as previously described (203), for each animal on day 20 post-
infection. Blood was sampled by cardiac puncture and RNA extracted with 
TRIzol LS according to the manufacturer’s instructions (Life Technologies). 
Reverse transcription and real-time PCR were performed as described 
previously (216). Primer efficiencies were determined using standard curves 
with 3-log10 coverage. Transcript levels were normalized to genes whose 
expression remained constant in both temperature and light alternating 
conditions. Primer sequences are listed in table S2.  
 
Assessment of Metabolic Activity and Cell Cycle Stage 
Bloodstream form parasites were cultured and entrained by temperature as 
described above for the RNA-seq experiment. Samples were collected every 4 
h throughout the day.  
For metabolic activity assessment, parasitemia was assessed and metabolic 
activity was measured according to the manufacturer’s instructions of CellTiter-
Glo® Luminescent Cell Viability Assay (Promega) from 1 x 105 parasites 
centrifuged and resuspended in 25µl trypanosome dilution buffer (TDB, 5 mM 
KCl, 80 mM NaCl, 1 mM MgSO4, 20mM Na2HPO4, 2 mM NaH2PO4, 20 mM 
glucose, pH 7.7). 
For cell cycle analysis, 2 x 106 parasites were fixed by slowly adding ethanol to 
a final concentration of 70%. Fixed trypanosomes were pelleted and stained 
with 0.5 mL in PBS / 2 mM EDTA containing 10 µg RNAse A and 1 mg 
propidium iodide for 30 min at 37°C. Intensity of red fluorescence was 
measured using a FACSCalibur flow cytometer (BD Biosciences) and data were 
analyzed using FlowJo.  
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Functional analysis of cycling genes 
Cycling genes identified by RNA-seq were clustered in 12 groups (CT0-CT2, 
CT2-CT4, etc.) based on their expression peak. T. brucei GO term annotations 
were obtained from TriTrypDB. GO term enrichment was assessed in each 
group by Hypergeometric test using GOstats (251) and by Fisher’s Exact Test 
and plotted as heatmap in figure 4A. Manually curated GO term was defined 
when both statistical tests show enrichment (p < 0.05) and more than 3 genes 
annotated to a GO term were cycling with the determined phase (see table S5 
and S6). 
 
Suramin and H2O2 sensitivity assay 
Bloodstream form parasites were cultured and entrained by temperature as 
described above for the RNA-seq experiment. Every 4 h, parasites were 
harvested from exponential phase cultures, counted and plated in 96 well flat-
bottom microtiter plates at a cell density of 10,000–20,000 cells/well. Serial 
dilution concentrations (1:3) of suramin (Sigma) were added. The compound 
was applied in triplicate at eight concentrations and incubated for 24 h at 37°C. 
For the oxidative stress experiment, H2O2 (Sigma) at six different dilutions were 
tested (1:10) and parasites were incubated for one hour at 37°C. Alamar Blue 
(Sigma) was used to determine cell viability by adding at ten percent of the well 
volume followed by 4h incubation at 37°C. Fluorescence was measured with 
530ex/590em nm and percentage of live cells calculated by normalizing to non 
treated parasites. Calculation of IC50 values was done by 4-parameter nonlinear 
curve fit (GraphPad Prism). H2O2 sensitivity was tested in two independent 
experiments from a total of six biological replicates. Suramin resistance was 
tested in three independent experiments and IC50 values are shown as the 
mean of those experiments (N = 9). 
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3.4. Supplementary figures 
 
Fig. S1. Experimental design for RNA-seq experiments. Parasites were cultured in 
individual flasks and their density was calculated to reach 1 x 106 at each collection 
time point. (A) Bloodstream parasites were synchronized either with temperature or 
light. (B) Insect procyclic parasites were synchronized with temperature only. 
Synchronizations were done for three days in alternating temperature or light 
conditions. At the end of day three (72 h), culture flasks were split into alternating or 
constant conditions groups. RNA samples were collected for two days (a total of 13 
samples per condition, with the second cycle acting as biological replicate).  
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Fig. S2.Unbiased assessment of cycling gene expression patterns. Clustered 
heatmap of sample correlations and PCA from (A) bloodstream temperature-entrained, 
(B) insect procyclic temperature-entrained and (C) bloodstream light-entrained 
datasets. Cyclic component of the PCA is identified as a solid line, in the same color as 
the dashed line of its fitted cosine curve. 
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Fig. S3. Venn diagram of the number of cycling genes identified by each 
algorithm (ARSER, JTK_CYCLE and Fisher’s G-Test, p < 0.05). 
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Fig. S4. Number of cycling genes identified by each algorithm or in two algorithms in 
the correct sampling order (colored bars) and the distribution of the number of cycling 
genes identified by permutating 10,000 times the time point order of sample collection 
(violin plots). Median and quartiles are represented inside the violin plots in black and * 
represents statically significance between the number of cycling genes in the real order 
and permutated order at FDR < 0.05, ** represents FDR < 0.01 and *** represents 
FDR < 0.001. 
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Fig. S5. Top 25 most significant cycling genes of temperature-entrained 
bloodstream forms in alternating and constant conditions. Order defined by 
ARSER p value. Black line represents the raw RPKM, teal represents JTK_CYCLE fit, 
gray represents ARSER fit and orange represents Fisher’s G-Test fit. 
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Fig. S6. Top 25 most significant cycling genes of temperature-entrained insect 
procyclic forms in alternating and constant conditions. Order defined by ARSER p 
value. Black line represents the raw RPKM, teal represents JTK_CYCLE fit, gray 
represents ARSER fit and orange represents Fisher’s G-Test fit. 
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Fig. S7. Top 25 most significant cycling genes of light-entrained bloodstream 
forms in alternating and constant conditions. Order defined by ARSER p value. 
Black line represents the raw RPKM, teal represents JTK_CYCLE fit, gray represents 
ARSER fit and orange represents Fisher’s G-Test fit. 
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Fig. S8. The correlation plots of circadian parameters phase and amplitude between 
constant and alternating conditions show that most cycling genes maintain their 
circadian characteristics in both conditions. (A) bloodstream temperature-entrained, (B) 
insect-stage temperature-entrained and (C) bloodstream light-entrained datasets. 
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Fig. S9. Venn diagram of the intersection of endogenous cycling genes from 
different RNA-seq datasets. (A) Samples collected in constant conditions after 
entrainment to temperature in bloodstream (rose) or insect procyclic-forms (teal). (B) 
Samples collected in constant conditions after entrainment to temperature or light 
(gray) in bloodstream forms. (C) Samples collected in constant conditions after 
entrainment to temperature (bloodstream and procyclic forms) or light (bloodstream 
forms). 
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Fig. S10. Transcript levels oscillate in parasites isolated from blood of infected 
mice. Upper panel represents endogenous cycling gene expression from culture of 
temperature-entrained bloodstream form parasites, detected by RNA-seq. Bottom 
panel represents the in vivo expression profile of the same genes. Represented genes 
are Tb927.9.12320 (cystathionine gamma lyase, putative), Tb927.9.11580 (glycosomal 
membrane protein, gim5a), Tb927.5.900 (oligosaccharyl transferase subunit, putative), 
Tb927.1.4830 (phospholipase A1), Tb927.8.7740 (aminoacid transporter, putative) and 
Tb927.11.2690 (succinyl-coA:3-ketoacid-coenzyme A transferase, putative). Cycling 
genes expression levels were normalized to non-cycling genes zinc finger protein 3 
(ZFP3, Tb927.3.720, green) or to a putative acidic phosphatase (Tb927.5.610, dark 
green). N = 18 (3 mice/time point). Gim5A is the example of a transcript for which in 
vitro RNA-Seq and in vivo qPCR have opposite phases. 
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Fig. S11. Bloodstream form clock driven genes are distributed randomly across 
the genome (continuation of figure 3A).  Individual chromosomes are represented with 
polycistronic units (PCUs) marked by its Transcription start site (TSS) in black line. 
Genes are either gray when non-cycling, orange when cycling with maximal expression 
between CT3-CT18 and teal when cycling with maximal expression between CT19-
CT2. 
 
 
 
 
Fig. S12. Insect procyclic clock driven genes are distributed randomly across the 
genome (continuation of figure 3B). Individual chromosomes are represented with 
Polycistronic units (PCUs) marked by its Transcription start site (TSS) in black line. 
Genes are either gray when non-cycling, teal when cycling with maximal expression 
between CT10-CT19 and orange when cycling with maximal expression between 
CT18-CT9. 
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Fig. S13. Gene expression profile of genes belonging to the same polycistronic 
unit. Representative polycistronic units (PCUs) from each chromosome are 
shown (continuation of figure 3C and 3D). For the bloodstream forms, teal represents 
RPKM levels of cycling genes with maximal expression between CT19-CT2 and 
orange when cycling with maximal expression between CT3-CT18. For the insect 
procyclic forms, teal represents genes with maximal expression levels between CT10-
CT19 and orange for genes with maximal expression between CT18-CT9. 
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Fig. S14. Untranslated regions (UTRs) of cycling genes in T. brucei (A) 
bloodstream and insect procyclic forms. Cycling genes from two phase clusters 
were defined by centering at the phase mean of the cluster ± 2h, which was expanded 
if the consecutive cluster had more than 100 genes. (B) 5’UTR and (C) 3’UTR 
sequences length, GC content and mean expression were compared with non-cycling 
genes (Group 0). Both clusters of cycling genes groups were pooled (red) to compare 
with non-cycling genes (NonCyc, gray). * in the x axis label following the group number 
indicates mean of cycling genes is significantly different from mean of non-cycling 
genes, p < 0.05, Wilcoxon test. 
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Fig. S15. Enriched motifs identified in (A-B) bloodstream and (C-D) procyclic UTR 
sequences using six different motif finder algorithms. Results in red represent the 
number of enriched motifs identified in the UTRs of cycling genes and the gray 
represents the distribution of the motifs identified when the genes in each cluster 
assignment were randomly selected 25 times (FDR < 0.05). In the bottom panel are 
representative sequence logos of two top putative cis-regulatory elements (pCREs) 
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enriched in the UTRs of cycling genes. (E) Percentage of orthologous genes that 
contain the conserved motif in the UTR. Red represents the percentage of all motifs 
identified in the UTR of cycling genes, and gray represents the conservation of motifs 
found in 25 random groups of genes (F) Global conservation of T. brucei motifs relative 
to five other kinetoplastida species. Motifs identified in cycling genes (red) are more 
conserved than motifs identified in randomly selected genes (gray). P values are 
annotated on the plot title. 
 
 
Fig. S16. Circadian gene expression is not correlated with cell cycle stage. (A) 
Gating strategy to identify frequency of live single parasites in each cell cycle stage 
(G1, S and G2/M phase) based on DNA content profile. (B) Parasite growth curve in 
different culture conditions and calculated doubling times. N = 6, Šídák multiple 
comparison of the means. 
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Fig. S17. Eleven genes of the glycolytic pathway cycle through the day, three have 
maximum expression close to phase CT0 (green) and eight have their maximum 
expression closer to CT24 (red). 
Post-transcriptional circadian regulation of gene expression in T. brucei 
 
 
 
146
 
Fig. S18. Parasite sensitivity to oxidative stress changes throughout the day. (A) 
Glutathione pathway has multiple genes whose mRNA is cycling (colored red or 
green). Color gradient represents phase of maximum gene expression from CT0 
(green) to CT24 (red). (B) Percentage of live cells collected around the clock and 
treated with serial dilution of H2O2 concentrations. p < 0.0001 non linear regression 
(variable slope, four parameters) comparison shows LogIC50 is different between data 
sets. 
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Fig. S19. Parasite sensitivity to suramin drug treatment changes throughout the 
day. Percentage of live cells collected around the clock and treated with serial dilution 
of suramin concentrations. p < 0.0001 non linear regression (variable slope, four 
parameters) comparison shows LogIC50 is different between data sets. Error bars 
represent standard error. N = 9 biological replicates tested in three independent 
experiments. 
 
 
 
Table S1. 
Cell cycle associated genes are not enriched among the clock-regulated gene 
pool. 
 
Life cycle 
stage Synchronization 
Condition 
during 
collection 
Number 
genes 
Number 
of cell 
cycle 
genes 
Proportion p value 
Bloodstream 
Temperature 
32/37°C 1490 117 0.0599 0.2702 
37°C 1092 44 0.0504 0.7815 
Light 
LD 366 16 0.0734 0.0957 
DD 242 19 0.0547 1.0000 
Insect-stage Temperature 
32/37°C 1123 82 0.0595 0.3723 
37°C 854 43 0.0646 0.1519 
Bloodstream - - 9499 530 # 0.0528 - 
 
 
# cell cycle genes identified in 
Archer et al.  
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Table S2. 
Primer sequences used for real-time PCR 
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CHAPTER III – General discussion and future directions 
 
1. Main findings 
 
  
The main findings of this thesis are summarized below: 
 
T. brucei parasites adapt to adipose tissue 
• Later in infection the adipose tissue is the host tissue with highest parasite load. 
• T. brucei adapts to the lipid-rich environment of adipose tissue by remodeling its 
gene expression. 
• In the adipose tissue T. brucei activates the beta-oxidation of fatty acids as 
carbon source. 
 
T. brucei accelerates the circadian clock of its host 
• T. brucei deregulates the daily locomotor activity and body temperature of its 
mouse host. 
• Since early in infection the daily locomotor activity period is shortened by the 
infection. 
• Organs with higher parasite load – adipose tissue – show a short period of 
PER2 expression, which can be rescued with suramin treatment. 
• Later in infection, PER2 expression period in SCN is shorter than in controls, 
coinciding with the period when disruption of daily locomotor activity and 
temperature are observed. 
• Plasmodium chabaudi infection does not interfere with the period of clock 
genes. 
• In vitro, in the absence of immune cells, T. brucei shortens the period of 
fibroblasts. 
 
T. brucei parasites have an endogenous circadian clock 
• 10% of T. brucei gene expression oscillates daily. 
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• The daily gene expression oscillation is temperature compensated and cell 
cycle independent. 
• In T. brucei the circadian regulation of gene expression is post-transcriptional. 
• Most of the genes whose expression cycles are related to metabolic pathways. 
• During the day T. brucei population experiences two ‘rush hours’ of gene 
expression, which correlates with higher ATP production. 
• Parasites are more resistant to oxidative stress during the morning. 
• During the day, there is a window when parasites are more susceptible to 
suramin treatment. 
 
 
2. Discussion and potential future approaches   
 
Extensive research and efforts to understand Trypanosoma brucei 
infection have been made, which have led to significant understanding of the 
process of antigenic variation, the parasite life cycle, as well as the parasite 
distribution in the mammalian host. However, with this thesis I hope I have 
emphasized that many aspects of this infection remain a mystery, even among 
the themes in which more work has been done.  
 What causes the symptoms in sleeping sickness patients? Why are there 
so many different manifestations: from sleep/wake cycle disruption and mood 
alterations, to weight loss? These are the aspects of this disease that have 
been lacking more attention due to their complexity. For my Ph.D. project I was 
particularly intrigued by the circadian features of this infection. I hope these 
projects have, even if humbly, contributed to a better understanding of it, and 
that they will serve as a foundation for future and more detailed studies. 
 
Why do parasites occupy the adipose tissue? 
 The surprising observation of the adipose tissue as a major parasite 
reservoir raises many questions: Why do the parasites infiltrate preferentially 
this tissue? Is it to access the lipids it needs? Is it to hide from the massive 
antibody response in the blood circulation? If so, is immune response less 
effective against this parasite in this particular tissue versus others? Does the 
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parasite always need to infiltrate the host adipose tissue in order to progress in 
its life cycle? Perhaps it is going to turn out to be a combination of multiple 
factors, but with the high numbers of infiltrated parasites observed in this tissue 
and the metabolic changes it undergoes, it seems unlikely that the parasite is 
there just by chance. 
 In order to test if the upregulated pathway of beta-oxidation of fatty acids 
is indeed crucial for the parasite presence in the adipose tissue, or for the 
general fate of the infection, it would be interesting to knock out genes in this 
pathway and compare the parasitemia, the parasite distribution and host 
survival upon infection with beta-oxidation deficient parasites. 
T. brucei invades the brain parenchyma through a mechanism of 
diapedesis, which seems to be in part dependent on IFN-γ, since IFN-γ-/- and 
IFN-γ receptor -/- mice have fewer parasites in the brain. This process of 
diapedesis is how inflammatory cells cross from the bloodstream to the tissues. 
Therefore it would be interesting to test whether IFN-γ-/- and IFN-γ receptor -/- 
mice have also fewer parasites in adipose tissue. It would be an approach to 
assess if crossing the vessels to the adipose tissue involve, at least in part, a 
similar process to crossing the blood vessels to the brain.  
 
Why would parasites disrupt the host circadian clock? 
T. brucei infection disrupts the circadian rhythm of its host. Why would 
such consequence be evolutionarily advantageous for the parasite? It seems 
plausible to assume that sleepiness during daytime increases the chances of 
trypanosomes to be transmitted to the insect. Tsetse flies are pool feeders, i.e. 
they cut the skin and suck up blood from the respective lesion. This bite is 
rather painful and sufficient feeding takes time. Humans can reach any part of 
the body with their hands therefore feeding would be more effective if the 
person does not react. Plus, tsetse flies are diurnal feeder and attracted to 
movement, so a disease in which the person is relatively active, with little 
sudden naps during the day, seems an optimal scenario for the fly blood meal. 
On the contrary, we could assume that the disruption of the sleep/wake cycle is 
not the most advantageous circadian disruption the parasite induces. The 
circadian clock regulates multiple physiological and metabolic functions in the 
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body, including immune response. The deregulation of the host clock might 
mean a deregulation of the very sophisticated and well-orchestrated immune 
response to pathogens, which would lead to a rather easier evasion to this 
response by the parasite. Finally we could assume the deregulation of the host 
metabolism is advantageous for the parasite. This parasite divides every 7 
hours and therefore the need for nutrients is demanding. The deregulation of 
the circadian metabolism of the host, including the potential deregulation of its 
feeding behavior would provide more frequent abundance of nutrients, rather 
than only once a day.  
It would be interesting to test these last two possibilities, if immune 
response and metabolism are dramatically affected in T. brucei-infected mice. I 
would start by collecting both blood and adipose tissue of control and infected 
mice during 48 h and extract RNA for RNAseq. With this we could analyze the 
circadian parameters of immune and metabolic functions among the two mice 
groups. 
 
Interestingly, with our studies we provided insights of the potential 
specific changes T. brucei has on circadian clock of the host: a period 
shortening. This detailed characterization has not been studied in humans, 
however is curious to correlated with the indirect observations made. Pineal 
hormone melatonin, which is the hormone that anticipates the daily onset of 
darkness, is maintained in sleeping sickness patients in the encephalitic stage, 
although it is still cycling, it is being secreted rather earlier than expected 
(phase advanced) (40). Phase advance means the peak of the expression of 
melatonin is happening earlier, which is also what we observe in the expression 
of PER2 protein. Since our approach allows measuring continuously PER2 
expression and without the interference of external stimuli, we uncovered that 
this phase advance in PER2 expression coincided with a shorter period in mice. 
Do melatonin levels also peak earlier in the mouse model? Perhaps this 
melatonin phase adavance indicates that in humans there is also a shortening 
of the host period upon infection. This would be complicated but interesting to 
address in patients, by isolating them from external cues. 
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The hypothesis of sleeping sickness being a circadian disorder has been 
previously considered. In fact Lundkvist et al. tested this hypothesis in the rat 
model of sleeping sickness. They also reported a shorter Per1 expression 
period of the pituitary gland of infected rats, although they were not able to 
detect any period changes in the SCN, nor disruption of the circadian locomotor 
activity and temperature (252). The difference in findings between our studies is 
likely due to the rodent model used. The rat model of sleeping sickness has a 
high variability, probably associated with the fact that Wistar rats are outbred, 
i.e. bred from parents not closely related. This leads to high variability among 
rats, which is clear when assessing their survival to T. brucei infection, which 
happens on average 15.3 ± 12.4 days post-infection, with death occurring 
between the tenth and forty-sixth days of infection (253). In addition their study 
of locomotor activity and temperature was assessed in light/dark conditions. 
When we assessed those parameters in LD, we also did not detect changes 
between infected and control mice early after infection, other than reduced 
activity. Only when we used the infection protocol that better mimicks the low 
parasitemia and chronic infection observed in humans (by treating mice with 
suramin) we were able to uncover the disruption of the timing at which both 
locomotor activity and higher body temperature occur. Possibly these circadian 
disruptions in LD require a more chronic infection in order to emerge.  
 
T. brucei parasites also count the time 
 Trypanosoma brucei turned out to be an ideal system to test whether 
parasites have intrinsic circadian rhythms: it is extracellular, more than one life 
cycle stage can be cultured, the cell cycle is different from 24 h and its genome 
fully sequenced. The first two features, being extracellular and cultured allowed 
us to exclude any possible effect from the host on this timekeeping time. All the 
circadian oscillations have to be driven by the parasite itself.  
 
43% of all protein coding genes showed circadian rhythms in 
transcription somewhere in the body, largely in an organ-specific manner (138). 
Even, when considering individual tissues the number of cycling genes is 
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substantial, with approximately ~20% of genes cycling in the liver and the SCN 
(Table 1).  
In our study we found that ~10% of the transcriptome of T. brucei was 
oscillating daily, but the amplitude of such oscillations are not as high as in the 
liver: ~2.5-fold in liver versus ~1.3-fold in T. brucei. This could possibly be due, 
to some extent, to asynchrony among the parasite population (which would 
dilute the maximum and minimum expression levels). Perhaps the temperature 
entrainment we performed in vitro is not sufficient to fully synchronize all 
parasites in culture. 
This might be also the reason why the number of cycling genes in 
immortalized cell lines, of both humans and mice, are extremely low (0.1-1.2%), 
and those that cycle, do so with very low amplitude. 
 
 
Table 1. Summary of the percentage of cycling genes identified by RNA 
sequencing or microarray in different species and organs. 
Species Tissue Method 
% cycling 
transcripts 
Reference 
Mouse 
Liver 
RNAseq 
RNAseq 
microarray 
22% 
15% 
16% 
(137) 
(138) 
(254) 
Hypothalamus RNAseq 2.9% (138) 
SCN RNAseq 24% (255) 
Macrophages RNAseq 8.1% (140) 
Mouse cell line NIH3T3 microarray 0.1% (254) 
Human Blood RNAseq 6.4% (256) 
Human cell line U2OS cells 
RNAseq 
microarray 
1.2% 
0.1% 
(257) 
(254) 
Chlamydomonas 
reinhardtii 
Whole 
photosynthetic 
algae 
RNAseq 50% (258) 
T. brucei Whole parasite RNAseq 10% 
Present 
thesis 
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 Based on these previous observations, 10% of cycling gene expression 
in vitro is high, and this could anticipate that both number of cycling genes and 
their amplitude would increase if we measure the T. brucei transcriptome in 
vivo. It would be interesting to do a circadian analysis of the in vivo 
transcriptome in both mammalian tissues (particularly adipose tissue and brain) 
and in the tsetse fly. 
 
 One approach we are attempting to follow up with this project is the 
development of a circadian transcriptional reporter cell line for the parasite. This 
means cloning the 3’UTR of a gene whose expression is cycling fused to Firefly 
Luciferase, which would allow us to measure in the lumicycle (real-time 
luminescence measurement) the expression of this gene. This tool will allow 
multiple further characterizations, such as what are the stimuli T. brucei entrains 
to: serum, glucose, lipids etc. Furthermore, this tool would allow us to easily test 
whether some genes are essential, or at least impact the circadian clock once 
mutated / knocked out. Since the parasite circadian transcriptome appears to 
be regulated at the post-transcriptional level, good candidates for T. brucei 
clock genes would be RNA binding proteins and/or potentially non-coding 
RNAs. 
 Once circadian mutants have been identified the next exciting 
experiment would be to assess if these mutants are viable and able to establish 
infection in mouse. In case they are viable, further analyses would be to test 
assess parasitemia profile, progression in the parasite’s life cycle, mouse 
survival and ultimately whether these parasites still lead to the circadian 
manifestations in the mouse model. Since the circadian clock genes across 
species are so little conserved, it seems plausible that once T. brucei clock 
genes are identified, and if their mutation leads to impaired infection, they could 
be potential new drug targets to treat this disease. 
 
This study also begs for the study of potential circadian rhythms in gene 
expression and other outputs in other pathogens, which are possibly not only 
restricted to parasites. 
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As little Annie would say: 
 
 
‘The sun will come out tomorrow 
So you gotta hang on 
‘till tomorrow, come what may! 
Tomorrow, tomorrow, I love ya, tomorrow 
You’re only a day away’ 
 
 
 
 
Graffiti at Deep Ellum, Dallas, TX by @Joeskilz52  
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Smith, Luisa M. Figueiredo 2016. Trypanosoma brucei parasites occupy and 
functionally adapt to adipose tissue in mice. Cell Host&Microbe (in press) 
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Takahashi# 2016. Trypanosoma brucei infection accelerates the mouse 
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